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A B S T R A C T
Background
People with abdominal aortic aneurysm who receive endovascular aneurysm repair (EVAR) need lifetime surveillance to detect potential
endoleaks. Endoleak is defined as persistent blood flow within the aneurysm sac following EVAR. Computed tomography (CT)
angiography is considered the reference standard for endoleak surveillance. Colour duplex ultrasound (CDUS) and contrast-enhanced
CDUS (CE-CDUS) are less invasive but considered less accurate than CT.
Objectives
To determine the diagnostic accuracy of colour duplex ultrasound (CDUS) and contrast-enhanced-colour duplex ultrasound (CE-
CDUS) in terms of sensitivity and specificity for endoleak detection after endoluminal abdominal aortic aneurysm repair (EVAR).
Search methods
We searched MEDLINE, Embase, LILACS, ISI Conference Proceedings, Zetoc, and trial registries in June 2016 without language
restrictions and without use of filters to maximize sensitivity.
Selection criteria
Any cross-sectional diagnostic study evaluating participants who received EVAR by both ultrasound (with or without contrast) and
CT scan assessed at regular intervals.
Data collection and analysis
Two pairs of review authors independently extracted data and assessed quality of included studies using the QUADAS 1 tool. A third
review author resolved discrepancies. The unit of analysis was number of participants for the primary analysis and number of scans
performed for the secondary analysis. We carried out a meta-analysis to estimate sensitivity and specificity of CDUS or CE-CDUS
using a bivariate model. We analysed each index test separately. As potential sources of heterogeneity, we explored year of publication,
characteristics of included participants (age and gender), direction of the study (retrospective, prospective), country of origin, number
of CDUS operators, and ultrasound manufacturer.
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Main results
We identified 42 primary studies with 4220 participants. Twenty studies provided accuracy data based on the number of individual
participants (seven of which provided data with and without the use of contrast). Sixteen of these studies evaluated the accuracy of
CDUS. These studies were generally of moderate to low quality: only three studies fulfilled all the QUADAS items; in six (40%) of
the studies, the delay between the tests was unclear or longer than four weeks; in eight (50%), the blinding of either the index test or
the reference standard was not clearly reported or was not performed; and in two studies (12%), the interpretation of the reference
standard was not clearly reported. Eleven studies evaluated the accuracy of CE-CDUS. These studies were of better quality than the
CDUS studies: five (45%) studies fulfilled all the QUADAS items; four (36%) did not report clearly the blinding interpretation of the
reference standard; and two (18%) did not clearly report the delay between the two tests.
Based on the bivariate model, the summary estimates for CDUS were 0.82 (95% confidence interval (CI) 0.66 to 0.91) for sensitivity
and 0.93 (95% CI 0.87 to 0.96) for specificity whereas for CE-CDUS the estimates were 0.94 (95% CI 0.85 to 0.98) for sensitivity and
0.95 (95% CI 0.90 to 0.98) for specificity. Regression analysis showed that CE-CDUS was superior to CDUS in terms of sensitivity
(LR Chi2 = 5.08, 1 degree of freedom (df ); P = 0.0242 for model improvement).
Seven studies provided estimates before and after administration of contrast. Sensitivity before contrast was 0.67 (95% CI 0.47 to 0.83)
and after contrast was 0.97 (95% CI 0.92 to 0.99). The improvement in sensitivity with of contrast use was statistically significant (LR
Chi2 = 13.47, 1 df; P = 0.0002 for model improvement).
Regression testing showed evidence of statistically significant effect bias related to year of publication and study quality within individual
participants based CDUS studies. Sensitivity estimates were higher in the studies published before 2006 than the estimates obtained
from studies published in 2006 or later (P < 0.001); and studies judged as low/unclear quality provided higher estimates in sensitivity.
When regression testing was applied to the individual based CE-CDUS studies, none of the items, namely direction of the study design,
quality, and age, were identified as a source of heterogeneity.
Twenty-two studies provided accuracy data based on number of scans performed (of which four provided data with and without the
use of contrast). Analysis of the studies that provided scan based data showed similar results. Summary estimates for CDUS (18 studies)
showed 0.72 (95% CI 0.55 to 0.85) for sensitivity and 0.95 (95% CI 0.90 to 0.96) for specificity whereas summary estimates for CE-
CDUS (eight studies) were 0.91 (95% CI 0.68 to 0.98) for sensitivity and 0.89 (95% CI 0.71 to 0.96) for specificity.
Authors’ conclusions
This review demonstrates that both ultrasound modalities (with or without contrast) showed high specificity. For ruling in endoleaks,
CE-CDUS appears superior to CDUS. In an endoleak surveillance programme CE-CDUS can be introduced as a routine diagnostic
modality followed by CT scan only when the ultrasound is positive to establish the type of endoleak and the subsequent therapeutic
management.
P L A I N L A N G U A G E S U M M A R Y
Ultrasonography versus computed tomography scan for endoleak detection after endoluminal abdominal aortic aneurysm
repair
Background
An abdominal aortic aneurysm (AAA) is a localised swelling or widening of a major vessel that carries blood to the abdomen (tummy),
pelvis, and legs. People with AAA are at risk from sudden death due to AAA rupture (bursting). Once detected, intervention (treatment)
is recommended once the AAA is bigger than about 5 cm in diameter. Most repairs are now performed using a new vessel lining inside
the aneurysm guided by x-ray control (endovascular aneurysm repair or EVAR).
Once the new lining is in place, the seals at either end may leak or vessel branches arising from the aneurysm wall may bleed backwards
into the AAA sac. These are collectively referred to as endoleaks. Endoleaks are common after EVAR, developing in about 40% of people
during monitoring (follow-up). Endoleaks can be associated with late aneurysm rupture and, therefore, detection and monitoring is
essential. Ultrasound (uses high-frequency sound waves), computed tomography (uses x-rays), and magnetic resonance scans (uses
strong magnetic fields and radio waves) have all been used to detect and monitor endoleaks. Sometimes, dye (contrast) is injected into
a vein to improve the accuracy of ultrasound (contrast-enhanced ultrasound).
Study characteristics
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We collected the most recent evidence (to July 2016) and conducted a meta-analysis according to the most appropriate methods for
diagnostic tests. We included 42 studies with 4220 participants in the review.
Key results
The analyses measured sensitivity (how well a test identified people with endoleak correctly) and specificity (how well a test identified
people without endoleak correctly). The summary accuracy estimates were sensitivity 82% (95% confidence interval 66% to 91%) and
specificity 93% (95% confidence interval 87% to 96%) for ultrasonography without contrast; and sensitivity 94% (95% confidence
interval 85% to 98%) and specificity 95% (95% confidence interval 90% to 98%) for ultrasonography with contrast. Use of contrast
improved the sensitivity of ultrasound significantly. Based on these results, we would expect 94% of people with endoleaks will be
correctly identified by contrast-enhanced ultrasound.
Quality of the evidence
Studies that evaluated contrast-enhanced ultrasound used better methods than the studies that evaluated ultrasound alone.
B A C K G R O U N D
Target condition being diagnosed
Abdominal aortic aneurysm (AAA) is a localised dilation (of 3 cm
ormore) of the aorta. The prevalence of AAA increaseswith age and
occurs much more frequently in men than women. The Tromsø
Study, a population-based study with 6386 participants, estimated
an AAA prevalence of 8.9% in men and 2.2% in women (Singh
2001). In addition to gender, the following were strong risk factors
forAAA: smoking, hypertension, hypercholesterolaemia (Forsdahl
2009), and family history (Hemminki 2006; Ogata 2005).
Most aneurysms are asymptomatic and once the AAA diameter
exceeds 5 cm, rupture risk is considered to exceed the operative re-
pair risk and therefore, elective repair is usually offered. The aim of
endoluminal or endovascular abdominal aneurysm repair (EVAR)
is to reach the target site via a remote vessel to deliver the stent, se-
cure endograft fixation, and allow the formation of a haemostatic
seal between the graft and the vessel wall. Several randomised con-
trolled trials have documented the efficacy of EVAR.The anatomic
suitability rate for EVAR varies between 15% (Wilson 2004) and
49% (Kristmundsson 2014) depending on multiple factors, in-
cluding aortic anatomy and size, individual clinical judgement,
and manufacturers’ guidelines (Erbel 2014). Although, there is no
advantage of EVAR in terms of long-term mortality, the applica-
tionEVAR technology is effective in reducing the 30-daymortality
rates, intensive care unit and hospital stay, and other complication
rates (Adriaensen 2002; Brown 2012; Greenhalgh 2004; Prinssen
2004). Two randomised trials confirmed this with six years’ (De
Bruin 2010) and eight’ years follow-up (Greenhalgh 2010). EVAR
is associated with significant long-term complications such as late
conversion to open repair, late rupture, and endoleaks (De Bruin
2010; Greenhalgh 2010; Leurs 2004).
Endoleak is the most common complication of the EVAR pro-
cedure and is characterized by persistent blood flow within the
aneurysm sac. There are different types of endoleak (Table 1).
Type II endoleaks are the most common, caused by back-bleeding
into the aneurysm sac from the lumber, inferior mesenteric, or
other branch arteries. Persistent endoleak may cause enlargement
and rupture of the aneurysm which may become the main indi-
cation for surgical late conversion (Becquemin 1999; Bush 2001;
Hechelhammer 2005; Makaroun 1999; Zarins 2000). Estimates
of the incidence rate of endoleak are highly variable and range from
10% to 50% (Cuypers 1999; Franco 2000; Gilling-Smith 2000;
Golzarian 1997; Gorich 2000; Schurink 1998). This variability
may have different origins including the type of stent used or the
sensitivity of the means used to perform the diagnosis. Moreover,
the rate of complications does not diminish over time (Sampram
2003).
In contrast to open surgery, people with EVAR need lifetime
surveillance with the purpose of controlling graft position and
fixation, monitor aneurysmal sac diameter, and detect endoleak.
Any enlarging aneurysm sac after EVAR can be an indicator of
endoleak and this requires careful investigation. Identification of
endoleak is critical because if left untreated, it can enhance the risk
of aneurysmal rupture due to its progressive enlargement (Harris
2000; Hinchliffe 2001). In two randomised trials, the cumulative
rate of reintervention for people who received EVARwas 30% (De
Bruin 2010; Greenhalgh 2010).While some type II endoleaks can
resolve spontaneously or result in aneurismal stability and shrink-
age (Lawrence-Brown 2009), most endoleak types need conver-
sion to surgical repair or insertion of a new stent or graft. A variety
of other methods to treat or repair endoleaks have been proposed:
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coil embolization, direct thrombin injection of the aneurysm sac,
or direct surgical and laparoscopic ligation (Faries 2003; Rhee
2003).
Index test(s)
Different modalities exist for postoperative surveillance of aortic
endograft including plain film radiograph, computed tomography
(CT) scan, colour duplex ultrasound (CDUS) including contrast-
enhanced CDUS (CE-CDUS), magnetic resonance (MR), and
angiography.
The index test for the present review is ultrasound (US) (either
CDUS or CE-CDUS). US is a widely available instrument used
in clinical practice for endoleak detection in people who have un-
dergone EVAR and offers several potential advantages compared
to CT: less invasive, lower cost, and easier to perform. In addition,
factors such as the absence of the risk associated with ionising ra-
diation, shorter scan times, and absence of nephrotoxicity make
the CDUS an attractive alternative to CT scanning.
The main limitation of US is that it is highly dependent on oper-
ator skills. Another limitation is that, in a few circumstances, such
as obesity or bowel gas, the aorta cannot be visualized.
Clinical pathway
The occurrence of endoleaks, migration of stent, or aneurysm
enlargement following EVAR render the execution of a systematic
surveillance programme mandatory for all patients.
There are no uniformly accepted guidelines for EVAR-related
complication surveillance. Generally, however, patients are sched-
uled for clinical and imaging visits at one, six, and 12months post-
operatively and, from the second year onwards, follow-up every
six or 12 months. In addition, any potential clinical pathway al-
gorithm depends on the type of the endoleak. For example, Karch
1999 suggest CT scanning as a surveillance modality of choice in
endografted patients, supplemented with angiography to localize
the precise aetiology of any endoleak detected. After confirmation
with angiography, their algorithm suggests surgical or endovascu-
lar repair for type I, III, and IV endoleaks and observation for
type II endoleaks. This algorithm does not mention the use of US
probably because the accuracy of US to detect endoleak was low.
Themost recent clinical guideline provides a similar but simplified
algorithm that indicates CT scan at 30 days and at 12 months
followed thereafter by yearly US in addition to plain radiography.
When type I and III endoleaks are detected, surgical treatment
is usually recommended. In the event of type II endoleak, the
guideline recommends CT scan plus plain radiography at six and
12 months (Moll 2011). However, in general, the role of US in
a clinical pathway for people who require endoleak monitoring is
unclear. We expect that the results from the present review may
clarify the role of US as a triage test for people who received EVAR
for AAA.
Alternative test(s)
Despite the availability of advanced equipment, abdominal plain
radiography is a useful technique for endoleak surveillance. Radio-
graphs are necessary for the confirmations of stent or to identify
stent fracture or migration.
Gadolinium-enhanced MR angiography (MRA) is an alternative
test to detect endoleaks and may be particularly indicated for peo-
ple who have contraindications to CT scan. MRA is as sensitive
as CT in detecting endoleaks (Cejna 2002; Insko 2003; Van der
Laan 2006). However, the image quality of MRA depends on the
material composition of the graft. For example, nitinol stents are
the best candidates forMRA surveillance while stainless steel or el-
giloy stents produce significant artefacts (Engellau 1998; Haulon
2001). In addition, MRA has the disadvantages of high cost and
may not be widely available.
Rationale
People with AAAwho received EVARneed lifetime surveillance to
detect potential endoleaks. CTA is considered the reference stan-
dard for endoleak surveillance due to its high sensitivity (Gorich
2001; Iezzi 2006; Stolzmann 2008). There is no agreement about
the timing and the number of examinations to be performed,
mainly in the presence of complications requiring further adjunc-
tive surveillance. TheEuropeanCollaborators onStent/graftTech-
niques for Aortic Aneurysm Repair (EUROSTAR) Registry rec-
ommends CTA follow-up at one, six, and 12 months after stent
positioning (Vallabhaneni 2001). However, CT scans can be per-
formed more frequently than expected, raising the possibility of
radiation exposition concerns (Brenner 2007). In addition, theCT
scan is associated with a cumulative risk of nephrotoxicity due to
the use of contrast (Brenner 2007). US with or without the use of
contrast agents is widely available, easy to use, and less expensive
diagnostic tool for identifying endoleaks and can be a potential
alternative to CT scan.
With the presence of false positives, the use of US may have no
consequence since a suspected endoleak will always need a further
investigation by a CT scan. With the presence of false negatives,
people can be at risk of having a spontaneous abdominal rupture
until the next examination is performed.
O B J E C T I V E S
To determine the diagnostic accuracy of colour duplex ultrasound
(CDUS) and contrast-enhanced-colour duplex ultrasound (CE-
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CDUS) in terms of sensitivity and specificity for endoleak detec-
tion after endoluminal abdominal aortic aneurysm repair (EVAR).
Secondary objectives
We aimed to explore several potential sources of heterogeneity by
examining differences in diagnostic accuracy estimation accord-
ing to technical differences of the imaging tests, US of different
generations, and age of participants. We also aimed to explore
heterogeneity related to methodological study quality items of the
Quality Assessment of Diagnostic Accuracy Studies (QUADAS)
checklists. We planned to explore further sources of heterogene-
ity concerning the size of the aneurysm, characteristics of patient
population (concomitant disease, severity of aneurismal disease,
location of aneurysm), and rupture of aneurysm.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Any cross-sectional diagnostic study was considered for inclusion
if:
• the participants were evaluated by both US (with or
without contrast) and CT scan;
• the assessments of both US and CT scan were performed at
regular intervals during follow-up.
Participants
People who received EVAR for AAA treatment and were under
follow-up for endoleak detection.
Index tests
The index test was Doppler US (either CDUS or CE-CDUS) for
the assessment of endoleak in people with EVAR.
The CDUS is a non-invasive, non-expensive, easy-to-use instru-
ment for endoleak detection. CDUS depends on the experience
of the operator and provides limited images for independent re-
view by others. CE-CDUS requires an intravenous injection with
a contrast which consists of microbubbles that resonate when ex-
amined with sound of low intensity. The outcome of the index test
is the presence of a leak from the endovascular graft that allows
blood flow outside the stent but within the aneurysm sac.
Target conditions
Endoleak detected during follow-up surveillance in people who
received EVAR for AAA.
Reference standards
CT is the imaging technique of choice for follow-up after EVAR.
Search methods for identification of studies
The review authors performed a comprehensive literature search to
identify relevant studies. We did not use methodology filters when
searching for diagnostic accuracy studies to maximise sensitivity.
We sought translations for non-English language studies.
Electronic searches
We searched the following trial databases were searched in June
2016:
• MEDLINE (OvidSP) Appendix 1;
• Embase (OvidSP) Appendix 2;
• LILACS (lilacs.bvsalud.org/en/) Appendix 3;
• ISI Conference Proceedings Citation Index - Science;
Appendix 4;
• British Library Zetoc conference search (
zetoc.mimas.ac.uk); Appendix 5.
We searched the following trial registries (June 2016) for details
of ongoing and unpublished studies (see Appendix 6):
• World Health Organization International Clinical Trials
Registry (apps.who.int/trialsearch/);
• ClinicalTrials.gov (ClinicalTrials.gov/);
• ISRCTN Register (www.isrctn.com/).
Searching other resources
We contacted study authors for further details on the published
studies when data were unclear.
We checked bibliographic citations of reviews for additional ref-
erences.
We checked bibliographic citations in reports and in other reviews
relevant to our topic for additional references.
We consulted the Science Citation Index to identify articles that
have cited the studies included in the review.
Data collection and analysis
Selection of studies
Two pairs of review authors independently screened the title and
abstract of all studies identified by the search strategy and obtained
5Ultrasonography for endoleak detection after endoluminal abdominal aortic aneurysm repair (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
the full articles for all potentially relevant studies. We re-assessed
the full text of these reports independently and extracted data using
a standardised form. When studies were excluded, we stated the
reason of exclusion. A third review author resolved disagreements.
Data extraction and management
Twopairs of review authors extracted data independently and com-
pared data. Another review author checked data for consistency.
We contacted authors of diagnostic accuracy studies for details
when data from the reports were insufficient.
Unit of analysis issues
The primary unit of analysis was the number of individual partic-
ipants included in the studies. The studies that provided accuracy
data based on number of scans performed (and not on individual
participant basis) were used for a secondary (explanatory only)
analysis.
Assessment of methodological quality
Two review authors independently assessed the methodological
quality of each included study using the QUADAS checklist
(Whiting 2003). We classified each item as ’yes’ (adequately ad-
dressed), ’no’ (inadequately addressed), or ’unclear’ (if insufficient
information was reported) according to the criteria listed in Table
2. We resolved discrepancies by consensus.
In addition toproviding amethodological quality graph that shows
the judgements for each QUADAS item of all the studies, we also
generated overall graphical representation of the quality for each
type of US that were included in the primary analysis (individual
based data).
Statistical analysis and data synthesis
To perform analysis, studies differed in the use of the unit of
analysis, that is, while in some studies the unit of analysis was the
number of participants, in other studies the unit of analysis was
the number of scans. This means that in the studies that used the
number of scans some of the participants were counted more than
once and this may introduce bias. Hence, in the primary analysis,
we considered studies that used the number of participants as
the unit of analysis and, in the secondary analysis, we considered
studies that performed analysis based on the number of scans (the
latter was used as an explanatory or corroborative to the primary
analysis).
For both primary and secondary analyses, we carried out the statis-
tical analyses following recommendations reported in Chapter 10
of the Cochrane Handbook for Systematic Reviews of Diagnostic Test
Accuracy (Macaskill 2010). We used Review Manager 5 software
for analyses and plots (RevMan 2014). For studies that, in addi-
tion to the standard US, used different modalities (such as three-
(3D) or four-dimensional (4D) US) to assess the accuracy of US,
we considered primarily the data based on standard US data in
our analyses.
We generated a 2 × 2 table of true positive cases, false positive
cases, false negative cases, and true negative cases. We calculated
sensitivity and specificity with 95% confidence intervals (CIs) for
each study.We performedmeta-analyses using the bivariate model
(Reitsma 2005). Since fitting the model is too complex to im-
plement within Review Manager 5, we used SAS statistical soft-
ware (SAS 2008) and STATA 13 to generate parameter estimates
(logit and variances). Parameter estimates from the bivariatemodel
were transferred to Review Manager to produce the summary re-
ceiver operating characteristic (ROC) curve, the summary oper-
ating point (i.e. summary values for sensitivity and specificity), a
95% confidence region around the summary operating point, and
a 95% prediction region.
We opted to employ the bivariate model as it is recommended
for purely binary tests or when different studies report similar
thresholds (Leeflang 2014).
We calculated positive (LR+) and negative (LR-) likelihood ratios
using summary sensitivity and specificity.
To determine the meaningfulness or clinical utility of US either
with or without contrast we employed a Fagan plot as well as the
likelihood ratio (LR) scatterplot matrix. Fagan plot is a graphi-
cal tool for estimating how much the result on a diagnostic test
changes the probability that a person has a disease (Fagan 1975).
LR ratio scatterplot matrix plots LR+ against LR- with 95% CIs
and illustrates the distribution of accuracy estimates of individ-
ual studies. The matrix allows identification of outliers, as well as
studies relevant for sensitivity analyses (Stengel 2003).
Investigations of heterogeneity
The factors that we proposed in the protocol to investigate for
potential heterogeneity included:
• characteristics of participant population (age, concomitant
disease, severity of aneurismal disease, location of aneurysm);
• size of the aneurysm (diameter and length);
• technical differences of imaging tests (advanced, recent
instruments versus older);
• type of stent;
• rupture of aneurysm.
We were able to investigate the following variables as a source of
heterogeneity: use of contrast (CDUS versus CE-CDUS), year of
publication, characteristics of included participants (age and gen-
der), direction of study (retrospective, prospective), methodolog-
ical quality, country of origin, number of CDUS operators, and
US manufacturer.
We investigated heterogeneity by visual inspection of forest plots
and ROC plots. Moreover, we used a regression analysis to inves-
tigate the effects of the sources of heterogeneity on sensitivity and
specificity by including the factors in the bivariate models.
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For the covariate ’use of contrast,’ we performed direct and in-
direct comparisons between CDUS and CE-CDUS. The direct
comparison refers to the studies that performed on the same occa-
sion accuracy analysis before and after administration of contrast.
For both comparisons, we performed a bivariate analysis including
all the studies in one data set and inserting a binary covariate ’test
type’ in the model. Using the derived logit estimates of sensitiv-
ity and specificity and their respective covariances, we constructed
summary ROC curves for CDUS and CE-CDUS, with summary
operating points for sensitivity and specificity on the curves and a
95% confidence region. The variance coefficients were assessed to
investigate heterogeneity in sensitivities and specificities. The size
of the prediction region on the summary receiver operator curve
(SROC) plot can indicate the magnitude of potential heterogene-
ity. A regression test was used to assess the effects of the covariate
’use of contrast’ on sensitivity and specificity.
Sensitivity analyses
We planned a sensitivity analysis based on type of study design
(prospective versus retrospective study designs), type and genera-
tion of the index tests, and individual quality items.
Assessment of reporting bias
We did not assess reporting bias.
R E S U L T S
Results of the search
See Figure 1.
Figure 1. Study flow diagram.
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The search strategy generated 9389 records for evaluation after
removing duplicates. After screening the titles, we considered 175
abstracts relevant for investigation leaving 63 records for which
a full-text assessment was necessary. After excluding 22 studies
with reasons, we included 42 studies in qualitative and quan-
titative analyses. We checked the reference lists of five reviews
(Ashoke 2005a; Bakken 2010; Karthikesalingam 2012; Mirza
2010; Sun 2006) and identified and included two unpublished
studies (Ashoke 2005b; Ashoke 2005c), both of which were re-
ported in one review (Ashoke 2005a).
Characteristics of excluded studies
See Characteristics of excluded studies table.
Twenty-two studies were excluded with the following reasons: in
four studies the performance of one test depended on the results of
the other (Chisci 2012; Collins 2007; Greenfield 2002; Harrison
2011); three studies included participants in the follow-up pro-
gramme based on the suspicion of endoleak (Clevert 2008a; Pfister
2009; Sommer 2012); four studies used US and CT scan for
EVAR surveillance but did not evaluate endoleak (Almaroof 2013;
Bredahl 2013; Clevert 2013;Han 2010); three studies reported in-
sufficient data for 2 × 2 table production (Elkouri 2004; Hertault
2015; Nyheim 2013); two studies did not perform the two tests
concurrently (Manning 2009; Napoli 2004); two studies evalu-
ated a subset of participants with probable or possible endoleaks
(Millen 2013: Yang 2015); one study used angiography as refer-
ence standard (Ormesher 2014); one study selected participants
based on the presence of insurance coverage (Beeman 2009); one
study was a follow-up study of Beeman 2009 (Troutman 2014);
and one study selected retrospectively participants with EVAR
based on the presence of both tests (Sorrentino 2015).
Characteristics of included studies
See Characteristics of included studies table.
Forty-two studies with 4220 participants were eligible for in-
clusion. Of these, 11 evaluated US with and without contrast
(Bendick 2003; Cantisani 2011; Clevert 2008b; Clevert 2011;
Costa 2013; Giannoni 2003; Heilberger 1997; Henao 2006; Iezzi
2009;McWilliams 1999;McWilliams 2002); 23 studies evaluated
only CDUS (without contrast) (AbuRahma 2005; Arsicot 2014;
Ashoke 2005b; Ashoke 2005c; Badri 2010; d’Audiffret 2001;
Demirpolat 2011; França 2013; Golzarian 2002; Gray 2012;
McLafferty 2002; Nagre 2011; Nerlekar 2006;Oikonomou 2012;
Pages 2001; Parent 2002; Raman 2003; Sandford 2006; Sato
1998; Schmieder 2009; Thompson 1998; Wolf 2000; Zannetti
2000); and eight studies evaluated only CE-CDUS (Abbas 2014;
Gargiulo 2014; Giannoni 2007;Gurtler 2013;Motta 2012; Perini
2011; Perini 2012; Ten Bosch 2010). The distribution of the stud-
ies based on the unit of analysis is displayed in Appendix 7.
In terms of US, Gargiulo 2014 evaluated the accuracy of 4D and
the standard two-dimensional (2D) CE-CDUS; Abbas 2014 com-
pared 3D and 2D CE-CDUS with CT scan; and Arsicot 2014
used 3DCDUS. All the studies provided sufficient detail aboutUS
image acquisition to replicate the index test except forMcWilliams
1999; Nerlekar 2006; Thompson 1998; and Sandford 2006.
In terms of CT scan, Clevert 2011 andGray 2012 reported insuffi-
cient details to replicate the reference test. Costa 2013;McLafferty
2002; Parent 2002; Sato 1998; and Zannetti 2000, despite report-
ing sufficient details of the reference standard, did not report the
type of scanner used. Giannoni 2007 and Sandford 2006 reported
the type of scanner used but reported no details about image ac-
quisition. Gray 2012; Ashoke 2005b; and Ashoke 2005c reported
no information about the use of contrast for CT scan.
The overall number of participants in the 42 studies was 4220
ranging from 10 to 445. The studies were performed in different
geographical areas: 10 (24%) were performed in the USA, eight
(19%) in the UK, seven (17%) in Italy, six (14%) in France, five
(12%) in Germany, and one (2%) each in Australia, Belgium,
Ireland, the Netherlands, Turkey, and Brazil.
Seven studies did not report any information related to the age of
participants (McLafferty 2002; McWilliams 1999; Parent 2002;
Perini 2011; Sandford 2006; Sato 1998; Wolf 2000). The mean
age was 72 years across the remaining studies.
Ten studies did not report gender characteristics of the included
participants (Giannoni 2007; McLafferty 2002; McWilliams
1999; Nerlekar 2006; Parent 2002; Perini 2011; Sandford 2006;
Sato 1998; Thompson 1998; Wolf 2000). The percentage males
in the remaining studies was 75% or greater; in four studies, all the
included participants were males (Ashoke 2005c; Clevert 2008b;
Henao 2006; Perini 2012).
Only 16 studies reported information about the aneurysm size.
One study reported the range of aneurysm size (from 5.1 to 7.8
cm) (Golzarian 2002), whereas in 15 studies (Abbas 2014; Ashoke
2005b; Cantisani 2011; Costa 2013; Demirpolat 2011; França
2013; Gargiulo 2014; Giannoni 2007; Henao 2006; Nerlekar
2006; Oikonomou 2012; Pages 2001; Perini 2011; Perini 2012;
Zannetti 2000), the aneurysmal mean size ranged from 5.0
(Zannetti 2000) to 6.4 cm (Abbas 2014).
Overall, in most of the studies there was no information about
participants’ comorbidities except in four studies (Arsicot 2014;
Costa 2013; d’Audiffret 2001; Nagre 2011). In these studies, com-
mon comorbidities were cardiovascular diseases, dyslipidaemia,
diabetes, and overweight (see Characteristics of included studies
table).
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Type of stents
The description of the type of stent was not uniformly reported.
Perini 2012 stated that all participants received fenestrated grafts
but did not provde other information. Costa 2013 and Perini 2011
reported that some participants received fenestrated stents. Abbas
2014; Ashoke 2005b; d’Audiffret 2001; Gurtler 2013; Iezzi 2009;
Motta 2012; Parent 2002; and Thompson 1998 reported use of
bifurcated and aorto-uni-iliac stents.
Twenty-one studies reported the brand names of the stents
(AbuRahma 2005; Arsicot 2014; Badri 2010; Cantisani 2011;
Ashoke 2005b; d’Audiffret 2001; Gargiulo 2014; Giannoni 2007;
Iezzi 2009; McLafferty 2002; McWilliams 1999; Motta 2012;
Parent 2002; Raman 2003; Sato 1998; Schmieder 2009; Ashoke
2005c; Ten Bosch 2010; Thompson 1998; Wolf 2000; Zannetti
2000).
The most used type of stent was AneuRx (32.5%) followed by
Ancure (27.1%), Talent (13.3), and Excluder (9.6%). Only six
studies administered the same type of stent to all the included par-
ticipants: Gargiulo 2014 used Advanta, Parent 2002 used Ancure,
McLafferty 2002 and Wolf 2000 used AneuRx, Sato 1998 used
Endovascular Technology, and Thompson 1998 used Talent.
The distribution of the stents used across the 21 studies that re-
ported the brand names is displayed in Table 3. Two studies re-
ported the types of stent used but did not provide the number
of participants for each stent deployed (Oikonomou 2012; Perini
2011).
Endoleaks: prevalence and types
Overall, there were 1208 endoleaks in 4220 participants. The me-
dian prevalence of endoleaks was 24.5% ranging from 5.4% (Gray
2012) to 56.7% (Abbas 2014).
Eleven studies did not report the type of endoleak (Arsicot 2014;
Bendick 2003; Giannoni 2003; Heilberger 1997; McLafferty
2002; McWilliams 1999; Sandford 2006; Sato 1998; Thompson
1998; Wolf 2000; Zannetti 2000).
The number of endoleaks in the remaining studies was 975. Of
these, 166 (17%) were type I, 736 (75%) were type II, 29 (3%)
were type III, and three (0.3%) were type IV endoleaks.
Methodological quality of included studies
The following is the assessment of the quality of the 42 studies
based on each QUADAS items as depicted in Figure 2.
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Figure 2. Methodological quality summary: review authors’ judgements about each methodological quality
item for all included study (42 participants).
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Representative spectrum? All included studies considered a con-
secutive series of participants referred for follow-up to detect po-
tential endoleaks except for Costa 2013; Gurtler 2013; and Nagre
2011 who did not report sufficient information to make judge-
ment; Bendick 2003 in which 10 of 20 participants were selected
based on the participant’s habitus or the presence of bowel gas;
and Schmieder 2009, where from a cohort of 496 consecutive par-
ticipants, 236 participants were identified with paired CDUS and
CT scan.
Acceptable reference standard? All included studies reported the
use of CT scan as a reference standard. However, three studies did
not clearly report who interpreted the images (Heilberger 1997;
Henao 2006; Nagre 2011).
Acceptable delay between tests? The time period between US
and CT scan was four weeks or less in 27 studies and unclear in 11
studies (Ashoke 2005b; Ashoke 2005c; Clevert 2011; Gray 2012;
McLafferty 2002; Pages 2001; Parent 2002; Perini 2012; Sato
1998; Wolf 2000; Zannetti 2000). Nerlekar 2006 and Ten Bosch
2010 considered the inclusion of participants with tests performed
within one month and were at low risk of bias. Five studies were at
high risk of bias: in Abbas 2014, the interval between the tests was
(mean ± standard deviation) 3.9 ± 2.7 weeks; in Arsicot 2014, it
was 48 ± 37 days; in Schmieder 2009, it was 18 days with a range
between 0 and 90 days; in França 2013 concurrent scans were
defined as having occurred within three months of each other;
and in Sandford 2006 concurrent scans were defined as having
occurred within six months of each other,
Partial verification avoided? In all included studies, all partici-
pants were accounted for and the results of the reference standard
were reported for all.
Differential verification bias avoided? In all included studies, all
participants who received US test were subjected to the same CT
scan.
Incorporation avoided? In all included studies, the index test was
not part of the reference standard.
Reference tests blinded? Twenty-nine trials explicitly stated that
the index test was interpreted without knowledge of the reference
standard. Twelve studies reported insufficient information tomake
a judgement (Abbas 2014; Badri 2010; Clevert 2011; Gargiulo
2014; Golzarian 2002; Heilberger 1997; McLafferty 2002; Nagre
2011; Oikonomou 2012; Parent 2002; Perini 2012; Sandford
2006). In one study, the physician performing the US scan was
not blinded to the results of the CT scan (d’Audiffret 2001).
Index test results blinded? In 12 studies, there was insufficient
information to make a judgement (Abbas 2014; Arsicot 2014;
Badri 2010;Gray 2012;Heilberger 1997;McLafferty 2002;Nagre
2011; Oikonomou 2012; Parent 2002; Raman 2003; Sandford
2006; Thompson 1998), whereas in one study, authors reported
that the radiologist interpreting the results of the CT scan could
have been aware of the results of the index test (d’Audiffret 2001).
Relevant clinical information? Appropriate clinical information
was available in all included studies.
Uninterpretable results reported? Two studies did not report
sufficient information to make any judgement (Clevert 2011;
Thompson 1998); another study reported that inadequate ex-
aminations were excluded but did not provide detailed numbers
(Schmieder 2009).
Withdrawals explained? Nine studies did not adequately ex-
plain the occurrence ofwithdrawals (d’Audiffret 2001;Demirpolat
2011; Heilberger 1997; Nagre 2011; Sandford 2006; Sato 1998;
Schmieder 2009; Ten Bosch 2010; Wolf 2000).
Overall summary of quality of studies included in
primary analysis
Figure 3 provides the overall summary of the quality of studies that
evaluated CDUS and CE-CDUS and used number of individuals
as the unit of analysis.
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Figure 3. Risk of bias according to QUADAS 1: review authors’ judgements about each domain presented
as percentages for colour duplex ultrasound (CDUS) (n = 16) and contrast-enhanced colour duplex ultrasound
(CE-CDUS) (n = 11) that were included in primary analysis. The unit of analysis was number of individuals (not
number of scans).
Sixteen CDUS studies reported accuracy analysis based on in-
dividual data (Arsicot 2014; Bendick 2003; Cantisani 2011;
Clevert 2008b; Clevert 2011; d’Audiffret 2001; Golzarian 2002;
Heilberger 1997; Henao 2006; Iezzi 2009; McLafferty 2002;
Oikonomou 2012; Parent 2002; Sandford 2006; Thompson
1998; Zannetti 2000). These studies were generally of moderate/
low quality. Only three studies fulfilled all the QUADAS items
(Cantisani 2011; Clevert 2008b; Iezzi 2009). In 6/16 (40%)
studies, the delay between the tests was unclear (Clevert 2011;
McLafferty 2002; Parent 2002; Zannetti 2000), or longer than
four weeks (Arsicot 2014; Sandford 2006); in 50% of the stud-
ies, the blinding of either the index test or the reference standard
was not clearly reported or was not performed; and in two studies
(12%) the interpretation of the reference standard was not clearly
reported (Heilberger 1997; Henao 2006).
Eleven CE-CDUS studies reported accuracy analysis based on
individual data (Bendick 2003; Cantisani 2011; Clevert 2008b;
Clevert 2011; Gargiulo 2014; Giannoni 2007; Heilberger 1997;
Henao 2006; Iezzi 2009; Perini 2011; Perini 2012). These stud-
ies were of better quality than the CDUS studies. Five studies
(45%) fulfilled all the QUADAS items (Cantisani 2011; Clevert
2008b; Giannoni 2007; Iezzi 2009; Perini 2011). Four studies
(36%) did not report the blinding interpretation of the reference
standard clearly (Clevert 2011; Gargiulo 2014; Heilberger 1997;
Perini 2012); in two (18%) studies, the delay between the two
tests was not clearly reported (Clevert 2011; Perini 2012).
Findings
Diagnostic performance of colour duplex ultrasound
and contrast-enhanced colour duplex ultrasound
(primary analysis)
Sixteen studies provided sufficient individual data on CDUS com-
pared to CT to perform a meta-analysis (Arsicot 2014; Bendick
2003; Cantisani 2011; Clevert 2008b; Clevert 2011; d’Audiffret
2001; Golzarian 2002; Heilberger 1997; Henao 2006; Iezzi 2009;
McLafferty 2002; Oikonomou 2012; Parent 2002; Sandford
2006; Thompson 1998; Zannetti 2000). Individual estimates of
sensitivity and specificity are shown in Figure 4. The sensitivities
ranged between 33% and 100% while the specificities ranged be-
tween 64% and 100%. Using the bivariate model, the summary
estimate of sensitivity was 0.82 (95% CI 0.66 to 0.91), and the
summary estimate of specificity was 0.93 (95% CI 0.87 to 0.96).
In Arsicot 2014, the accuracy estimates between standard US ver-
sus CT and 3D US versus CT were similar (equal rates of false/
true positives or negatives).
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Figure 4. A forest plot of colour duplex ultrasound (CDUS) (n = 16) and contrast-enhanced colour duplex
ultrasound (CE-CDUS) (n = 11) that were included in primary analysis.
Eleven CE-CDUS studies provided individual data that allowed
the performance of a meta-analysis (Bendick 2003; Cantisani
2011; Clevert 2008b; Clevert 2011; Gargiulo 2014; Giannoni
2007; Heilberger 1997; Henao 2006; Iezzi 2009; Perini 2011;
Perini 2012). The sensitivities ranged between 67% and 100%
and the specificities ranged from 79% to 100% (Figure 4). The
bivariate model meta-analysis showed a sensitivity of 0.94 (95%
CI 0.85 to 0.98) and a specificity of 0.95 (95% CI 0.90 to 0.98).
In Gargiulo 2014, the accuracy estimates between standard US
versus CT and 4DUS versus CT were similar (equal rates of false/
true positives or negatives).
Comparing the accuracy data between CDUS and CE-CDUS
based on the bivariate model, it appeared that sensitivity differed
significantly with CE-CDUS being superior to CDUS (LR Chi2=
5.08; P = 0.0242). Conversely, there was no statistical difference in
the specificity estimates between CE-CDUS and CDUS. Figure 5
shows the resulting SROC curves, with summary operating points
for sensitivity and specificity on the curves and a 95% confidence
region around these points.
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Figure 5. Summary receiver operating characteristic plot of studies assessing the accuracy of colour duplex
ultrasound (CDUS) and contrast-enhanced colour duplex ultrasound (CE-CDUS) in discriminating endoleak
(primary analysis). Each value of sensitivity and specificity is represented by a circle. The filled circle
represents the summary point. Dotted closed line represent 95% confidence region of the summary point.
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The diagnostic odds ratio (DOR), LR+, and LR- for CDUS and
CE-CDUS are reported in Table 4.
To identify the implication of our results into clinical practice,
using the Fagan’s nomogram, we simulated three scenarios with
low (5.4%), median (24.5%), and high (47.6%) prevalence of
endoleak to obtain the post-test probability. With low prevalence
scenarios. if a personhas a positiveUS test, the post-test probability
that the person has an endoleak would be 37% for CDUS and
53% for CE-CDUS. In contrast, if a person has a negative US test,
the post-test probability that the person has an endoleak would
be less than 1% for CDUS and 0% for CE-CDUS. In a high
prevalence scenario, the post-test probability that the person has
an endoleak would be 90% when a person has a positive CDUS
and 95% with a positive CE-CDUS; conversely, with a negative
US result, the post-test probability would be 14% for CDUS and
6% for CE-CDUS (Figure 6).
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Figure 6. Fagan plot estimating changes in the probability that a person has an endoleak given a pre-test
probability: a presumed pre-test probability at low (5.4%), median (24.5%) and high (47.6%) prevalence of
endoleak for CDUS and CE-CDUS. Left vertical axis represents the pre-test probability, axis in the middle
represents the likelihood ratio, and right vertical axis represents the post-test probability (LR-: negative
likelihood ratio; LR+: positive likelihood ratio).
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The LR scattergram shows that the summary point of LR+ and
LR- for CDUS is located in the upper right quadrant (LR+ = 10;
LR- = 0.17), suggesting that the accuracy is optimal for endoleak
confirmation whereas the summary point of LR+ and LR- for CE-
CDUS is optimal for endoleak confirmation and exclusion (LR+
= 19; LR- = 0.06) (Figure 7).
Figure 7. Likelihood ratio scatterplot matrix. Circles represent individual studies. The filled square circle
shows the weighted summary likelihood ratios. Error bars represent 95% confidence intervals. The likelihood
ratio profile shows that contrast-enhanced colour duplex ultrasound (CE-CDUS) is a potent tool for endoleak
conformation or exclusion in people who received endovascular aneurysm repair (EVAR).
Subgroup analysis 1: direct comparison of colour duplex
ultrasound and contrast-enhanced colour duplex ultrasound
Seven studies provided accuracy data of US for endoleak detection
before and after the administration of contrast (Bendick 2003;
Cantisani 2011; Clevert 2008b; Clevert 2011; Heilberger 1997;
Henao 2006; Iezzi 2009). Based on the confidence regions in
Figure 8, there is evidence that the sensitivity varies with contrast,
but not specificity. A regression analysis showed that CE-CDUS
was significantly superior to CDUS in terms of sensitivity (LR
Chi2 = 13.47; P = 0.0002) but not specificity (LR Chi2 = 0.01;
P = 0.9124). Table 4 compares the diagnostic accuracy estimates
including DOR, LR+, and LR- between CDUS and CE-CDUS.
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Figure 8. Summary Receiver Operating Characteristic Plot of studies (n = 7) that assessed accuracy
measures for endoleak detection before and after administration of contrast. Studies used individual based
analysis. The filled circle represents the summary point. Dotted closed line represent 95% confidence region of
the summary point. CDUS: colour duplex ultrasound; CE-CDUS: contrast-enhanced colour duplex ultrasound.
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Subgroup analysis 2: diagnostic performance of contrast-
enhanced colour duplex ultrasound for type I and type III
endoleaks
We performed a posthoc subgroup analysis with seven CE-CDUS
studies that provided usable data regarding type I and type III
endoleaks. Summary sensitivity estimate was 0.97 (95% CI 0.81
to 0.99) and specificity was 0.99 (95% CI 0.96 to 1.00) (Table 4).
Diagnostic performance of colour duplex ultrasound
and contrast-enhanced colour duplex ultrasound
(secondary analysis)
Eighteen CDUS studies provided accuracy estimates based on the
number of scans performed (AbuRahma 2005; Ashoke 2005b;
Ashoke 2005c; Badri 2010; Costa 2013; Demirpolat 2011;
França 2013; Giannoni 2003; Gray 2012; McWilliams 1999;
McWilliams 2002; Nagre 2011; Nerlekar 2006; Pages 2001;
Raman 2003; Sato 1998; Schmieder 2009; Wolf 2000). Meta-
analyses based on the bivariate model showed a sensitivity of 0.72
(95% CI 0.55 to 0.85) and specificity of 0.95 (95% CI 0.90 to
0.96).
Eight CE-CDUS studies provided data based on number of scans
performed (Abbas 2014; Costa 2013; Giannoni 2003; Gurtler
2013; McWilliams 1999; McWilliams 2002; Motta 2012; Ten
Bosch 2010). The summary sensitivity was 0.91 (95% CI 0.68
to 0.98) and the specificity was 0.89 (95% CI 0.71 to 0.96). In
Abbas 2014, the accuracy estimates between standard US versus
CT and 3D US versus CT were similar (equal rates of false/true
positives or negatives). In Abbas 2014, the accuracy estimates be-
tween standard US versus CT and 3D US versus CT were similar
(equal rates of false/true positives or negatives).
An indirect comparison between CDUS and CE-CDUS showed
a higher sensitivity for CE-CDUS but with no statistical differ-
ence. An ROC plot showed a wide confidence region for estimates
of both index tests. The exclusion of two outliers (McWilliams
2002; Nagre 2011) reduced the CI, and the sensitivity estimates
for CE-CDUS were higher than those of CDUS with a statistical
significant difference (LR Chi2= 5.40, 1 df, P = 0.0202). Figure
9 shows the reduction in the confidence region after exclusion of
the outliers.
Figure 9. Figure A. Indirect comparison of summary estimates of studies assessing the accuracy of CDUS
(colour duplex ultrasound) and CE-CDUS (contrast-enhanced colour duplex ultrasound) in discriminating
endoleak (secondary analysis). Figure B. Summary Receiver Operating Characteristic plots of CDUS and CE-
CDUS (indirect) estimates excluding two outliers. The confidence region was significantly reduced when the
outliers were excluded.
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Details of accuracy estimates for both types of US modality (with
and without outliers) are reported in Table 4.
Investigating heterogeneity
Due to absence of data, we were unable to explore sources of het-
erogeneity concerning the size of the aneurysm, characteristics of
participant population (concomitant disease, severity of aneuris-
mal disease, location of aneurysm), and rupture of aneurysm.
We were able to investigate the following potential sources of het-
erogeneity within the studies included in the primary analysis: year
of publication, characteristics of included participants (age and
gender), direction of study (retrospective, prospective), method-
ological quality (low quality versus unclear/high risk of bias), sam-
ple size, country of origin, number of US operators, and US man-
ufacturer.
Regression testing showed evidence of statistically significant ef-
fect bias related to year of publication and study quality within
participant-based CDUS studies. Sensitivity estimates were higher
in the studies published before 2006 than the estimates obtained
from studies published in 2006 or later (P < 0.001); similarly,
studies judged as low/unclear quality provided higher estimates of
sensitivity. None of the remaining covariates were identified as a
possible source of heterogeneity (Table 5). When regression test-
ing was applied in the participant-based CE-CDUS studies, none
of the items, namely direction of the study design, quality, and
age, were identified as a source of heterogeneity.
Sensitivity analysis
We carried out a sensitivity analysis based on type of study design
(prospective versus retrospective study designs), generation of the
index tests, and individual quality items.
Excluding retrospective studies in design, CDUS showed a lower
sensitivity (0.68, 95% CI 0.50 to 0.83) than CE-CDUS (0.95,
95% CI 0.83 to 0.99).
Similarly, the sensitivity of CDUS studies with unclear/low qual-
ity items was lower (0.53, 95% CI 0.40 to 0.66) than the corre-
sponding sensitivity of CE-CDUS studies (0.96, 95% CI 0.88 to
0.99).
There was no uniform use of the type of US across the studies. We
performed sensitivity analysis based on the studies that used US
produced by the same manufacturer but there were no significant
differences (Table 5).
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Summary of findings
Ultrasound for endoleak detection in participants who received endoluminal abdominal aortic aneurysm repair
Population Part icipants who received endovascular stent for abdominal aort ic aneurysm
Index test Ultrasound with or without contrast.
Target condition Endoleak (type I, II, III or IV).
Reference standard CT scan.
Included studies Cross-sect ional studies (studies that provided individual data only)
Test Number of studies (partici-
pants)
Prevalence % (median) Summary accuracy Implications Quality
CDUS 16 studies
(1357)
22% Sensit ivity: 0.82 (95% CI 0.66
to 0.91)
Specif icity: 0.93 (95%CI 0.87
to 0.96)
Of 1000 people who receive
CDUS, 35 people will have
their endoleaks missed and
47 people will have an unnec-
essary CT scan
Moderate/ low: in 40% of
studies, delay between tests
was unclear (4/ 16) or > 4
weeks (2/ 16); in 50% of stud-
ies, blinding of either index
test or reference standard
not clearly reported or not
performed; in 12%, interpre-
tat ion of reference standard
not clearly reported
CE-CDUS 11 studies
(947)
25% Sensit ivity: 0.94 (95% CI 0.85
to 0.98)
Specif icity: 0.95 (95%CI 0.90
to 0.98)
Of 1000 people who receive
CE-CDUS, 15 people will have
their endoleaks missed and
47 people will have an unnec-
essary CT scan
High/ moderate: 5 studies
(45%) fulf il led all QUADAS
items; 4 (36%) studies did not
report clearly blinding inter-
pretat ion of reference stan-
dard; in 2 (18%) studies, the
delay between the 2 tests not
clearly reported
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CDUS: colour duplex ultrasound; CE-CDUS: contrast-enhanced colour duplex ultrasound; CT: computed tomography.
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D I S C U S S I O N
Summary of main results
Using data from the largest set of published studies in the medical
literature, this review summarised the evidence for the diagnostic
accuracy of US for the detection of endoleak in people who re-
ceived EVAR.
The results suggested that US provides clinically helpful informa-
tion to rule in or rule out endoleak (Summary of findings). CDUS
summary sensitivities ranged from 82% to 91% and specificities
ranged from 93% to 96%. This means that, under a prevalence
of endoleaks of 22%, for every 1000 people who receive a CDUS
evaluation, endoleaks will be missed in 35 people and 47 people
will undergo anunnecessaryCT scan.However, accuracy estimates
showed that CE-CDUS has better sensitivity than CDUS with
values ranging from 85% to 98%. Hence, for every 1000 people
who will receive a CE-CDUS evaluation, 15 people will have their
endoleaks missed rather than 35, under similar prevalence of en-
doleaks. In conclusion, while CDUS usage is limited to ruling in
endoleaks, CE-CDUS has the advantage of use for both endoleak
confirmation and exclusion and, therefore, it should be considered
the primary alternative to CT scan for endoleak surveillance in
people who have received EVAR.
Strengths and weaknesses of the review
The most relevant strength of our review is that our primary unit
analysis was based on data derived from 20 primary studies. We
provided separate summary estimates of sensitivity and specificity
for CDUS (16 studies) and CE-CDUS (11 studies) and, using
appropriate statistical models, we compared the difference in ac-
curacy between CDUS and CE-CDUS. Results showed that sen-
sitivity improves when contrast is used increasing from 82% to
94%. Figure 5 shows clearly that there is an important gain in
sensitivity for CE-CDUS, and that all the CE-CDUS studies were
distributed above the ROC curve of CDUS studies. Using the
Fagan plot, we also demonstrated that a positive US raises signifi-
cantly the probability of having an endoleak at different levels of
disease prevalence (Figure 7).
In addition, based on the LR calculation we plotted the LR ratio in
a four quadrant presentation (Figure 7). The weighted summary
LRs for the CDUS studies lay within the upper right quadrant
suggesting that the test should be indicated for confirmation only.
However, the CIs for the LR+ crossed the lower right quadrant,
which suggests no confirmation or exclusion - in which half of the
CDUS results were scattered. Conversely, the summary LR for the
CE-CDUS studies lay within the left upper quadrant suggesting
that the test can be indicated for exclusion or confirmation. No
CE-CDUS study was located in the lower right quadrant.
We also performed accuracy estimates based on 22 studies that
provided scan-based analysis. This type of approach may have ac-
counted for more than one endoleak in the same participant in
some circumstances. Nerlekar 2006 included 121 participants but
reported data about 243 pairs of scans. In this study, the number
of people with endoleak was 20 whereas the number of endoleaks
considered in the contingency table was 29. This discrepancy may
affect the estimation of the prevalence and consequently the cal-
culation of the positive and negative predictive values. However,
the accuracy estimates in this secondary analysis provided similar
results to those observed in the primary analysis.
Other strengths of our review include: transparent objectives and
methods based on a prepublished protocol and comprehensive
and systematic methods to search for and select eligible studies;
thorough quality assessment of the primary studies; and a sensi-
tivity analysis of studies with similar methodological features into
a meta-analytic summary based on recommended methods.
The most important limitation of our review concerns the issue
of reproducibility. Unlike CT, the reliability of US measurement
is highly dependent on the experience of the US operator. One
systematic review that examined the potential observer bias and
variability inUSmeasurements in nine studies duringAAA screen-
ing or surveillance programmes reported that six studies did not
show a correlation between increasing standard deviation and in-
creasing aortic diameter. In addition, five studies had repeatability
coefficients lower than the 5-mm level of acceptability (as sug-
gested by the UK Abdominal Aortic Aneurysm Screening Pro-
gramme), whereas two studies produced repeatability coefficients
that were greater than 5 mm (Beales 2011). However, it should
be emphasized that the studies used different US machines with
no standardized measurement techniques (Beales 2011). In our
review, most of the studies reported the operators performing US
had good experience. In clinical practice, the operator/technician
would likely be aware of an increasing aneurysm sac and, there-
fore, are likely to look more closely for an endoleak. However, we
are unsure to what extent this would have affected the estimates
of the diagnostic studies. Additionally, we found an US variability
in the type of machine used and the protocol applied to acquire
images that may have contributed to the heterogeneity especially
in the CDUS studies.
Year of publication and study quality could be other potential
sources of heterogeneity. However, comparing the two graphical
representation of the accuracy estimates between CDUS and CE-
CDUS, we can conclude that heterogeneity was less in the CE-
CDUS studies.
We acknowledge that due to operational reasons blinding of one
test operator to the results the other test especially in the presence
of an enlarging sac may be difficult. However, 29 (69%) studies
succeeded in interpreting the index test without knowledge of the
reference standard and 31 (74%) studies succeeded in interpreting
the reference standard without knowledge of the test.
Finally, we acknowledge that we used the bivariate model as it is
recommended for purely binary tests or when different studies re-
port similar thresholds (Leeflang 2014). In our analysis, the target
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condition was a dichotomous outcome (endoleak present or en-
doleak absent) and none of the included studies mentioned or de-
fined any sort of threshold. However, by visual inspection of stud-
ies plotted in the ROC space, the presence of an implicit threshold
effect seems unlikely, as the variation of sensitivity between studies
seems to be unrelated to the variation of specificity (Figure 5).The
studies with similar specificity have quite different sensitivities and
the studies with similar sensitivity have quite different specificities,
suggesting a random effect rather than a threshold effect.
Comparison with existing literature
Our results can be compared to four systematic reviews that have
been published since 2005.
The most recent review was published in 2012 and compared
CDUS or CE-CDUS versus CT scan (Karthikesalingam 2012).
Karthikesalingam 2012 searched MEDLINE and Embase and
identified 25 studies that compared CDUS and 11 studies (961
paired scans) that compared CE-CDUSwith CT for all endoleaks.
All these studies were included in the present review. With respect
to the review fromKarthikesalingam 2012, our review included 13
additional studies (Abbas 2014; Arsicot 2014; Badri 2010; Clevert
2011; Costa 2013; Demirpolat 2011; França 2013; Gargiulo
2014; Gray 2012; Gurtler 2013; Motta 2012; Oikonomou 2012;
Perini 2012). The results of Karthikesalingam 2012 were similar
to our results despite the fact that review by Karthikesalingam
2012 did not differentiate the results based on the unit of analysis
(number of participants from number of scans): the sensitivity for
CDUS was 0.74 (95% CI 0.62 to 0.83) and the specificity was
0.94 (95%CI 0.90 to 0.97); whereas the sensitivity for CE-CDUS
was 0.96 (95%CI 0.85 to 0.99) and the specificity was 0.85 (95%
CI 0.76 to 0.92).
The second review searched MEDLINE, Embase, trial registries,
and conference proceedings to identify studies comparing CDUS
orCE-CDUSwithCT followingEVAR (Mirza 2010). The review
identified 21 studies for CDUS and provided a summary estimate
of sensitivity of 0.77 (95% CI 0.64 to 0.86) and specificity of
0.94 of (95% CI 0.88); in addition, for CE-CDUS, seven studies
were meta-analysed providing a sensitivity of 0.98 (95% CI 0.90
to 0.99) and a specificity of 0.88 (95% CI 0.78 to 0.94).
The third reviewwas a single author review that performed a search
in 2005 in MEDLINE only to identify studies that evaluated
the accuracy of CDUS to detect endoleaks (Sun 2006). From 21
included studies, the summary estimates of sensitivity was 66%
(95% CI 52% to 81%) and of specificity was 93% (95% 89% to
97%). Sun 2006 did not evaluate the accuracy of CE-CDUS.
The fourth review searched MEDLINE, Embase, BioMED Cen-
tral, and other databases in 2004 (Ashoke 2005a); it identified
eight published and two unpublished studies (Ashoke 2005b;
Ashoke 2005c) that evaluated the accuracy of CDUS in detecting
endoleaks. Overall, 711 participants (1355 paired scans) were eli-
gible for inclusion. Compared to CT scan, the summary estimates
of CDUS were 69% (95% CI 52% to 87%) for sensitivity and
91% (95% CI 87% to 95%) for specificity. Ashoke 2005a did not
consider studies that used contrast agents for image enhancement.
Applicability of findings to the review question
We identified a considerable number of studies with adequate
number of participants enrolled to sufficiently address the diag-
nostic performance of US for endoleak detection in people who
received EVAR for AAA. The characteristics of the participants in-
cluded, clinical setting in which participants received the tests, and
technical features of both index test and reference standard were
appropriate in most of the studies. However, the main concern
for applicability of the results from the present review was high
heterogeneity mainly related to studies that used CDUS. Calcu-
lating the predictive values based on the results of CDUS, of 1000
subjects with EVAR who will undergo CDUS, 35 subjects will
have their endoleaks missed and 47 will undergo unnecessary CT
scan since they will be incorrectly classified as having endoleak.
The number of missed endoleaks is significantly reduced to 15
when CE-CDUS is used (Summary of findings). Hence, the re-
sults from the present review suggest that in a clinical pathway
CE-CDUS can be the first modality for monitoring people who
receive EVAR. The proposed approach will permit people to avoid
the risk of nephrotoxicity and the burden of ionising radiation
from CT scans.
Knowledge of the type of endoleak is important for their manage-
ment. Type II endoleaks are the most common leaks after EVAR,
they are at low risk of rupture, and generally conservative man-
agement is not associated with increased risk of aneurysm rupture
(Lawrence-Brown 2009; Pippin 2016; Rayt 2009; Tolia 2005).
In one retrospective-prospective study of 77 endoleaks occurring
in 369 participants who received EVAR for infrarenal AAA be-
tweenMarch 1994 and June 2006, 41 (53%) were of type II. After
a mean follow-up period of four years, 48% had spontaneously
sealed, another 48% remained under observation (with an enlarg-
ing or stable sac), whereas only 20% had an enlarging sac; no rup-
tured aneurysms occurred and no participant required conversion
to open repair (Rayt 2009). These results were confirmed in amore
recent retrospective study in which type II endoleak occurred in
66/163 (40%) people who received EVAR (40%). Over a median
follow-up of 24.7 months, the aneurysm size remained unchanged
in 48.5%, decreased in 33.3%, and increased in 18.2% without
aneurysm ruptures, conversion to open repair, or aneurysm-re-
lated deaths (Pippin 2016).Hence, in light of our evidence, we can
conclude that type II endoleaks could be monitored safely with
CE-CDUS without employing CT. In this regard, it is relevant to
mention that US can offer the additional advantage of providing
dynamic information (the ability to document flow velocity and
direction in the aneurysm sac) that is not available with CT. For
example, Arko 2003, by comparing intrasac Doppler velocities
between sealed versus persistent type II endoleaks, concluded that
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US properties can be used to predict whether type II endoleaks
will spontaneously seal. Further research is needed regarding this
issue.
The management of type I and type III endoleak is quite differ-
ent and the role of US needs to be addressed. Type I endoleak is
characterized by a blood leak at the distal or proximal attachment
site of the stent due to a poor cohesion between the stent and the
aortic or iliac wall (Bashir 2009). A type I endoleak can occur im-
mediately after stent deployment requiring an immediate correc-
tion. Type I endoleak can also develop later and it requires urgent
intervention as it is characterized by high pressure with a risk of
aneurysm rupture or tearing (Bashir 2009). Type III endoleak is
characterized by leakage of blood through the body of a stent due
to poor apposition or separation of the components of the stent,
or it can be due to rupture or tear of the graft material. Similar to
type I endoleaks, type III endoleaks are considered high-pressure
leaks, with a high rupture risk and require prompt management
(Bashir 2009), although some suggest this complication is less fre-
quent with technological improvements (Lawrence-Brown 2009).
Notwithstanding, in a subgroup analysis, our results showed that
CE-CDUS can accurately identify both types I and III endoleaks
although specific accuracy studies for detection of type I and type
III are required.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Our findings support the use of contrast-enhanced colour duplex
ultrasound (CE-CDUS) as a primary approach with which clin-
icians can allocate people to subsequent ultrasound (US) moni-
toring and subsequent therapeutic or diagnostic management of
endoleaks in people who received endoluminal abdominal aortic
aneurysm repair (EVAR) for the treatment of abdominal aortic
aneurysm (AAA). When results of CE-CDUS are negative, clini-
cians can appoint patients for a subsequent US monitoring while
avoiding the performance of computed tomography (CT). When
results are positive, the performance of CT scan becomes manda-
tory to establish the type of endoleak and the subsequent thera-
peutic management.
Implications for research
Guidelines suggest endoleak monitoring at one, six, and 12
months and every year thereafter. Future studies may consider as-
sessing the diagnostic performance of US for each time frame in
which monitoring is performed and assess whether US accuracy
may vary during follow-up.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Abbas 2014
Clinical features and settings 23 consecutive participants attending for CTA and 3DCEUS imaging whowere thought
to have an endoleak following an EVAR
Type of stents received: bifurcated: 87% (n = 20); uni-iliac: 13% (n = 3).
Aneurysm diameter (mean ± SD): CTA measure: 6.6 ± 1.1 cm; US measure: 6.0 ± 0.97
cm.
Setting: tertiary referral vascular centre.
Participants 23 participants; 20 men; age (mean ± SD): 77.4 ± 6 years.
Comorbidities: not reported.
Geography: UK.
Study design Retrospective cross-sectional study; participants were consecutively enrolled
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: “The 3D reconstruction enables the operator to view the path
of the endoleak. The ability to manoeuvre the 3D reconstruction and view the images
in sagittal, coronal, and transverse planes simultaneously without moving the probe,
enables the operator to accurately identify if flow is within or outside the aneurysm sac.”
Endoleak (absolute n): 17.
Prevalence of endoleak: 56.7% (17/30).
Reference standard: CTA.
Image acquisition:
• contrast-enhanced images obtained on a 16-slice helical scanner with a 1-mm
slice thickness;
• CTA from diaphragm to femoral heads performed with participant supine;
• diameter measured antero-posterior inner to inner.
Type of CT scanner: Siemens Sensation (Siemens Medical, Germany).
Use of contrast: 100 mL of iodinated contrast medium Omnipaque 240 (iohexol, 240
mg/mL) administered at flow rate of 3 mL/s
Operator: consultant interventional radiologist.
Index and comparator tests Index test: 3D CE-CDUS.
Image production: with participants supine, AAA and stent-graft visualized and traced
to proximal neck, which was measured in cross-section and interrogated for potential
endoleak using low colour flow velocity or power Doppler colour flow settings
Type of US: Curefab 3D system comprises tracking sensors installed in transducer of
a high-definition duplex Doppler US system (IU22-C5) and an electromagnetic box.
This technology uses motion tracking mini-GPS with magnetic field emitter and 2
tracking sensors that transform standard 2D CEUS images into high-definition 3D
format (Curefab, Munich, Germany)
Use of contrast: yes, “SonoVue, Bracco, Milan, Italy.”
Operator: all images reviewed by a research fellow and reported by either an accredited
vascular or laboratory technologist
Comparator: 2D CE-CDUS.
Image production: with participants supine, AAA and stent-graft visualized and traced
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to proximal neck, which was measured in cross-section and interrogated for potential
endoleak using low colour flow velocity or power Doppler colour flow settings
Type of US: DUS instrument (Philips IU22) with C5-1 curved array transducer
Use of contrast: yes, “SonoVue, Bracco, Milan, Italy.”
Operator: all images reviewed by research fellow and reported by either an accredited
vascular laboratory technologist
Follow-up No loss to follow-up, missing data, or adverse events.
Notes • Study based on paired images rather than individual participants. Therefore, 30
paired images from 23 participants analyzed.
• Participants recruited from South Manchester EVAR surveillance programme
between May 2012 and May 2013.
• Interval between paired images 3.9 ± 2.7 (mean ± SD) weeks. Endoleaks detected
in 17 images with CTA, 18 with 2D CEUS, and 18 with 3D CEUS.
• 2D and 3D CEUS had the same accuracy for the simple detection of an endoleak.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants consecutively enrolled.
Acceptable reference standard?
All tests
Yes Reference standard was CTA.
Acceptable delay between tests?
All tests
No “The interval between paired images was 3.
9 ± 2.7 (mean ± SD) weeks. Range: same
day to 8 weeks.”
Partial verification avoided?
All tests
Yes Appeared all participants received both
tests.
Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
Incorporation avoided?
All tests
Yes Index testwas not part of the reference stan-
dard.
Reference standard results blinded?
All tests
Unclear No description provided.
Index test results blinded?
All tests
Unclear No description provided.
Relevant clinical information?
All tests
Yes Yes.
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Uninterpretable results reported?
All tests
Yes No apparent uninterpretable data oc-
curred.
Withdrawals explained?
All tests
Yes No explicit report concerning loss to fol-
low-up, missing data, or adverse events
AbuRahma 2005
Clinical features and settings 178 participants treated with aortic stent grafts for AAA.
Type of stents received: 86 Ancure (Guidant Corporation, USA), 55 AneuRx (Medtronic,
USA), and 37 Excluder (WL Gore & Associates, USA)
Aneurysm diameter: not reported.
Setting: vascular laboratory.
Participants 156 men; mean age: 74 years; range: 49-89 years.
Comorbidities: not reported.
Geography: USA.
Study design Cross-sectional study; participantswere consecutively enrolled; all participantswerewith-
out the target condition at the start of study
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: “An endoleak was determined using CT scans based on extravasa-
tion of contrast between the prosthesis and the aneurysm wall; by CDUS, endoleak was
indicated by flow and spectral signals outside the prosthesis. Primary or early endoleak
occurred within 30 days of the procedure; late endoleak referred to leaks observed beyond
30 days postoperatively.”
Endoleak (absolute n): 34.
Prevalence of endoleak: 9.3% (34/367).
Reference standard: helical CT imaging.
Image acquisition:
• non-contrasted and contrasted axial images of the abdominal aorta, 3D multiple
rotational projections and sagittal and coronal views;
• from 1 cm above celiac trunk to femoral bifurcation;
• thickness: 3 mm.
Type of CT scanner: Philips Medical Systems, Inc (Shelton, CT, USA).
Use of contrast: Optiray 350 (125 mL; Mallinkrodt Medical, USA).
Index and comparator tests Index test: CDUS.
Image production: transverse and anteroposterior images obtained from level of suprarenal
aorta above graft to distal iliac or femoral arteries
Type of US: HDI 5000 scanner, ATL-Philips, USA.
Use of contrast: no.
Operator: registered vascular technologist and board-certified vascular surgeon
Follow-up No loss to follow-up, missing data, or adverse events.
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Notes • Secondary objective: to compare pre- and postoperative maximal aneurysm
diameters.
• Study conducted between February 2000 and October 2004.
• Endoleaks, 26 (14.6%) early and 8 (4.5%) late; the 26 early endoleaks included
11 (6.2%) type I, 13 (7.3%) type II, and 2 (1.1%) type IV endoleaks; the 8 late
endoleaks after 30 days included 5 (2.7%) type I and 3 (1.6%) type II.
• Follow-up protocol for serial CT and CDUS scans at 1 month and every 6
months thereafter. Overall mean follow-up: 16 months, range: 1-53 months.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants consecutively enrolled.
Acceptable reference standard?
All tests
Yes Reference standard was CT scan.
Acceptable delay between tests?
All tests
Yes “CT and CDUS scans were considered
concurrent if they were done within 7 days.
”
Partial verification avoided?
All tests
Yes Appeared all participants that received both
tests.
Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Yes Reference standard performed before
CDUS.
Index test results blinded?
All tests
Yes “Neither the registered vascular technolo-
gist nor the reviewing surgeon was aware
of the CT results during any portion of the
CDUS examination.”
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes No apparent uninterpretable data (“no de-
layed imaging was performed to detect
questionable endoleaks”)
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Withdrawals explained?
All tests
Yes No explicit report concerning loss to fol-
low-up, missing data, or adverse events
Arsicot 2014
Clinical features and settings 75 consecutive participants treated with EVAR for infrarenal AAA, representing 116
pairs of examinations (3D US and CTA)
Type of stents received: Anaconda (Vascutek) 30, Low Profile (Cook) 4, Zenith (Cook)
28, Endurant (Medtronic) 1, Aneurx (Medtronic) 2, Excluder (WL Gore & Associates)
8, Powerlink (Edwards) 2
Aneurysm diameter: not reported.
Setting: academic hospital.
Participants 73 men; age (mean ± SD): 76.3 ± 9.2 years.
Comorbidities: diabetes (n = 18), dyslipidaemia (n = 67), BMI ≥ 30 kg/m2 (n = 15),
renal insufficiency (n = 24), supra-aortic trunks lesions (n = 19), angina (n = 42), ASA
score III-IV (n = 56)
Geography: France.
Study design Retrospective cross-sectional study; participants consecutively enrolled
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: not reported.
Endoleak (absolute n): 14.
Prevalence of endoleak: 29.2% (14/48).
Reference standard: CTA.
Image acquisition:
• volumetric calculation by CTA carried out by data processing of native sections of
CTA;
• native sections analysed by the free computer software OsiriX.
Type of CT scanner: Siemens Medical Solutions Inc (Somatom Definition AS+, Malvern)
Use of contrast: “The protocol of imagery included an injection of 100 mL of iodised
contrast of 250 concentration, with a 5 mL/s flow IV in the upper limb right.”
Operators: vascular surgeon.
Index and comparator tests Index test: 3D US
Image production: “The examination was carried out by 1 of the 3 vascular sonographers
of our institution with a transperitoneal approach. The ultrasound probe was placed
over the umbilicus in the longitudinal axis of the infrarenal abdominal aorta, and side
electronic scanning allowed a 3D acquisition of the infrarenal aneurysm to the aortic
bifurcation.”
Type of US: Toshiba Aplio XG ultrasound system (Toshiba Medical Systems, Zoetermeer,
the Netherlands) equipped with a marketed 3D 3.5-MHz dedicated probe
Use of contrast: no.
Operator: 1 vascular sonographer.
Follow-up No loss to follow-up, missing data, or adverse events.
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Notes • Study aimed to assess if US measurement of volume of aneurysmal sac was
comparable with that obtained by CTA (gold standard). Interobserver reproducibility
during follow-up of AAAs after EVAR also investigated.
• Study conducted between January 2010 and December 2012.
• “The subgroup analysis on 48 patients that had at least 2 volumetric echography
performed during their follow-up made it possible to highlight a threshold of increase
in volume of 6.5 cm3 to suspect an endoleak. This cutoff value of 6.5 cm3 allowed the
diagnosis with sensitivity, specificity, predictive positive value, and predictive negative
values of 85.7%, 85.3%; 71% and 94%; respectively. The area under the curve was 0.
854 (95% CI [0.793-0.915].”
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Patients were consecutively enrolled
Acceptable reference standard?
All tests
Yes The reference standard was CTA
Acceptable delay between tests?
All tests
No The average time interval between the
achievements of CTA and 3DU for a given
patient was 48.18 ± 36.52 days
Partial verification avoided?
All tests
Yes It appears that all patients that received
both tests
Differential verification avoided?
All tests
Yes All patients who received the index test
were subjected to the same reference stan-
dard
Incorporation avoided?
All tests
Yes The index test is not part of the reference
standard
Reference standard results blinded?
All tests
Yes “Volumetric calculation by CTA was car-
ried out by a single person, vascular surgeon
of formation, by data processing of the na-
tive sections of the CTA (Siemens Medical
Solutions Inc., Somatom Definition AS+,
Malvern). He did not know the results of
ultrasound measurements of volume”
Index test results blinded?
All tests
Unclear No description was reported
Relevant clinical information?
All tests
Yes Yes
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Uninterpretable results reported?
All tests
Yes No apparent uninterpretable data occurred
Withdrawals explained?
All tests
Yes No explicit report concerning loss to fol-
low-up, missing data or adverse events
Ashoke 2005b
Clinical features and settings 30 participants undergoing EVAR recruited consecutively.
1 participant underwent EVAR as treatment for a pseudoaneurysm, and 4 did not have
CT and CDUS scans within the required time intervals during follow-up. Remaining
25 participants had a mean (± SD) original AAA diameter of 6.0 ± 0.6 cm
Type of stents received: AneuRx (n = 3), Zenith Bifurcated (n = 8), Zenith Trifab (n =
5), EVT (n = 1), and Nottingham-style aortomonoiliac grafts with a femorofemoral
crossover (n = 8)
Aneurysm diameter: mean (± SD) original AAA diameter was 6.0 ± 0.6 cm.
Setting: hospital.
Participants 25 participants; 22 men; mean (± SD) age: 72.4 ± 6.9 years.
Comorbidities: not reported.
Geography: London, UK.
Study design Cross-sectional study; participants consecutively enrolled.
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: “Presence or absence of flowwithin the aneurysm sac.…Endoleaks
were defined by the presence of contrast within the aneurysm sac, and an attempt was
made to determine the site of any leak” (Thompson 1998).
Endoleak (absolute n): 6.
Prevalence of endoleak: 9.1% (6/66).
Reference standard: contrast-enhanced CT.
Image acquisition:
• CT using a Siemens HiQ scanner (Munich, Germany). Initial tomogram
determined cranial extent of proximal metallic stent. 30 s following IV contrast, serial
10-mm slices were performed from renal arteries to level of the femoral head.
Endograft imaged to determine presence of thrombus within graft lumen.
Type of CT scanner: Siemens HiQ scanner (Munich, Germany).
Use of contrast: not reported.
Index and comparator tests Index test: CDUS.
Image production: duplex imaging performed with participant supine. CDU utilized to
image flow within graft, and any flow disturbance noted. Endoleaks specifically sought
with colour Doppler set to detect low flow. CDUS scan times 35-55 minutes
Type of US: 3.5-MHz curved linear array transducer, HDI Ultramark 9 (ATL, Letch-
worth, UK)
Use of contrast: no.
Operator: not reported.
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Follow-up “The 30 patients all received follow-up scans at 1, 3, 12, 18, and 24 months postoper-
atively and annually thereafter, although not all follow-up procedures were undertaken
at the correct time intervals.”
Notes • Study conducted between July 1997 and September 2003.
• Endoleaks determined on CT scan in 6 participants (5 type II and 1 type III).
• Data reported in review by Ashoke 2005a.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants consecutively enrolled.
Acceptable reference standard?
All tests
Yes Reference standard was CT scan.
Acceptable delay between tests?
All tests
Unclear Interval between the 2 tests not clearly
stated: “At each visit, patients had a clinical
examination followed by CT and duplex
imaging.”
Partial verification avoided?
All tests
Yes Appeared all participants received both
tests.
Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Yes “Diagnostic imaging was performed by in-
vestigators who were blinded of the result
from the other imaging technique and pre-
vious scans.”
Index test results blinded?
All tests
Yes “Diagnostic imaging was performed by in-
vestigators who were blinded of the result
from the other imaging technique and pre-
vious scans.”
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes “The CT scans were suboptimal in 2 cases
due to calcification, but a diagnosis was still
made.”
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Withdrawals explained?
All tests
Yes “One pair of scans was excluded because
theCT scanswere not archived or reported,
and the films were lost from the hospital.”
Ashoke 2005c
Clinical features and settings 78 people received regular follow-up scans.
64 participants did not have CT and CDUS scans within required time intervals at any
point during follow-up. 10 remaining participants with paired scans were men
Type of stents received: AneuRx (n = 3), Excluder (n = 5), and Talent (n = 2).
Aneurysm diameter: mean (± SD) original AAA diameter: 6.0 ± 0.6 cm.
Setting: hospital.
Participants 10 men; mean (± SD) age: 75.0 ± 5.2 years.
Comorbidities: not reported.
Geography: London, UK.
Study design Cross-sectional study; participants consecutively enrolled.
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: “Presence or absence of flowwithin the aneurysm sac.…Endoleaks
were defined by the presence of contrast within the aneurysm sac, and an attempt was
made to determine the site of any leak” (Thompson 1998).
Endoleak (absolute n): 7.
Prevalence of endoleak: 30.4% (7/23).
Reference standard: contrast-enhanced CT.
Image acquisition:
• CT using Siemens HiQ scanner (Munich, Germany). Initial tomogram
determined cranial extent of proximal metallic stent. 30 s following IV contrast, serial
10-mm slices performed from renal arteries to level of femoral head. Endograft imaged
to determine presence of thrombus within graft lumen.
Type of CT scanner: Siemens HiQ scanner (Munich, Germany).
Use of contrast: not reported.
Index and comparator tests Index test: CDUS.
Image production: duplex imaging performed with participant supine. Colour Doppler
ultrasonography utilized to image flow within graft, and any flow disturbance noted.
Endoleaks specifically sought with colour Doppler set to detect low flow. CDUS scan
times 35-55 minutes
Type of US: 3.5-MHz curved linear array transducer, HDI Ultramark 9 (ATL, Letch-
worth, UK)
Use of contrast: no.
Operator: not reported.
Follow-up “2 patients were lost to follow-up, and CT films could not be located for 2 patients.”
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Notes • 78 participants received regular follow-up scans. However, 2 participants lost to
follow-up, and CT films could not be located for 2 participants. 64 participants did
not have CT and CDUS scans within required time intervals at any point during their
follow-up. All 10 remaining participants with paired scans were men (mean (± SD) age:
75.0 ± 5.2 years) with a mean (± SD) AAA diameter 6.5 ± 1.1 cm. Graft types used
were AneuRx (n = 3), Excluder (n = 5), and Talent (n = 2). These 10 participants
yielded 23 paired scans from 1 to 60 months (mean (±) SD: 11.6 ± 8.9 months).
• Study conducted between July 1997 and September 2003.
• 7 endoleaks detected by CT, all type II.
• 6 were also detected by CDUS, and 5 were identified as type II endoleaks.
• Remaining endoleak detected by CDUS but unclassified because of suboptimal
images due to participant habitus.
• 1 endoleak detected on CT not seen on US. CDUS detected 9 endoleaks, 3 of
which were type II endoleaks not seen on CT.
Data reported in review by Ashoke 2005a.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants consecutively enrolled.
Acceptable reference standard?
All tests
Yes Reference standard was CT scan.
Acceptable delay between tests?
All tests
Unclear Interval period between the 2 tests not
clearly stated: “At each visit, patients had
a clinical examination followed by CT and
duplex imaging.”
Partial verification avoided?
All tests
Yes It appeared all participants received both
tests.
Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Yes “Diagnostic imaging was performed by in-
vestigators who were blinded of the result
from the other imaging technique and pre-
vious scans.”
Index test results blinded?
All tests
Yes “Diagnostic imaging was performed by in-
vestigators who were blinded of the result
from the other imaging technique and pre-
vious scans.”
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Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes “The remaining endoleak was detected by
CDU [CDUS] but unclassified because of
suboptimal images due to patient habitus.
”
Withdrawals explained?
All tests
Yes “2 patients were lost to follow-up, and CT
films could not be located for 2 patients.”
Badri 2010
Clinical features and settings People with AAA who underwent EVAR between April 1998 and December 2007.
During this period, 93 procedures performed but complete records unavailable in 34
participants
Type of stents received: Cook-Zenith (William A Cook, Australia; 54 participants), Talent
Medtronic (Medtronic, UK) aortic stent graft (5 participants)
Aneurysm diameter: not reported.
Setting: Department of Vascular Surgery.
Participants 59 participants; 50 males; mean age: 79 years.
Comorbidities: not reported.
Geography: UK.
Study design Retrospective design; participants identified retrospectively based on availability of com-
plete records (“93 procedures were performed but complete records were unavailable in
34 patients”)
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: not reported.
Endoleak (absolute n): 14.
Prevalence of endoleak: 11.8% (37/314).
Reference standard: CTA (dual-phase multidetector CT).
Type of CT scanner: Philips MX80000 IDT or GE Prospeed SX.
Image acquisition for Philips MX80000 IDT:
• arterial and delayed phase acquisitions to cover the stent, 3D multiple rotational
projections and sagittal and coronal views;
• thickness: 5-mm slice, pitch 1;
• use of contrast: 120 mL of Iohexol (Omnipaque, GE Healthcare, Milwaukee, WI,
USA) IV contrast given at 3 mL/s, with bolus tracking to determine timing of arterial
phase, and delayed phase acquisition performed 60 s after.
Image acquisition for GE Prospeed SX:
• arterial and delayed phase acquisitions to cover the stent; 3D multiple rotational
projections and sagittal and coronal views;
• thickness: 3-mm slice, pitch 1.5;
• use of contrast: 120 mL Iohexol (Omnipaque, GE Healthcare, Milwaukee, WI,
USA) IV contrast given at 3 mL/s with arterial phase timing at 20-25 s and delayed
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acquisition at 60 s.
Index and comparator tests Index test: DUS (2-to 5-MHz transducer, Philips IU22 scanner).
Image production: anterior posterior and transverse aortic sac diameters measured in
transverse and longitudinal section. Pulsed Doppler used to evaluate any colour Doppler
signals exterior to graft
Type of US: 2- to 5-MHz transducer (Philips IU22 scanner).
Use of contrast: no.
Operator: registered vascular technologist and board-certified vascular surgeon
Follow-up 1, 3, 6, 12, and 18 months, and then yearly afterward (total of 314 paired scans obtained
over a follow-up period from 3 days to 9 years); no apparent loss to follow-up or missing
data
Notes Other endpoints: sac size: anterior posterior, transverse, and maximum diameter (Dmax )
; graft patency.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Although enrolled people with AAA who
underwent EVAR, they were retrospec-
tively studied and from 93 procedures per-
formed complete records were available for
only 59 participants
Acceptable reference standard?
All tests
Yes CTA (dual-phase multi-detector CT on a
Philips MX80000 IDT or GE Prospeed
SX)
Acceptable delay between tests?
All tests
Yes “Three hundred and fourteen paired scans
were studied. Paired scans and almost all
scans took place on the same day. Single
scans outside this timeframewere excluded.
”
Partial verification avoided?
All tests
Yes All study participants accounted for and re-
sults of reference standard reported for all
Differential verification avoided?
All tests
Yes All participants who received US subjected
to CT scan.
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Unclear “Two consultant interventional radiolo-
gists reported the CTA studies and 3
specialist vascular ultrasonographers per-
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formed and reported the DUS.”
Index test results blinded?
All tests
Unclear “Two consultant interventional radiolo-
gists reported the CTA studies and 3
specialist vascular ultrasonographers per-
formed and reported the DUS.”
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes All data interpreted.
Withdrawals explained?
All tests
Yes No apparent withdrawal occurred.
Bendick 2003
Clinical features and settings Overall population who received a stent composed of 63 male and 6 female participants,
mean (± SD) age 72.6 ± 8.7 years (range 58-87 years);
Type of stents received: not reported. 64 grafts hadmodular design and5 grafts had unibody
bifurcated design
Aneurysm diameter: mean (± SD) aneurysm size: 5.6 ± 0.9 cm.
Setting: vascular laboratory.
Participants Included participants were 19 males and one female patient; mean (± SD) age: 74.5 ±
7.6 years; range: 65-86 years. 18 of these participants had modular graft design and 2
participants had unibody bifurcated graft placed
Comorbidities: not reported.
Geography: USA.
Study design Unclear. Probably a retrospective study.
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: any endoleaks that were seen with DUS were classified as being
related to the stent graft itself (group l), at either proximal or distal attachment sites or at
any graft module junctions or secondary to patent aortic branch vessels (group II), such
as the inferior mesenteric artery or lumbar arteries, which showed collateral filing and
back-bleeding into the aneurysm sac. Endoleak classified as indeterminate if it could not
be definitively identified as being in group I or group II
Endoleak (absolute n): 8.
Prevalence of endoleak: 40% (8/20).
Reference standard: CT scan.
Image acquisition:
• delayed dual spiral imaging before and after (60-s and 120-s delays) a 175-200
mL bolus of IV contrast;
• thickness: multiple axial images with 2- to 3-mm slice thickness with 1.5-mm
reconstruction algorithm throughout the region of interest.
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Type of CT scanner: not reported.
Use of contrast: not clearly reported.
Index and comparator tests Index test: CDUS.
Image production: aorta scanned in long axis and in cross-sectional views from level
of diaphragm distally to below attachment sites of iliac limbs of stent graft. Residual
aneurysm sac size measured in both anterior-posterior and transverse dimensions at its
widest point, and arterial flow haemodynamics documented throughout stent graft with
spectral Doppler velocity measurements. Suspected endoleak further documented for
flow characteristics with spectral Doppler velocities
Type of US: standard DUS scan examination (LOGIQ 700, GE, Milwaukee, WI, USA)
with CDI and spectral Doppler velocity measurements
Use of contrast: yes (1-mL bolus of US scan contrast agent (Optison, Mallinckrodt, St
Louis, MO)
Operator: unclear.
Follow-up No apparent missing data or adverse events.
Notes • Overall population who received stent composed of 63 males and 6 females; mean
(± SD) age: 72.6 ± 8.7 years: range: 58-87 years; mean (± SD) aneurysm size: 5.6 ± 0.9
cm. 64 grafts had modular design, and 5 grafts had unibody bifurcated design.
• Timing of follow-up examination ranged from 1 to 12 months after graft
placement, with a mean (± SD) follow-up time 5.3 ± 3.0 months.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
No Of the whole sample who received stents,
20 participants included. While 10 partic-
ipants selected at random, remaining 10
participants selected based on participant’s
habitus or presence of bowel gas
Acceptable reference standard?
All tests
Yes Reference standard was CT scan.
Acceptable delay between tests?
All tests
Yes “All CT angiography were read within a 2-
week period of the duplex ultrasound scan.
”
Partial verification avoided?
All tests
Yes All study participants accounted for and re-
sults of reference standard reported for all
Differential verification avoided?
All tests
Yes All participants who received US subjected
to CT scan.
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
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Reference standard results blinded?
All tests
Yes “The operator was blinded to the results
of any previous ultrasound scans and of
any prior angiographic or CT angiography
studies.”
Index test results blinded?
All tests
Yes All CTA studies read independently for
presence or absence of endoleaks
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes “CT angiography identified eight en-
doleaks and classified two of them into
group I and three into group II; three ad-
ditional posterior sac endoleaks were seen,
but their origin was not clearly identified.”
Withdrawals explained?
All tests
Yes No withdrawals occurred.
Cantisani 2011
Clinical features and settings People who had undergone EVAR for AAA.
Type of stents received: EVAR devices employed were Excluder (WL Gore & Associates,
Flagstaff, AZ, USA) in 50 participants, Talent (Medtronic, Santa Rosa, CA, USA) in 55,
Powerlink (Endologix, Irvine, CA, USA) in 12, and Jomed (Jomed International AB,
Helsingborg, Sweden) in 6
Aneurysm diameter (mean ± SD): 5.4 ± 0.5 cm; range 3.9-8.7 cm.
Setting: vascular laboratory.
Participants 123 participants; 92 males and 31 females; mean (± SD) age: 63.0 ± 7.3 years; who had
undergone EVAR for AAA; aneurysm baseline mean (± SD) diameter: 5.4 ± 0.5 cm;
range 3.9-8.7 cm
Comorbidities: not reported.
Geography: Italy.
Study design Prospective, observational (cross-sectional) study.
Target condition and reference standard(s) Target condition: aneurysm sac size, attachment and integrity of prosthesis, andpresence
and type of any endoleak
Definition of endoleak: incomplete exclusion of aneurysm sac from circulation.
Endoleak (absolute n): 24.
Prevalence of endoleak: 22.2% (24/108).
Reference standard: CTA.
Image acquisition:
• CTA performed with 64-slice CT scanner. Triple-phase CT protocol carried out
with an unenhanced, an arterial (with bolus-tracking), and a delayed phase at 120s;
• thickness: 1.2 mm; reconstruction with soft kernel algorithm (B30), 1.5 and 3
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mm with 1.5 of recon increment.
Type of CT scanner: Somaton Sensation (SiemensMedical Solutions, Erlangen,Germany)
Use of contrast: non-ionic contrast media: Iomeron, Bracco, Milan, Italy, flow 4 mL/s
Index and comparator tests Index test: CDUS.
Image production: 3- to 5-MHz probe, with longitudinal and transversal scans with par-
ticipant lying in dorsal or lateral position. Aneurysm sac size measured in both anterior-
posterior and transverse dimensions at widest point and mean of these measurements
used for purposes of study. Arterial flow haemodynamics documented throughout stent
graft with spectral Doppler velocity measurements
CE-CDUS: 3- to 5-MHz probe and with low mechanical index (varying from 0.06 to
0.10; about 35-45 kPa), with real-time tissue harmonic imaging and contrast harmonic
imaging (pulse subtraction)
Type of US: Aplio XV (Toshiba Vx, Zoetermeer, the Netherlands) and Technos MPX US
(ESAOTE Biomedica, Genoa, Italy)
Use of contrast: yes; second-generation contrast agent (SonoVue, Bracco, Milan, Italy)
consisting of sulphur hexafluoride gas microbubbles in a phospholipid membrane
Operator: 2 radiologists with 20 and 10 years of experience in this particular field
Follow-up 15 participants excluded: 8 participants not undergo MRA (2 with claustrophobia; 6
had pace-maker); 3 because of renal failure; 1 participant because of the allergy to iodine;
3 because of presence of severe comorbidity (heart failure and severe pulmonary disease)
Notes • MRA also used as a comparator test.
• DSA performed in case of contradictory results at different modalities. Cases
positive for endoleak and considered for possible reintervention also underwent DSA
study and were eventually treated.
• MRA examinations conducted on 1.5-T scanner (Magnetom Avanto, Siemens
Medical System, Erlangen, Germany).
• Specific definitions for types of endoleaks not provided.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants consecutively enrolled for fol-
low-up to detect potential endoleaks
Acceptable reference standard?
All tests
Yes CTA used to detect target disease.
Acceptable delay between tests?
All tests
Yes CDUS and CE-CDUS performed on same
day, and, within 1 week, CTA and MRA
Partial verification avoided?
All tests
Yes All study participants accounted for and re-
sults of reference standard reported for all
Differential verification avoided?
All tests
Yes All participants who received US subjected
to CT scan.
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Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Yes “The radiologists were blinded to the re-
sults of any previous examination.”
Index test results blinded?
All tests
Yes Index test performed before reference stan-
dard.
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes Yes.
Withdrawals explained?
All tests
Yes 15 participants excluded from study be-
cause of the following reasons: 8 partic-
ipants could not undergo MRA (2 with
claustrophobia; 6 had pace-maker); 3 par-
ticipants because of renal failure, 1 partic-
ipant because of allergy to iodine, and 3
because of presence of severe comorbidity
(heart failure and severe pulmonary disease)
Clevert 2008b
Clinical features and settings People who received a stent for AAA and were included in surveillance programme for
endoleak detection
Type of stents received: not reported.
Aneurysm diameter: not reported.
Setting: radiology division.
Participants 43 consecutive participants; 43 males; mean age: 63 years.
Comorbidities: not reported.
Geography: Germany.
Study design Prospective recruitment of participants (“patients who were referred to our radiology
division to have a MS-CT using commercially available equipment, a supplementary
ultrasound investigation with a 4 MHz multi-frequency probe was conducted with the
modalities of colour duplex ultrasound and CEUS”)
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: persistence of blood flow outside lumen of endoluminal graft but
within an aneurysm sac or adjacent vascular segment being treated by the graft
Endoleak type I:
If flow into aneurysm sac originated from around stent graft attachment site, it was
classified as type I. Further categorization of type I endoleaks suggested as type IA
(proximal), type IB (distal), or type IC, indicating persistent flow lateral to an iliac
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occlusion stent graft in contralateral limb after implantation of a mono-iliac stent graft
Endoleak type II:
Type II endoleaks represent retrograde blood flow through aortic branch vessels into
aneurysm sac. They occur when blood travels through branches from unstented portion
of aorta or iliac arteries that anastomose with vessels in direct communication with
aneurysm sac. Typical sources include inferiormesenteric and lumbar arteries andRiolan’s
anastomosis
Endoleak type III:
Type III endoleaks occur when there is structural failure with the stent graft such as
stent-graft fractures or holes that develop in fabric of device. In addition, category in-
cludes junctional separations seen with modular devices. Although type III endoleaks
are currently rare, they will probably become more prevalent as stent grafts begin to age
and long-term follow-up of these participants accrues
Endoleak (absolute n): 15.
Prevalence of endoleak: 34.9% (15/43).
Reference standard: 16- or 64-detector CT scanner.
Image acquisition:
• imaged volume included entire abdominal aorta from lower thoracic portion and
common and external iliac arteries to upper femoral arteries. Acquisition direction
cranio-caudal;
• thin-slice maximum-intensity projections with increments of 0.6 mm and slice of
0.75 mm in coronal planes;
• for Sensation 64, collimation and table feed were 64 × 0.6 mm, rotation time 0.
33, pitch 0.9, slice thickness 0.3 mm, reconstruction interval 0.3 mm;
• for Sensation 16, collimation and table feed were 16 × 0.75 mm, rotation time 0.
5 s, pitch 1, slice thickness 3 mm, reconstruction interval 3 mm.
Type of CT scanner: 16- or 64-detector CT scanner (Somatom Sensation 16 or 64,
Siemens Medical Systems, Forchheim, Germany)
Use of contrast: 100-120 mL Imeron (Altana Pharma, Germany) with iodine concentra-
tion 350 mg/mL
Index and comparator tests Index test: CDUS/CE-CDUS.
Image production: transverse and sagittal imaging. In CDUS, colour gain selected just as
high as necessary to avoid overwriting artefacts (i.e. colour pixels outside perfused lumen
of vessel). Additionally, an automatic image gain optimisation could be selected. For
CEUS examinations, Sequoia systems were equipped with CPS software which detects
the microbubbles’ fundamental non-linear response. CEUS employed continuous low
mechanical index (0.15-0.19) real-time tissue harmonic imaging (Cadence) CPS imag-
ing. The US device featured a high-performance processor and allowed documentation
of dynamic image sequences in cine mode by a digital frame buffer
Type of US: 4-MHz multifrequency transducer (curved array).
Use of contrast: yes; contrast agent (SonoVue, Bracco, Milan, Italy) consisting of stabilised
microbubbles of sulphur hexafluoride administered into antecubital vein through 18-G
needle and followed by flush of 10 mL saline solution (0.9% NaCl)
Operator: 1 (sonographer was unaware of CT scan).
Follow-up No loss to follow-up, missing data, or adverse events.
Notes
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Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants consecutively enrolled for fol-
low-up to detect potential endoleaks
Acceptable reference standard?
All tests
Yes Reference standard was CT scan.
Acceptable delay between tests?
All tests
Yes “For the whole study population, con-
trast-enhanced CT examinations were per-
formed within 1 day before contrast-en-
hanced sonography.”
Partial verification avoided?
All tests
Yes All participants who received US were sub-
jected to CT scan.
Differential verification avoided?
All tests
Yes Index test not part of reference standard.
Incorporation avoided?
All tests
Yes Two tests were not incorporated.
Reference standard results blinded?
All tests
Yes All CT examinations performed and read
by experienced radiologists who were
blinded to results of both sonography and
contrast-enhanced sonography
Index test results blinded?
All tests
Yes Sonographer unaware of CT scan results
during the examination and reading of du-
plex and CEUS examination
Relevant clinical information?
All tests
Yes Relevant clinical information reported.
Uninterpretable results reported?
All tests
Yes All data were interpreted. (“In the follow
up the two false positive endoleaks (types
I and II) in CE-CDUS were confirmed as
true positive endoleaks by CE-CDUS and
MS-CT (Figs 7-9). The sensitivity of CE-
CDUS was therefore 100% and its speci-
ficity 100%; the positive and negative pre-
dictive values were 1 and 1, respectively.”)
Withdrawals explained?
All tests
Yes No withdrawals occurred.
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Clinical features and settings Participants referred to interdisciplinary ultrasound centre (KlinikumGrosshadern, Mu-
nich, Germany) for further diagnostic work-up and follow-up after EVAR for AAA
Type of stents received: not reported.
Aneurysm diameter: not reported.
Setting: interdisciplinary ultrasound centre.
Participants 35 consecutive participants; 33 men; mean age: 73 years; range: 54-83 years
Comorbidities: not reported.
Geography: Germany.
Study design Retrospective study; consecutively enrolled participants.
Target condition and reference standard(s) Target condition: endoleak (not defined).
Definition of endoleak: no definition provided.
Endoleak (absolute n): 4.
Prevalence of endoleak: 11.4% (4/35).
Reference standard: CTS (not clearly defined); image fusion with CTA.
No further information was reported.
Image acquisition: not reported.
Type of CT scanner: not reported.
Use of contrast: not reported.
Index and comparator tests Index test: CDUS.
Image production:-
Type of US: curved array multi-frequency probe: Siemens ACUSON S2000 (Siemens
Healthcare, Erlangen, Germany) system or a GE Logic E9 (GE Healthcare, Milwaukee,
WI, USA)
Use of contrast: yes, IV bolus of 1.0 mL of a second-generation blood pool contrast
agent (SonoVue, Bracco, Milan, Italy) consisting of stabilized microbubbles of sulphur
hexafluoride, followed by a second bolus injection of 10 mL saline solution (0.9%NaCl)
Operator: US examinations performed by experienced sonographer and were later read
by 2 blinded unbiased investigators with > 5 years of clinical US experience in consensus
Follow-up No loss to follow-up, missing data, or adverse events.
Notes • Period of enrolment: 15 months.
• Evaluation of stent graft flow artefacts in CCDS, CE-CDUS, and image fusion
(score 0, 1, 2):
◦ score 0 = incomplete flow detection with pronounced overwriting artefacts;
◦ score 1 = partial artefacts due to flow overwriting;
◦ score 2 = no artefacts with optimal flow detection.
• In CCDS followed by CE-CDUS and image fusion, detectability of endoleaks
and flow artefacts was evaluated semi-quantitatively by comparing image sequences in a
consensus reading performed by 2 experienced sonographers.
• Additional image fusion with CTA then performed.
• Period of follow-up unclear.
Table of Methodological Quality
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Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants consecutively referred for fol-
low-up to detect potential endoleaks
Acceptable reference standard?
All tests
Yes Reference standard was CTA.
Acceptable delay between tests?
All tests
Unclear No information provided.
Partial verification avoided?
All tests
Yes All study participants accounted for and re-
sults of CTA reported for all. (“All patients
who were sent to our department for fur-
ther diagnostic work-up and follow-up af-
ter EVAR, and who did not match any of
the exclusion criteria were included in the
study. We screened a total of thirty-five pa-
tients. Each patient was examined using all
diagnostic ultrasound and CT tools of the
study.”)
Differential verification avoided?
All tests
Yes All participants who received US subjected
to CT scan.
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Unclear Information not clearly reported.
Index test results blinded?
All tests
Yes Examiner initially blinded to CT results.
US examinations performed by experi-
enced sonographer and later read by 2
blinded unbiased investigators with > 5
years of clinical US experience in consensus
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Unclear Unclear.
Withdrawals explained?
All tests
Yes No apparent withdrawal.
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Clinical features and settings 40 people within the scope of stents monitoring protocol and risk of endoleaks type II
followed from November 2010 to February 2013
Type of stents received: fenestrated.
Aneurysm diameter (mean ± SD): 55 ± 8 mm in anteroposterior diameter.
Setting: vascular surgery department at the University Hospital of Lyon
Participants 39 men; age (mean ± SD): 75 ± 8 years.
Comorbidities: smoking habits, hypertension, dyslipidaemia, diabetes, overweight
Geography: France.
Study design Cross-sectional study.
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: ”Endoleaks (the most common complication) are responsible for
feeding the aneurysm sac and is a breaking risk factor. The type I endoleak is a leak at a
site proximal or distal attachment, type II is a reflux from the collateral of the aorta, the
type III is a defect in the wall of the stent, and Type IV is a result of a porosity of the
prosthesis.“
Endoleak (absolute n): 19.
Prevalence of endoleak: 31.7% (19/60).
Reference standard: CT.
Image acquisition:
• ”computed tomography of the aortic stent comprised of: a sequence without
injection, injection sequence with 120 mL of contrast medium, and a delayed sequence
of two minutes after injection;“
• ”the acquisition of the sequence without injection could be performed with a
wide collimation (two and one half millimeters), whereas the sequences with injection
should be performed with a collimating infra millimeter.“
Type of CT scanner: not reported.
Use of contrast: 120 mL of unspecified contrast medium.
Operator: CT performed and interpreted in radiology.
Index and comparator tests Index test: echo-Doppler with and without contrast injection. Contrast agent used in
people at risk of endoleak and had no contraindications to product
Image production: participants supine.
Type of US: General Electric equipment with a convex abdominal probe (4C-A) and
Siemens Acuson with a convex abdominal probe (C5-2)
Use of contrast: ”The contrast agent used (the only available in France) was the Sonovue
Braco Milan. The dose used was that recommended: 2.4 mL bolus followed by washing
with 5 ml of isotonic saline.“
Operator: echo-Doppler performed and interpreted by trained vascular physicians
Follow-up 3 participants excluded from study because they had contraindication for contrast
medium injection (severe pulmonary hypertension, heart failure stage III)
Notes • Aim of study was to demonstrate that use of CE-CDUS by an experienced
vascular physician could increase sensitivity of detecting type II endoleaks compared
with CTA taken as the gold standard.
• Study conducted between November 2010 and February 2013.
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• People with type I, III, and IV endoleak associated with type II endoleak not
included.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear Not clearly stated if the participants were
consecutively enrolled
Acceptable reference standard?
All tests
Yes Reference standard was CT scan.
Acceptable delay between tests?
All tests
Yes ”TheDopplerwith andwithout ultrasound
contrast agent injection was made within
less than 24 hours and CT less than ten
days before or after.“
Partial verification avoided?
All tests
Yes All participants received both tests.
Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Yes ”Ultrasound and CT analyzes were per-
formed independently and blindly (vascu-
lar doctor did not know the results of the
CT scan, and the radiologist did not know
the results of echo-Doppler).“
Index test results blinded?
All tests
Yes ”Ultrasound and CT analyzes were per-
formed independently and blindly (vascu-
lar doctor did not know the results of the
CT scan, and the radiologist did not know
the results of echo-Doppler).“
Relevant clinical information?
All tests
Yes Age, gender, risk factors, and comorbidities
of the participants reported
Uninterpretable results reported?
All tests
Yes No apparent uninterpretable data oc-
curred.
Withdrawals explained?
All tests
Yes ”Three patients were excluded from the
study because they had against-indication
for the contrast medium injection (se-
vere pulmonary hypertension, heart failure
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stage III)
d’Audiffret 2001
Clinical features and settings People with AAA who underwent endoluminal exclusion with commercially available
endoprosthesis and had a minimum follow-up of 6 months
Type of stents received: devices included Mintec system (n = 7), Vanguard system (n = 56),
Endovascular Technology (n = 11), Aneuryx (n = 2), Talent (n = 1), and Stenford system
(n = 12)
Prosthesis configurations were aortic tube grafts (n = 3), aorto-uni-iliac (n = 5), and
bifurcated grafts (n = 81)
Aneurysm diameter: mean aneurysm diameter: 53.2 mm; range: 45-80 mm on preoper-
ative CT
Setting: department of vascular medicine.
Participants 89 participants; mean (± SD) age: 70 ± 5 years; female: 6, male: 83; ASA classification
1: 2, 2: 37, 3: 40, 4: 10
Comorbidities: risk factors: ischaemic heart disease 50 (56.2%), previous myocardial
infarction 17 (19.2%), obesity 28 (31.3%), smoking 43 (49%), hypertension 53 (59.
4%), pulmonary disease 25 (29%), diabetes mellitus 8 (9%), renal impairment 10 (11%)
, and hyperlipidaemia 27 (30.3%)
Geography: France.
Study design Retrospective study with consecutively selected participants (“A total of 89 patients were
followed up with serial CT and DUS at 1, 3, 6, 12, and 24 months after endoluminal
treatment. Special attention was directed toward the presence of endoleaks and aneurysm
diameter evolution.”)
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: presence of contrast between graft and arterial wall of aneurysm
Endoleak (absolute n): 32.
Prevalence of endoleak: 36.0% (32/89).
Reference standard: helical CT Twin scanner.
Image acquisition:
• maximum anteroposterior and transverse diameters measured on films with a
caliper:
• thickness: 3.2-mm slices, 2.7 mm thickness, pitch 1.
Type of CT scanner: helical Elscint CTTwin scanner (PickerMarconi, Chatenay-Malabry,
France)
Use of contrast: yes, type of contrast not reported (“100 to 150 mL of nonionic contrast
agent”)
Index and comparator tests Index test: CDUS.
Image production: “The aorta from the renal to the distal iliac arteries was examined with
B-mode imaging. The largest anteroposterior and transverse diameters were measured
and recorded. Colour flow samplingwithin the aneurysm sac, outside the endoprosthesis,
was used to detect endoleaks. When flow was detected, a Doppler waveform analysis
completed the investigation.”
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Type of US: 3.5-MHz probe Esaote which included Doppler flow velocity measurement,
CDUS, power Doppler, and B-mode US (AU 4; Biomedica, Genoa, Italy)
Use of contrast: no.
Operator: physicians certified in vascular medicine and US.
Follow-up No loss to follow-up, missing data, or adverse events.
Notes Secondary objective included value of transverse diameter preoperatively and at each
follow-up examination and variations of diameter from preoperative to latest available
examination
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Spectrumof participantswas representative
of participants who receive test
Acceptable reference standard?
All tests
Yes CTs performed with helical Elscint CT
Twin scanner.
Acceptable delay between tests?
All tests
Yes “Comparisons were performed when both
examinations were done within a 1-month
interval.”
Partial verification avoided?
All tests
Yes After device implantation, participants fol-
lowed up with serial CT and DUS at 1,
3, 6, 12, 18, and 24 months, then yearly.
Current analysis performed on first 89 par-
ticipants who underwent endoluminal ex-
clusion and had minimum follow-up of 6
months
Differential verification avoided?
All tests
Yes All participants who received US subjected
to CT scan.
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
No “The physicians performing the DU
[DUS] or the CT may have been aware of
the results of the examination, which was
done first.”
Index test results blinded?
All tests
No “The physicians performing the DU or the
CT may have been aware of the results of
the examination, which was done first.”
Relevant clinical information?
All tests
Yes Yes.
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Uninterpretable results reported?
All tests
Yes “One false positive leak was detected with
duplex ultrasound.The patient had an arte-
riogram that did not confirm the endoleak.
Themost likely explanationwas a flowarte-
fact due to the high position of a contralat-
eral graft limb into the main graft body.”
Withdrawals explained?
All tests
Unclear No apparent withdrawal occurred.
Demirpolat 2011
Clinical features and settings People with endovascular repair of AAA.
Type of stents received: nitinol-based grafts.
Aneurysm diameter: mean (± SD): 64 6 ± 18.4 mm; range: 37-103 mm. Participant with
smallest aneurysm diameter (37 mm) was treated because of an associated iliac artery
aneurysm
Setting: department of radiology.
Participants 29 participants; 26 males; 3 females; mean age: 72.2 years; range: 47-90 years
Comorbidities: not reported.
Geography: Turkey.
Study design Longitudinal study (consecutively selected participants, all received both tests)
Target condition and reference standard(s) Target condition: type I and II endoleaks.
Definition of endoleak: persistence of flow in aneurysm lumen after procedure; persistent
flow can lead to increase in diameter of aneurysm, with subsequent risk of rupture
Endoleak (absolute n): 9.
Prevalence of endoleak: 35.4% (17/48).
Reference standard: CT scan.
Image acquisition:
• all images reconstructed at intervals equal to 50% of nominal slice thickness and
sent to a work station where sagittal, coronal, and oblique reformatted images parallel
to longitudinal axis of abdominal aorta were created. Maximal outer-to-outer
transverse diameter of aneurysm perpendicular to longitudinal axis of aorta measured
on reformatted images. Axial and reformatted images archived in DICOM (Digital
Imaging and Communications in Medicine) format. No precontrast or delayed images
obtained.
• thickness: 2 mm.
Type of CT scanner: 16-detector-row CT scanner (Toshiba Medical Systems, Tochigi-
ken, Japan)
Use of contrast: yes, type not specified (“100 ml of nonionic contrast material was injected
through an antecubital vein with an automated injector at a rate of 3 ml/sec”)
Index and comparator tests Index test: CDUS.
Image production: “The aneurysm and the stent graft were evaluated in axial and lon-
gitudinal planes with B mode and CDUS. The transverse and sagittal outer to outer
58Ultrasonography for endoleak detection after endoluminal abdominal aortic aneurysm repair (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Demirpolat 2011 (Continued)
diameter of the aneurysm at the site of largest diameter was measured in the axial plane
perpendicular to the axis of the aorta. The patency of the stent graft and iliac arteries
was assessed and perigraft flow was searched for with CDUS. The colour box size was
adjusted to encompass the entire aneurysm sac.”
Type of US: 3 types of duplex scanner, sector or linear scan heads with varying frequencies
(9 to 4-MHz linear or 4 to 1-MHz sector) (Siemens Sonoline Antares or Siemens Ellegra,
Siemens, Erlangen, Germany; or ATL HDI 5000, Advanced Technology Laboratories,
Bothell, WA, USA)
Use of contrast: no.
Operator: a radiologist experienced in DU.
Follow-up 1 participant dropped out because of violation of study protocol: 1 stroke occurred
during the time interval between the 2 investigations
Notes Data analysis at 48 months.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Spectrumof participantswas representative
of participants who will receive test
Acceptable reference standard?
All tests
Yes Reference standard was CT scan.
Acceptable delay between tests?
All tests
Yes CTA and CDUS examinations were per-
formed same day.
Partial verification avoided?
All tests
Yes Whole sample received reference standard
test.
Differential verification avoided?
All tests
Yes All participants who received US subjected
to CT scan.
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Yes “All CTA and CDUS exams were inter-
preted independently by two radiologists
blinded to the results of the other study.”
Index test results blinded?
All tests
Yes “All CTA and CDUS exams were inter-
preted independently by two radiologists
blinded to the results of the other study.”
Relevant clinical information?
All tests
Yes Yes.
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Uninterpretable results reported?
All tests
Yes No apparent uninterpretable results.
Withdrawals explained?
All tests
Unclear Insufficient information.
França 2013
Clinical features and settings 33 participants who had undergone elective endovascular treatment of AAAs
Type of stents received: not reported.
Aneurysm diameter: maximum transverse diameters (mean ± SD): 54.5 ± 12.6 mm for
CTA; 52.5 ± 13.1 mm for US
Setting: vascular ultrasonography units.
Participants 30 men; mean age (± SD): 73 ± 6.0 years.
Comorbidities: not reported.
Geography: Brazil.
Study design Prospective study; participants were consecutively enrolled.
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: “The transmission of flow and pressure into the aneurysm sac.”
Endoleak (absolute n): 12.
Prevalence of endoleak: 44% (22/50).
Reference standard: multidetector spiral CTA.
Image acquisition:
• “CTA images were obtained in the axial plane using a multidetector spiral CTA
during intravenous injection of iodinated non-ionic contrast. Isotropic multiplanar
reconstructions and three-dimensional reconstructions were obtained.”
Type of CT scanner: Elscint Twin Flash/Dual Slice Helical, Toshiba Multislice Aquilion,
Siemens 64-channel, Somatom Definition AS+/Multislice 128 channels
Use of contrast: iodinated non-ionic contrast.
Index and comparator tests Index test: CDUS.
Image production: “The vascular ultrasound protocol required 40 minutes to complete
and followed the recommendations of Sato et al.”
Type of US: Philips EnVisor and Philips HD-11 (Bothell, WA, USA).
Use of contrast: no.
Operator: 3 experienced vascular ultrasonographists certified, 3 radiologists specialising
in diagnostic imaging for vascular studies
Follow-up No loss to follow-up, missing data, or adverse events.
Notes • CTA identified 22 endoleaks (44%), compared to 12 (22%) with CDUS. Total
number of endoleaks identified by CTA defined as type II in 17 cases, type III in 3
cases, and unspecified type in 4 cases.
• Interval between the 2 examinations not exceed 90 days.
• 3 aspects evaluated in the 2 examinations: presence or absence of endoleak,
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presence of flow in the aortoiliac segment, and maximum AAA diameter.
• Authors stated: “Considering CTA as the gold standard for the diagnosis of
endoleaks, Doppler ultrasound showed a sensitivity of 54.5%, a specificity of 92.8%, a
positive predictive value of 85.7%, a negative predictive value of 92.9%, and an overall
accuracy of 76%.” Actually, according to 2 × 2 presented table, the correct negative
predictive value was 72.2%.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants consecutively enrolled.
Acceptable reference standard?
All tests
Yes Reference standard was CT scan.
Acceptable delay between tests?
All tests
No Maximum delay between the 2 examina-
tions 90 days.
Partial verification avoided?
All tests
Yes All participants received both tests.
Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Yes “Exam interpretation was blinded for test
information, even in patients with more
than one test pair.”
Index test results blinded?
All tests
Yes “Exam interpretation was blinded for test
information, even in patients with more
than one test pair.”
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes No apparent uninterpretable data oc-
curred.
Withdrawals explained?
All tests
Yes No explicit report concerning loss to fol-
low-up, missing data, or adverse events
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Clinical features and settings 22 consecutive participants who underwent fenestrated EVAR follow-up
Type of stents received: fenestrations were joined to native visceral vessels with a balloon-
expandable covered stent-graft (Advanta V12, Atrium Medical, Hudson, NH, USA)
Aneurysm diameter: mean (± SD) preoperative AAA diameter: 55 ± 7 mm; range: 48-71
mm
Setting: ultrasound unit.
Participants 21 men; mean (± SD) age: 74 ± 7 years; range: 54-80 years.
Comorbidities: all ASA≥ III (ASA III/IV: 82%/18%). 5 (23%) participants had BMI≥
30 kg/m2.
Geography: Italy.
Study design Cross-sectional study. Participants consecutively enrolled.
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: ”Endoleaks were detected and classified according to the White
and May classification” (White GH, Yu W, May J, Chaufour X, Stephen MS. Endoleak
as a complication of endoluminal grafting of abdominal aortic aneurysms: classifica-
tion, incidence, diagnosis, and management. Journal of Endovascular Surgery 1997;4
(2):152e68)
Endoleak (absolute n): 3.
Prevalence of endoleak: 14% (3/22).
Reference standard: CTA.
Image acquisition:
• “triple-phase CTA (unenhanced, arterial contrast-enhanced, and delayed phases
[180 seconds]) was acquired from the thorax to the femoral artery bifurcations;”
• “reconstructions at a slice thickness of 1 mm were performed;”
• “the CTA was processed on independent dedicated software for visceral vessel
analysis (3Mensio; Vascular Imaging, Bilthoeven, the Netherlands), and evaluated by
radiologists and vascular surgeons expert in endovascular aneurysm repair (EVAR) and
FEVAR planning and procedures.”
Type of CT scanner: 64-slice CT scanner (GE Healthcare, Milwaukee, WI, USA).
Use of contrast: “Iodinate contrast (100-130 mL Iomeron 400; Bracco, Milan, Italy) was
injected at 4 mL/second for the first 100 mL and 2 mL/second for the last 30 mL.
Contrast injection was followed by saline solution (0.9%NaCl) at a rate of 2mL/second.
”
Operator: “CTA was performed by a radiologist with experience in vascular CTA evalu-
ations (MD).”
Index and comparator tests Index test: 4D CE-CDUS.
Image production: “The US examination started with B-mode evaluation of the aorta
by live x-plane imaging where the maximal aneurysm diameter and the stent-graft were
evaluated. The abdominal aorta was scanned from the diaphragm to the iliac arteries
and the entire sac was analysed to detect possible colour flow within the aneurysm sac.
Then, the blood flow in the visceral and renal arteries was analysed in colour flow and
pulse-wave modes.”
Type of US: iU22 system, software Q-Lab (Philips Medical Systems, Bothell, WA, USA).
Fully sampled matrix array with frequency 6.0-1.0 MHz (x6-1; PhilipsMedical Systems,
Bothell, WA, USA)
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Use of contrast: “A sulfur hexafluoride-filled microbubble contrast agent (SonoVue; BR1,
Bracco).”
Operator: 1 “one investigator (CS) who had more than 10 years of experience in contrast
ultrasound and who was blinded to the CTA.”
Follow-up No loss to follow-up, missing data, or adverse events.
Notes • All US examinations, including baseline US, CE-CDUS, and 4D CE-CDUS.
• Aim of study was to evaluate 4D CE-CDUS as an alternative imaging method to
CTA during follow-up of fenestrated EVAR for juxtarenal and pararenal AAA.
• Study conducted between October 2011 and March 2012.
• Endpoints were comparison of postoperative AAA diameter, AAA volume,
presence of endoleaks, revascularized visceral vessel visualization, and patency.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants consecutively enrolled.
Acceptable reference standard?
All tests
Yes Reference standard was CTA.
Acceptable delay between tests?
All tests
Yes “The interval between the two examina-
tions was always ≤ 30 days.”
Partial verification avoided?
All tests
Yes All participants received both tests.
Differential verification avoided?
All tests
Yes All participants who received index test
were subjected to same reference standard
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Unclear Not clearly stated if CTA scans were per-
formed before US scans or if reader of CTA
scans was blinded to results of the other test
Index test results blinded?
All tests
Yes “All US scanning was performed by one
investigator […] who was blinded to the
CTA.”
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes No apparent uninterpretable data oc-
curred.
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Withdrawals explained?
All tests
Yes No explicit report concerning loss to fol-
low-up, missing data, or adverse events
Giannoni 2003
Clinical features and settings Participants scheduled to undergo endovascular repair of aortoiliac aneurysms
Type of stents received: not reported.
Aneurysm diameter: not reported.
Setting: department of vascular surgery.
Participants 30 consecutive participants; 29 men; mean age: 69 years; range: 50-82 years
Comorbidities: not reported.
Geography: Italy.
Study design Cross-sectional study.
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: endoleaks detected classified according to location of flow: type I
at proximal or distal attachment sites, type II from patent lumbar or inferior mesenteric
arteries, and type III at junction between graft and modular device extension
Endoleak (absolute n): 8.
Prevalence of endoleak: 9.9% (8/81).
Reference standard: CTA.
Image acquisition:
• precontrast and contrast-enhanced breath-hold scans obtained in craniocaudal
direction using: 3-mm collimation, 4.5 mm/s table speed, 1.5:1 pitch ratio, 210 mA,
300 mm coverage, and 50 s exposure time (total of 62.5 rotations).
Type of CT scanner: Somatom Plus-S scanner (Siemens Medical Systems, Munich, Ger-
many)
Use of contrast: yes, used non-ionic contrast agent (Omnipaque 300, Nycomed-Amer-
sham, Princeton, NJ, USA)
Index and comparator tests Index test: CDUS. unenhanced US imaging; enhanced US imaging.
Image production: “The aorta was examined with transverse and longitudinal B-mode
imaging from the renal to the distal iliac arteries; the maximal external diameter of the
aneurysm sac in any direction was measured…To assess proper stent-graft placement,
the distance between the graft and the renal arteries and the diameter of the aortic neck
were measured; colour flow sampling inside and outside the stent-graft was used to
verify graft patency and to detect endoleaks. A Doppler waveform analysis completed
the investigation.”
Type of US: B-mode, 3.5-MHz probe (Acuson 128 XP 10; Acuson, Mountain View, CA,
USA)
Use of contrast: US enhancer was galactose-based microbubble suspension 300 mg/mL
(Levovist SHU508A, Schering AG, Germany)
Operator: not reported.
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Follow-up “Onday 1 after the endovascular repair, unenhanced and enhanced ultrasound scanswere
performed. At 3 and 12 months and annually thereafter, aortic endograft surveillance
included ultrasound (unenhanced and enhanced) imaging, CTA orMRA comparable to
the preoperative study, and plain biplanar abdominal radiography, all performed within
a 7-day period.”
Notes • 26 bifurcated Vanguard stent-grafts (Boston Scientific, Natick, MA, USA)
deployed; 8 cases also had a straight Passeger extension (Boston Scientific) implanted; 2
straight Vanguard devices, 1 straight Passeger, and 1 straight Parodi style device.
• Other comparator tests used: MRA; plain abdominal radiography.
• Mean follow-up: 30 months; range: 6-60 months.
• Examinations performed at 3, 12, and 24 months.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Consecutive series of participants referred
for follow-up to detect potential endoleaks
Acceptable reference standard?
All tests
Yes Reference standard was CTA.
Acceptable delay between tests?
All tests
Yes All performed within 7-day period.
Partial verification avoided?
All tests
Yes All study participants accounted for and re-
sults of reference standard reported for all
Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Yes 2 experienced radiologists blinded to results
of the US jointly assessed CTAs andMRAs
Index test results blinded?
All tests
Yes Index test performed before reference stan-
dard.
Relevant clinical information?
All tests
Yes Clinical data available at time of test inter-
pretation.
Uninterpretable results reported?
All tests
Yes All data were interpretable.
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Withdrawals explained?
All tests
Yes “Endovascular AAA repair was technically
successful in 27 (90%) patients. Two (6.
7%) patients died in the periprocedural pe-
riod: one after conversion to an open re-
pair and the other after an additional in-
tervention. Of the remaining 28 patients,
26 (93%) reached the 24-month follow-up
(mean 30 months, range 6-60). One pa-
tient died 6 months after the endovascu-
lar procedure of thoracic aortic dissection;
a broken femur immobilized the other pa-
tient after he had completed the 12-month
evaluation. Complications during follow-
up included 2 (6.6%) limb occlusions at 6
and 12months, 2 (6.6%) extension detach-
ments at 6 and 24 months, 1 (3.3%) prox-
imal detachment due to neck dilatation at
24 months, and 1 (3.3%) kinked stent-
graft that displayed wire breakage, necessi-
tating late conversion to open repair. Other
than the wire breakage, which was identi-
fied only at radiography, all major compli-
cations were detected by unenhanced ultra-
sound and by CTA/MRA.”
Giannoni 2007
Clinical features and settings Participants who received endovascular grafts for infrarenal aortic aneurysms; 13 aortic
and 17 aortoiliac aneurysms, all previously treated in Department of Vascular Surgery
Type of stents received: 24 participants received Excluder (WLGore&Associates, Flagstaff,
AZ, USA); 3 received Vanguard (Boston Scientific, Natik, MA, USA); and 3 received
Talent (Medtronic, Minneapolis, MN, USA)
Aneurysm diameter: mean (±SD) transverse diameter: 53.19 ± 15.69 mm on contrast
CT-scan
Setting: division of vascular surgery.
Participants 30 consecutive people; mean (± SD) age: 74.4 ± 5.4 years; range: 65-84 years; BMI 22-
38 kg/m2.
Comorbidities: not reported.
Geography: Italy.
Study design Cross-sectional study; consecutively selected participants; all received both tests
Target condition and reference standard(s) Target condition: type II endoleaks.
Definition of endoleak: persisting flow from patent lumbar or mesenteric arteries within
aneurysm sac and outside endograft
Endoleak (absolute n): 7.
Prevalence of endoleak: 24.1% (7/29).
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Reference standard: contrast CT scan performed with delayed triphasic sequences. No
further information provided
Image acquisition: not reported.
Type of CT scanner: Somatom Sensation Cardiac 64 (Siemens, Munich, Germany).
Use of contrast: not reported.
Index and comparator tests Index test: CDUS.
Image production: not reported.
Type of US: convex probe (3-4 MHz), equipped for Cadence CPS software (Sequoia
Acuson Siemens, Mountain View, CA, USA)
Use of contrast: echo-contrast solution (Sono Vue, Bracco, Italy) injected in bolus by hand
into antecubital vein and immediately followed by 10 mL of saline solution
Operator:> 1 (“The US examinations were performed by vascular doctors dedicated to
US imaging (MD), blinded to the results of CT angiography.”)
Follow-up “One patient dropped out because of violation of the study protocol: a stroke occurred
in the time interval between the two investigations.”
Notes
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants represented average patients
who after receiving EVAR are exposed to
endoleak surveillance
Acceptable reference standard?
All tests
Yes Reference standard was CT scan.
Acceptable delay between tests?
All tests
Yes “No more than 15 days elapsed between
the two examinations.”
Partial verification avoided?
All tests
Yes All participants received both tests except
1 who dropped-out due to occurrence of
stroke
Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Yes US examinations performed by vascular
doctors dedicated to US imaging, blinded
to results of CTA
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Index test results blinded?
All tests
Yes US examinations performed by vascular
doctors dedicated to US imaging, blinded
to results of CTA
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes “In one patient in which both investiga-
tions detected the increase of the diameter
of aneurysm sac, CPS US (Video 1) (Fig.
2) demonstrated the type II endoleak not
confirmed toCT-scan (Fig. 3). The angiog-
raphy disclosed a low flow type II endoleak
from a lumbar artery.”
Withdrawals explained?
All tests
Yes “One patient dropped out because of vio-
lation of the study protocol: a stroke oc-
curred in the time interval between the two
investigations.”
Golzarian 2002
Clinical features and settings People who underwent transfemoral insertion of stent grafts (endoluminal graft; Corvita
Europe, Brussels, Belgium) for AAA. In 21 participants, aneurysm was aortoiliac; re-
maining 34 participants had aortic aneurysms
Type of stents received: not reported.
Aneurysm diameter: range 5.1-7.8 cm.
Setting: department of radiology.
Participants 55 participants; 51 men; mean age: 73 years; range: 61-87 years
Comorbidities: no comorbidities reported.
Geography: Belgium.
Study design Prospectively and consecutively enrolled participants (”All patients prospectively under-
went colour Doppler sonography and biphasic helical CT within 7 days after stent-graft
implantation“)
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: Type I endoleak: direct flow into the aneurysmal sac related to
the incomplete sealing of the stent-graft to the aortic wall. Type II endoleak: retrograde
filling of the aneurysm mainly from the lumbar arteries and the inferior mesenteric
artery”. Mentioned but not defined: transgraft endoleak, graft-fabric degradation, and
graft-junction separation
Endoleak (absolute n): 22.
Prevalence of endoleak: 41.5% (22/53).
Reference standard: CT scan.
Image acquisition:
• “the aorta and iliac arteries were imaged from the celiac trunk to the common
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femoral arteries using the following parameters: a collimation of 5 mm with a pitch of
1.2, 120 kV, and 240 mA. All the images were reconstructed with a 4-mm increment.
A leak was considered present if contrast material was noted outside the stent-graft in
either acquisition. All images were reviewed on radiographs and a workstation in
conference with two radiologists who were unaware of the colour Doppler sonographic
results. In this study, biphasic helical CT was considered the gold standard. The
examination ranged from 15 to 20 min;”
• thickness: “a collimation of 5 mm with a pitch of 1.2, 120 kV, and 240 mA.”
Type of CT scanner: SomatomPlus S or a 4A scanner (SiemensMedical Systems, Erlangen,
Germany)
Use of contrast: 15 mL contrast medium or a bolus tracking system with threshold of
100 H used to determine optimal start delay. Participants received 80-120 mL contrast
medium at rate of 3.5 mL/s
Operators: “All helical CT examinations were performed by two experienced radiologists.
”
Index and comparator tests Index test: CDUS.
Image production: “The aorta was first scanned transversally from the top of the stent-
graft to the femoral arteries, and the maximal transversal diameter was measured. Colour
Doppler imaging was then performed in both the transverse and longitudinal axes.” A
leak considered present when signal associated with spectral Doppler signal observed
outside aorta. In case of a perigraft leak, attempted to identify origin and direction of
flow
Type of US: 2.5- and 3.75-MHz curved array transducer SSH-140A (Toshiba, Antwerp,
Belgium)
Use of contrast: no.
Operator: 2 experienced operators (1 angiologist and 1 radiologist).
Follow-up 1 participant lost to follow-up.
Notes • “Color Doppler sonography and CT angiography were used as follow-up
modalities in participants at 3, 6, and 12 months and every 6 months thereafter.”
• “Angiography was performed in cases of persistent leak to plan the optimal
treatment. CT angiography started with a global injection of the aorta. Acquisition
time was long enough to allow the detection of a type II endoleak. In case of a type I
endoleak, the origin of the sac was catheterized and an intra-aneurysmal injection was
performed for optimal evaluation of the outflow vessels. The superior mesenteric artery
and each of the internal iliac arteries were injected with contrast material to detect
retrograde filling of the aneurysm from the inferior mesenteric artery or the iliolumbar
arteries.”
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants represented average patients
who after receiving EVAR are exposed to
endoleak surveillance
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Acceptable reference standard?
All tests
Yes Reference standard was CT scan.
Acceptable delay between tests?
All tests
Yes “All patients prospectively underwent
colour Doppler sonography and biphasic
helical CT within 7 days after stent-graft
implantation. The maximum time inter-
val between helical CT and colour Doppler
sonography was 48 hr (mean, 11.5 hr);
however, 33 patients had both examina-
tions on the same day. In all patients, colour
Doppler sonography was performed before
helical CT.”
Partial verification avoided?
All tests
Yes All study participants accounted for and re-
sults of reference standard reported for all
Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Unclear “All patients prospectively underwent
colour Doppler sonography and biphasic
helical CT within 7 days after stent-graft
implantation. The maximum time inter-
val between helical CT and colour Doppler
sonography was 48 hr (mean, 11.5 hr);
however, 33 patients had both examina-
tions on the same day. In all patients, colour
Doppler sonography was performed before
helical CT.”
Index test results blinded?
All tests
Yes “In all patients, colourDoppler sonography
was performed before helical CT.”
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes “All helical CT scans were considered to be
of good quality. Two colour Doppler sono-
graphic examinations (3.6%) were consid-
ered to be uninterpretable because of pa-
tient obesity or intestinal gas. Six colour
Doppler sonograms (10.9%) were evalu-
ated as suboptimal because of excessive ar-
tifact caused by obesity, intestinal gas, or
inappropriate gain (colour artifact com-
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pletely filling the colour box).”
Withdrawals explained?
All tests
Yes No withdrawal occurred.
Gray 2012
Clinical features and settings People who underwent EVAR at the Mater Hospital from 1 June 2003 to 1 July 2010
retrospectively reviewed
Type of stents received: not reported.
Aneurysm diameter: not reported.
Setting: department of vascular surgery.
Participants 145 participants; 122 (84.1%) male; mean (± SD) age: 77.1 ± 7.9 years
Comorbidities: not reported.
Geography: Ireland.
Study design Retrospective design.
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: type I, evidence of high jet flow; type II, endoleak or low velocity
flow within the old aneurysm sac demonstrating forward and reversed flow
Endoleak (absolute n): 25.
Prevalence of endoleak: 5.4% (25/459).
Reference standard: CT scan.
Image acquisition: not reported.
• thickness: 0.75-mm slices.
Type of CT scanner: Somatom Definition AS 128-slice scanner (Siemens AG, Erlangen,
Germany)
Use of contrast: not reported.
Index and comparator tests Index test: CDUS.
Image production: all CDUS began with visualisation of aorta immediately inferior to
diaphragm. Residual aneurysm imaged in B-mode in both transverse and longitudinal
planes from diaphragm to iliac bifurcation. Multiple measurements obtained of residual
aneurysm sac in transverse plane. Maximum measurements of residual aneurysm sac
recorded and compared to last scan report to ensure there was no significant increase in
sac size. Careful note made in B-mode of stent walls to ensure there was no evidence of
obvious defects or kinking ofmetal exoskeleton. Iliac arteries imaged inB-mode through-
out entire length. Multiple transverse and anteroposterior measurements obtained and
maximum of the 2 measurements recorded for follow-up purposes
Type of US: 6-mHz curvilinear broadband transducer: Sequoia 512 Ultrasound system
and later in study an S200 Ultrasound system (Siemens AG, Erlangen, Germany)
Use of contrast: no.
Operator: 1 accredited vascular technologist.
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Follow-up CDUS and CT scans of 31 (21.4%) participants not compared due to inconsistent
timing of imaging modalities (scans performed > 90 days apart excluded), failure to
attend and CT being contraindicated due to IV contrast allergy
Notes After discharge, all participants CDUS scan at 1 month and then CDUS scan and CT
scan at 6months, 12months, and annually thereafter provided there was no documented
endoleak on either CDUS or CT
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants represented average patients
who after receiving EVAR are exposed to
endoleak surveillance
Acceptable reference standard?
All tests
Yes Reference standard was CT scan.
Acceptable delay between tests?
All tests
Unclear Number of participants with delays be-
tween the 2 test > 28days unclear.However,
study reported “scans performed greater
than 90 days apart were excluded.”
Partial verification avoided?
All tests
Yes All study participants accounted for and re-
sults of reference standard reported for all
Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Yes In all cases, technologist was blind to CT
results.
Index test results blinded?
All tests
Unclear No clear information provided.
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes Of the 2 participants who had type I
endoleak on CDUS and not on CT, 1
was anatomical abnormality and misinter-
preted on the CDUS scan. The second
participant was documented as type II en-
doleak on CT. 4/5 participants who had
type I endoleak detected on CDUS under-
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went further intervention
Withdrawals explained?
All tests
Yes “The CDUS and CT scans of the remain-
ing 31 (21.4%) patients were not com-
pared due to inconsistent timingof imaging
modalities (scans performed greater than
90 days apart were excluded), failure to at-
tend and CT being contra-indicated due to
i.v. contrast allergy
Of the 426 CDUS scans carried out 26
(6.1%) scans were reported as limited, due
to the presence of excess bowel gas and
body habitus curtailing the determination
of residual sac size and endoleak detection.
The maximum residual aneurysm size was
documented on the remaining 400 (93.
9%) CDUS scans. Of the 289 CT’s per-
formed 107 (37%) did not have the max-
imum residual aneurysm sac size docu-
mented in the report. Themaximum resid-
ual aneurysm size was documented on the
remaining 182 (63%) of CT scan reports.”
Gurtler 2013
Clinical features and settings 171 people after EVAR who received 489 CE-CDUS and 421 MS-CT examinations
during follow-up. 39 participants withdrawn because of timemismatch between imaging
studies. 200 contemporary examination pairs ± 30 days from 132 participants of the 489
CE-CDUS and 421 MS-CT examinations matched
Type of stents received: bi-iliac or mono-iliac stent graft.
Aneurysm diameter: not reported.
Setting: department for clinical radiology.
Participants 151 men; mean (± SD) age: 70.4 ± 8.6 years; range: 34-91 years
Comorbidities: not reported.
Geography: Germany.
Study design Cross-sectional study.
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: “An endoleak was defined as an extravasation of contrast between
the aneurysm wall and the prosthesis.”
Endoleak (absolute n): 87.
Prevalence of endoleak: 43.5% (87/200).
Reference standard: MSCT.
Image acquisition:
• “the imaged volume included the entire abdominal aorta from its lower thoracic
portion and the common and external iliac arteries to the upper femoral arteries. The
73Ultrasonography for endoleak detection after endoluminal abdominal aortic aneurysm repair (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Gurtler 2013 (Continued)
acquisition direction was craniocaudal;”
• “images were reconstructed as thin-slice maximum-intensity projections with
increments of 0.6 mm and slice of 0.75 mm in coronal planes.”
Type of CT scanner: Somaton Sensation 16-, 64-, or 128-slice detector MS-CT scanner
(Siemens Medical Systems, Forchheim, Germany)
Use of contrast: “A total of 100 to 120 mL Imeron (Bracco) with an iodine concentration
of 350 mg/mL was administered, followed by 50 mL saline (0.9% NaCl).”
Operator: 2 experienced radiologists.
Index and comparator tests Index test: CE-CDUS.
Image production: transverse and sagittal imaging.
Type of US: ACUSON Sequoia 512 and a ACUSON S2000 (Siemens Healthcare, Er-
langen, Germany) using a curved-array 4-MHz multi-frequency transducer
Use of contrast: “an intravenous bolus injection of 1.0 mL SonoVue, a second-generation
blood pool contrast agent, consisting of stabilized microbubbles of sulfur hexafluoride,
was administered into an antecubital vein through an 18-gauge needle and was followed
by a flush of 10 mL saline solution (0.9% NaCl).”
Operator: 1 experienced sonographer.
Follow-up 39 participants withdrawn because of time mismatch between imaging studies
Notes • Aim of studyto show that CE-CDUS imaging is as good as MS-CT in detecting
endoleaks and even better than MS-CT in classifying different endoleak types.
• Study conducted between February 2006 and February 2011.
• 2 study participants received new stent grafts during the follow-up, so total of 173
stents examined.
• During the follow-up interval, 97/173 participants (56.1%) showed an endoleak,
but 19 of the primary endoleaks sealed spontaneously.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear Not clearly stated if the participants were
consecutively enrolled
Acceptable reference standard?
All tests
Yes Reference standard was MS-CT scan.
Acceptable delay between tests?
All tests
Yes “We compared examinations that were per-
formed on the same day or ≤30 days.”
Partial verification avoided?
All tests
Yes All participants received both tests.
Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
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Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Yes “Radiologists reading one test did not have
access to the results of the other test.”
Index test results blinded?
All tests
Yes “Radiologists reading one test did not have
access to the results of the other test.”
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes No apparent uninterpretable data oc-
curred.
Withdrawals explained?
All tests
Yes “39 patients were withdrawn because of
time mismatch between imaging studies.”
Heilberger 1997
Clinical features and settings People with aortic aneurysm who received EVAR.
Indications for stent-graft placement were symptomatic thoracic aortic aneurysm in 2
participants, suprarenal AAA in 1 participant, and infrarenal AAAs in remaining 110
participants
Types of endografts used: 9 tube and 34 bifurcate stent-grafts; Chuter device, Stentor
(MinTec, Freeport, Grand Bahama), and EGS aortic endograft (Endovascular Technolo-
gies, Menlo Park, CA, USA)
Aneurysm diameter: mean: 45.5 mm; range: 32-72 mm.
Setting: department of vascular surgery, Klinikum Nurnberg.
Participants 113 participants; 108 men; mean age: 67.3 years; range: 40-83 years
Comorbidities: not reported.
Geography: Germany.
Study design Not clear description. Apparently participants were retrospectively identified
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: persistent blood flow within the aneurysm sac. Primary endoleaks
defined as those noted during or immediately after procedure, whereas secondary leaks
were detected at follow-up examinations. Endoleaks that were disclosed only with con-
trast-assisted contrast duplex sonography were deemed minor leaks; major endoleaks
were those whose flow was detected by routine CDUS
Endoleak (absolute n): 28.
Prevalence of endoleak: 24.8% (28/113).
Reference standard: helical CT.
Image acquisition:
• “the aorta and iliac arteries were imaged from the celiac trunk to the common
femoral arteries using the following parameters: a collimation of 5 mm with a pitch of
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1.2, 120 kV, and 240 mA. Fifteen seconds after the end of the arterial phase
acquisition, a delayed acquisition was performed using the same parameters as the
arterial phase and covering the stented volume. All the images were reconstructed with
a 4-mm increment. A leak was considered present if contrast material was noted
outside the stent-graft in either acquisition.”
Type of CT scanner: SomatomPlus S or a 4A scanner (SiemensMedical Systems, Erlangen,
Germany)
Use of contrast: “Either a bolus test injection of 15 mL of contrast medium or a bolus
tracking system with a threshold of 100 H was used to determine the optimal start delay
(unenhanced CT scans not obtained).”
Index and comparator tests Index test: CDUS.
Image production: 4-6 standard transverse images of aneurysm sac and stent graft to define
their positions. Bifurcated stent-grafts also examined using pulse Doppler frequency
analysis to evaluate flow characteristics in both stent-graft limbs
Type of US: unclear/not reported.
Use of contrast: yes, Levovist: 99.9% of D-galactose and 0.1% of palmitic acid
Operator: unclear.
Follow-up Excluded from follow-up were:
• 11 participants (9.7%) who required conversion to open surgical repair either
during or shortly after endovascular procedure. Included in this number was 1
participant who died from haemorrhagic shock secondary to a retroperitoneal
haematoma at the femoral puncture site;
• 5 participants died of causes unrelated to procedure: 1 prostate cancer, 1
bronchial carcinoma, and 3 cardiopulmonary disease.
Mean follow-up time: 7.2 months; range: 1-24 months.
Notes
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants represented average patients
who after receiving EVAR are exposed to
endoleak surveillance
Acceptable reference standard?
All tests
Unclear CT scan test with contrast agents per-
formed, but not reported that images eval-
uated by a radiologist
Acceptable delay between tests?
All tests
Yes “Computed tomography angiography was
performed on the same day.”
Partial verification avoided?
All tests
Yes All study participants accounted for and re-
sults of reference standard reported for all
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Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Unclear Unclear.
Index test results blinded?
All tests
Unclear Unclear.
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes “Among 5 endoleaks due to retrograde
side-branch perfusion, 3were detected only
with contrast-enhanced duplex scanning;
iliac artery occlusion was also documented
using duplex, however, 2 stent fractures
could not be seen with ultrasound…”
“One endoleak originating from the distal
iliac limb anchoring site was missed by du-
plex owing to bowel gas.”
“Two patients with retrograde aneurysm
perfusion via the lumbar arteries remain
under observation. In one, aminor leakwas
documented by duplex with Levovist only;
it was not seen on CT scans, even with frac-
tionated injection of contrast agent.”
Withdrawals explained?
All tests
Unclear Excluded from follow-up were 11 partici-
pants (9.7%) who required conversion to
open surgical repair either during or shortly
after endovascular procedure. Included in
this number was 1 participant who died
from haemorrhagic shock secondary to a
retroperitoneal haematoma at the femoral
puncture site
5 participants died during follow-up of
causes unrelated to the procedure: 1
prostate cancer, 1 bronchial carcinoma, and
3 cardiopulmonary disease
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Clinical features and settings People who underwent endovascular treatment for an infrarenal AAA
Type of stents received: not reported.
Aneurysm diameter: 5.3 cm.
Setting: unclear.
Participants 20 men; mean age: 70.4 years;
Mean height of group: 179 cm; range: 162-200 cm; mean weight: 91 kg; range: 61-137
kg; mean BMI: 28.2 kg/m2; mean aneurysm size: 5.27 cm at time of follow-up.
Comorbidities: not reported.
Geography: USA.
Study design Prospective study that included only men.
“A prospective study, approved by the Institutional Review Board of Baylor College of
Medicine, was conducted to evaluate the effectiveness of CE-CDUS imaging to detect
endoleaks in patientswhounderwent endovascular treatment for an infrarenal abdominal
aortic aneurysm. Patients are typically followed after a successful endovascular aneurysm
repair at 1, 6, 12, and 24 months, and annually thereafter. All men and postmenopausal
women seen at these follow-up intervals were asked to participate unless there was a
documented contraindication to the use of ultrasound contrast, blood products, or
albumin.”
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: presence of persistent intrasac flow outside stent-graft. Endoleaks
characterized in relation to endograft, aneurysm wall, and aortic side branches, and
recorded in accordance to the White-May classification
Endoleak (absolute n): 6.
Prevalence of endoleak: 30% (6/20).
Reference standard: CTA.
Image acquisition: unclear.
• Tomograms reconstructed using a 1.5-mm algorithm from celiac to iliac arteries.
Type of CT scanner: Lightspeed Ultra (GE Healthcare, Waukesha, WI, USA).
Use of contrast: yes (type unknown; injection of 150 mL of contrast agent at rate of 2.5
mL/s)
Index and comparator tests Index test: CDUS.
Image production: infrarenal aorta and native aneurysm sac scanned after Optison injec-
tion in longitudinal and transverse perspective from renal to distal iliac arteries. Flow
evaluated within lumen of graft and its components, as well as the presence or absence
of endoleaks
Type of US: 3.5-MHz probe on a Phillips iU22 unit (Phillips Medical Systems, Bothell,
WA, USA)
Use of contrast: yes, Optison (Perflutren Protein Type A Microspheres for Injection,
Amersham Health, Princeton, NJ, USA)
Operator: 4 experienced vascular sonographers.
Follow-up No missing data at follow-up.
No adverse events secondary to CE-CDUS.
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Notes • Participants typically followed after a successful EVAR at 1, 6, 12, and 24 months,
and annually thereafter.
• “Grey scale assessment protocols were performed, beginning at the level of the
renal arteries and followed to the iliac bifurcation. Colour Duplex was then performed,
using a curved array 2- to 5-MHz probe. A mechanical index of at least 1.2 was used.
Special attention was directed to the area of maximum dilatation of the aneurysm
where both limbs of the endograft were visualized. A meticulous evaluation for the
presence of pulsatile colour flow was performed at the attachment sites proximally and
distally as well as at the junctional points of the modular grafts. Potential areas of
endoleak, such as the inferior mesenteric artery or lumbar arteries were also inspected.
The inspection was performed in both transverse and longitudinal orientations.”
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants represented average patients
who after receiving EVAR are exposed to
endoleak surveillance
Acceptable reference standard?
All tests
Unclear CT scan with contrast agency but not de-
clared that images evaluated by a radiolo-
gist
Acceptable delay between tests?
All tests
Yes CTA performed on same day before CE-
CDUS.
Partial verification avoided?
All tests
Yes All study participants accounted for and re-
sults of reference standard reported for all
Differential verification avoided?
All tests
Yes 20 men underwent surveillance utilizing
both CTA and contrast-enhanced CDI
Incorporation avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
Reference standard results blinded?
All tests
Yes CTA performed on same day before CE-
CDUS.
Index test results blinded?
All tests
Yes Ultrasonographers blinded to results of pre-
vious angiographic or CTA results
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes No uninterpretable results occurred.
“Colour Duplex ultrasound scans identi-
fied four (44%) endoleaks, including the
type I endoleak. Six (67%) endoleaks were
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also identified with CTA. Three type II en-
doleaks found onCE-CDUSwere not con-
firmed on CTA (Fig 3). No endoleaks were
seen on CTA that had not been found on
CE-CDUS.”
Withdrawals explained?
All tests
Yes No withdrawals occurred.
Iezzi 2009
Clinical features and settings People who underwent endovascular repair of an unruptured infrarenal AAA
Type of stents received: 81 aorto-bi-iliac stent grafts, consisting of 43 Talent (Medtronic
AVE), 28 Excluder (WL Gore & Associates), 8 Zenith (Cook), 1 Vanguard, and 1
AneuRx (Medtronic AVE); and 3 aortomonoiliac stent grafts (Talent, Medtronic, AVE)
Aneurysm diameter: 5.3 cm.
Setting: department of radiology.
Participants 84 consecutive participants; 69 men; mean (± SD) age: 79.6 ± 5.2 years; range: 62-89
years; mean (± SD) BMI: 27.4 ± 3.5 kg/m2; range: 22-34.2 kg/m2.
Comorbidities: not reported.
Geography: Italy.
Study design Prospective single centre cross-sectional study.
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: persistent perigraft flow within aneurysmal sac excluded by stent
graft. Endoleaks classified according to size and aetiology
Endoleak (absolute n): 40.
Prevalence of endoleak: 47.6% (40/84).
Reference standard: multidetector row helical CT scanner.
Image acquisition:
• “unenhanced images were obtained with a slice collimation of 2.5 mm, whereas a
1-mm slice collimation was used for contrast-enhanced acquisitions, obtained after
bolus intravenous injection of 120 mL of iodinated nonionic contrast medium
(Iomeprol 300 mg/mL, Iomeron; Bracco) at a flow rate of 3 mL/s through an
antecubital vein. Delayed-phase acquisition, focused on the endovascular graft, was
performed 60 seconds after contrast medium injection;”
• thickness: unenhanced images were obtained with a slice collimation of 2.5 mm,
whereas a 1-mm slice collimation was used for contrast-enhanced acquisitions.
Type of CT scanner: Somatom Plus 4 Volume Zoom (Siemens, Forchheim, Germany).
Use of contrast: 120 mL iodinated non-ionic contrast medium (Iomeprol 300 mg/mL,
Iomeron; Bracco)
Index and comparator tests Index test: CDUS.
Image production: axial and longitudinal and acquisition scans used for US imaging.
CEUS scans performed after administration of bolus of 2 different doses of contrast
agent dissolved in 0.9% saline solution (1.2 mL and 2.4 mL), each followed by flush-
ing with 5 mL bolus of saline solution through an 18- to 20-gauge cannula placed in
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arm vein. A minimum interval of 10 minutes and complete bubble destruction, which
was achieved by scanning entire abdominal aorta at a high mechanical index, required
between the 2 injections to avoid carryover effects. Scanning started at beginning of
contrast agent injection and sweep was usually completed within 5 minutes. Phases of
CE-CDUS defined as arterial (10-40 s after contrast agent injection) and late (90-300 s
after injection)
Type of US: convex multi-frequency 5 to 2 MHz probe, Philips HDI 5000 scanner
(Philips Medical Systems, Bothell, WA, USA)
Use of contrast: second-generation contrast agent (SonoVue, Bracco,Milan, Italy) made of
sulphur hexafluoride-filledmicrobubbles with flexible shells that allow real-time imaging
at low acoustic pressure (mechanical index range: 0.12-0.14)
Operator: 2.
Follow-up “All patients completed the protocol, and no adverse events were recorded during CEUS
or multidetector CT examinations.”
Notes • Secondary objective: to define optimal dose of second-generation contrast agent
to routinely use in CEUS examinations for endoleak detection.
• Readers independently assigned a confidence level for endoleak diagnosis using 5-
point scale: 1, certainly absent; 2, probably absent; 3, possibly present; 4, probably
present; and 5, certainly present. Readers were informed that a confidence level ≥ 3
represented positive diagnosis of endoleak.
• Test analysis showed excellent interobserver agreement (analysis value ≥ 0.89) in
all reading sessions for endoleak detection.
• Mean (± SD) follow-up after EVAR: 8.6 ± 5.4 months; range: 1-24 months.
• US assessors “reviewed videotapes of each patient during three different sessions:
(1) the baseline unenhanced US scan - session A (CDUS), (2) CEUS after the
administration of 1.2 mL of the contrast agent - session B, low-dose contrast-enhanced
(LDCE) US imaging, (3) CEUS after the administration of 2.4 mL contrast medium -
session C, high-dose contrast-enhanced.”
• “Patients with unstable general conditions, such as heart failure (New York Heart
Association class IV), severe chronic bronchopulmonary disorders, severe pulmonary
hypertension, or uncontrolled hypertension were excluded.”
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants represented average patients
that after receiving EVAR are exposed to
endoleak surveillance
“The study enrolled all patients treated
with EVAR who underwent CTA as part
of a routine surveillance programme at 1,
6, and 12 months after the procedure and
annually thereafter. They underwent CTA
and CDUS and CEUS imaging on the
same day. To avoid selection bias in favor
of patients who were ’easy to scan’, patients
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were recruited before undergoing a baseline
US scan. No patient was excluded on the
basis of poor technical quality of the base-
line US study.”
Acceptable reference standard?
All tests
Yes Reference standard was CTA.
Acceptable delay between tests?
All tests
Yes Index test and reference standard per-
formed on same day.
Partial verification avoided?
All tests
Yes All study participants accounted for and re-
sults of reference standard reported for all
Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Yes “US examinations were randomly reviewed
independently by two radiologists not in-
volved in the imaging, one radiologist spe-
cialized in vascular radiology (D. P. with 10
years of experience) and the other in CEUS
(R. B. with 15 years of experience), and
neither was aware of the CTA outcomes or
dose of contrast used for CEUS.”
Index test results blinded?
All tests
Yes “The radiologist was blinded to all other
imaging findings at the time of examina-
tions.”
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes “None of theCTAs resulted in an uncertain
diagnosis (score 2)”. “Endoleaks classifica-
tion: two large endoleaks were not clearly
classified byCTA (differential diagnosis be-
tween type II and type III endoleak). These
two patients underwent selective conven-
tional angiography that detected two type
II endoleaks due to retrograde flow into the
aneurysm sac through lumbar arteries. Five
small type II endoleaks were detected only
on delayed phase and were classified as low-
flow leaks.”
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Withdrawals explained?
All tests
Yes “All patients completed the protocol, and
no adverse events were recorded during
CEUS or multidetector CT examinations.
”
McLafferty 2002
Clinical features and settings People with AAAs who received stent graft.
Type of stents received: AneuRx graft (Medtronics AVE, Sunnyvale, CA, USA).
Aneurysm diameter: not reported.
Setting: vascular laboratory (Intersocietal Commission for the Accreditation of Vascular
Laboratories) at Memorial Medical Center (Springfield, IL, USA)
Participants No further description about basic characteristics of participants provided
Comorbidities: not reported.
Geography: USA.
Period of recruitment: June 1997 to July 1999.
Study design Prospective design. Whole sample included.
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: “According to protocol, endoleaks were classified as arising from
proximal, distal, or junctional graft attachment sites (types I and III), from branch vessel
flow (Type II), or from undetermined source.”
Endoleak (absolute n): 7.
Prevalence of endoleak: 9.2% (7/20).
Reference standard: helical CT scan.
Image acquisition:
• “from the origin of the celiac artery to the bifurcation of the femoral arteries with
3 mm collimation and 2 mm reconstruction;”
• thickness: 2-mm slices.
Type of CT scanner: unclear.
Use of contrast: yes (type not reported).
Index and comparator tests Index test: CDUS.
Image production: “Imaging of the aorta was performed from the coeliac artery to the
iliac bifurcation in the longitudinal and transverse axes. The iliac and common femoral
arteries were scanned in a similar fashion. Transverse measurements, relative to the vessel,
were made just proximal to the coeliac artery, at the level of the renal arteries, at the
maximal aneurysm diameter, and just proximal to the iliac bifurcation. Measurement
of the proximal, middle, and distal common and external iliac arteries in the transverse
axis was performed. Similarly, Doppler scan waveforms and velocity measurements were
obtained proximally, within, and distal to the endograft. Colour-flow mode was used to
help identify endoleaks with further focus on determining the origin.”
Type of US: “Low frequency transducers ranging from 2.0 to 3.5 MHz were used with
either the Quantum 2000 scanner (Quantum Medical Systems, Issaquah, Wash) or the
Philips P800 scanner (Philips, North American Corp, Itasca, Ill).”
Use of contrast: no.
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Operator: registered vascular technologists.
Follow-up No missing data or adverse events.
Notes • “According to the AneuRx phase II and III protocols, CT scan was routinely
obtained at baseline, before discharge after erAAA, 6 months, 12 months, and yearly
thereafter.”
• “Between June 1997 and July 1999, all erAAAs were performed with the AneuRx
graft (Medtronics AVE, Sunnyvale, Calif ) with prospective phase II and phase III Food
and Drug Administration protocols.”
• “When compared with CT scan at 6 months, CFD scan had a sensitivity,
specificity, positive predictive value, negative predictive value, and accuracy of 100%,
99%, 88%, 100%, and 99%, respectively.”
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants represent average patients who
after receiving EVAR are exposed to en-
doleak surveillance
Acceptable reference standard?
All tests
Yes Reference standard was CTA.
Acceptable delay between tests?
All tests
Unclear Not reported.
Partial verification avoided?
All tests
Yes All study participants accounted for and re-
sults of reference standard reported for all
Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Unclear Not reported.
Index test results blinded?
All tests
Unclear Not reported.
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes “Three patients (3.6%) had to have CT
scan at the 1-month follow-up examination
because the CFD scan could not be per-
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formed as a result of the presence of large
body habitus or bowel gas. These patients
had negative results for endoleak with CT
scan at 1 month of follow-up study.”
Withdrawals explained?
All tests
Yes “Five patients who had negative results for
endoleak at 1 month with CFD scan did
not have CT scan at 6 months. One pa-
tient died of congestive heart failure before
6months, one patient was unable to return,
and three patients had lapses in scheduling.
These remaining four patients had negative
results for endoleak at 12 months. Four pa-
tients who had positive results for endoleak
with CFD scan at 1 month did not have a
CT scan at 3 months because of schedul-
ing problems. All of these patients still had
positive results for endoleak at 6 months
with CT scan.”
McWilliams 1999
Clinical features and settings People who received graft stents for AAA.
Type of stents received: 14 participants had Vanguard devices (Boston Scientific Vascular,
Natick, MA, USA), 1 participant a Stentor graft (Mintec, Freeport, Grand Bahama),
and 3 participants an Aneurx graft (Medtronic, Eden Prairie, MN, USA). All grafts were
modular bifurcated devices
Aneurysm diameter: not reported.
Setting: department of radiology.
Participants 18 participants.
Comorbidities: not reported.
Geography: UK.
Recruitment period: May 1998 to October 1998.
Study design Prospective design study (“FromMay 1998 to October 1998, patients who presented for
follow- up scans after endovascular aortic aneurysm repair were invited to participate in
the study. Eighteen patients were examined on 20 occasions. Levovist (Schering Health
Care, Surrey, United Kingdom) is contraindicated in patients with galactosemia, and
if there is a known or suspected right-to-left cardiac shunt. No patients were excluded
because of such contraindications.”)
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: persistence of blood flow outside lumen of endoluminal graft but
within aneurysmal sac or adjacent vascular segment being treated with graft
Endoleak (absolute n): 3.
Prevalence of endoleak: 15.0% (3/11).
Reference standard: spiral CT.
Image acquisition:
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• CT scans were performed with 5 mm collimation, pitch of 2, and reconstructions
every 5 mm. Single pass shown on contrast-enhanced CT;
• thickness: 5 mm
Type of CT scanner: spiral CT (HiSpeed Advantage; IGE Medical Systems, Slough, UK)
Use of contrast:yes (type not reported).
Index and comparator tests Index test: CDUS.
Image production: not reported.
Type of US: 3.5-MHz probe Diasonics Spectra machine (Sonotron Ltd, Bedford, UK)
Use of contrast: yes, single dose of 300 mg/mL Levovist (Schering Health Care, Felbridge,
UK)
Operator: 1 vascular sonographer.
Follow-up Unclear whether missing data or an adverse event occurred.
Notes
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants represented average patients
that after receiving EVAR are exposed to
endoleak surveillance
Acceptable reference standard?
All tests
Yes Reference standard CTA.
Acceptable delay between tests?
All tests
Yes CT scan performed on same day.
Partial verification avoided?
All tests
Yes All study participants accounted for and re-
sults of reference standard reported for all
Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Yes US performed before CT scan.
Index test results blinded?
All tests
Yes “TheCTwas reported as showing endoleak
or no endoleak by a radiologist (D.A.G.
) who was blinded to the results of ultra-
sound.”
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Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes Diagnostic confidence of scan was in-
creased in 10 participants after Levovist in-
jection by mean value of 15%. There was
considerable difficulty in 1 participant in
gaining venous access to inject Levovist af-
ter the unenhanced scan. The enhanced
scan was much poorer because of bowel gas
that was believed to be the result of partic-
ipant swallowing air
Withdrawals explained?
All tests
Yes No apparent withdrawal.
McWilliams 2002
Clinical features and settings People who received endovascular repair of an unruptured infrarenal AAA
Type of stents received: not reported (endografts were all bifurcated with either a modular
or 1-piece design except for 1 aortic tube device)
Aneurysm diameter: not reported.
Setting: department of radiology.
Participants 53 participants; 44 men; mean age 70 years; mean height of group: 171 cm; range: 150-
183 cm); mean weight: 77 kg; range: 47-107 kg)
Comorbidities: not reported.
Geography: UK.
Study design Prospectively enrolled participants.
“All patients seen at these follow-up intervals were asked to participate unless there was
a documented contraindication to the use of Levovist (e.g., galactosemia and a known
or suspected right-to-left cardiac shunt).”
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: presence of intrasac flow outside stent-graft; characterized by its
relationship to endograft, aneurysm wall, and aortic side branches and categorized using
White/May classification
Endoleak (absolute n): 7.
Prevalence of endoleak: 9.2% (7/20).
Reference standard: contrast-enhanced biphasic (arterial and delayed) CT.
Image acquisition: not reported.
• thickness: scanning parameters identical for both phases: 5 mm collimation, 1-s
tube rotation, pitch 2, reconstructions every 5 mm.
Type of CT scanner: HiSpeed Advantage (IGE Medical Systems, Slough, UK).
Use of contrast: yes (type not reported).
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Index and comparator tests Index test: CDUS.
Image production: not reported.
Type of US: 3.5-MHz probe on either a Dyna-View SSD-1700 or a ProSound 5500
(Aloka Co Ltd, Tokyo, Japan)
Use of contrast: yes, Levovist (Schering Health Care, Felbridge, UK).
Operator: 1 experienced vascular sonographer.
Follow-up 2 participants excluded because radiology staff failed to follow protocol during 5 imaging
sessions
Notes • Where there was evidence of endoleak on either the US or enhanced CT and sac
diameter had increased or remained static ≥ 6 months, then protocol allowed for
selective arteriography.
• Mean number of follow-up evaluations was 1.8 per participant; maximum
number was 4 over a follow-up period of 1-36 months. Mean and median intervals
since endovascular repair at the time of imaging were 11 and 6 months, respectively.
• Endoleak detected in 20 (21%) of the 96 CT examinations; majority were
isolated type II (18, 90%). The other 2 cases had graft-related endoleaks from 1 iliac
limb dislocation and 1 stump dislocation. In 7 of the CT examinations, endoleak
detected on the delayed phase CT only.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants represents average patients
who after receiving EVAR are exposed to
endoleak surveillance
Acceptable reference standard?
All tests
Yes Reference standard was biphasic enhanced
CT.
Acceptable delay between tests?
All tests
Yes “Biphasic enhanced CT was performed on
the same day using the same protocol and
imager.”
Partial verification avoided?
All tests
Yes All study participants accounted for and re-
sults of reference standard reported for all
Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Yes “Either of two radiologists (R.M.,D.A.G.),
who were blinded to the ultrasound results,
recorded all the CT studies.”
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Index test results blinded?
All tests
Yes US scan apparently performed before CT
scan.
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes “Angiography in the patient with a ’defi-
nite’ endoleak on the CT study confirmed
a lumbar endoleak, which was treated. One
patient with a ’probable’ endoleak on the
CT study showed lumbar vessels perfusing
the sac margin at 3 levels but no endoleak.
The other patient with a ’probable’ lumbar
endoleak onbiphasicCThad increasing sac
diameter, but no endoleak was seen on the
arteriogram
Comparing each of the 4 ultrasound tech-
niques with biphasic CT in the detection
of endoleak, the number of nondiagnostic
studies (flow detection too poor to allow
diagnosis) was highest (n 12) in the unen-
hanced ultrasound group and lowest (n 4)
with the enhanced power Doppler test.”
“One patient had nondiagnostic ultra-
sound examinations with all 4 test modali-
ties due to bowel gas; the CT showed iliac
limb dislocation.”
Withdrawals explained?
All tests
Yes 2 participants excluded because radiology
staff failed to follow protocol during 5
imaging sessions
Motta 2012
Clinical features and settings People who received EVAR (initial transverse diameter not reported)
Type of stents received: 87 bifurcated endografts and 1 aorto-uni-iliac endograft). Talent
(Medtronic, Minneapolis, MN, USA): 43; Endurant (Medtronic): 14; Excluder (WL
Gore&Associates, Flagstaff, AZ,USA): 20; Zenith (CookEurope, Ireland): 6; Anaconda
(Vascutek, Glasgow, UK): 3; E-vita (JOTEC GmbH, Hechingen, Germany): 2
Aneurysm diameter: not reported.
Setting: vascular medicine department.
Participants 88 participants; 86 men (97.7%); mean age 75 years; range: 55-95 years
Comorbidities: not reported.
Geography: Italy.
Study design Prospective single-centre study enrolled consecutive participants who received both test
(CTA and CEUS)
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Target condition and reference standard(s) Target condition: identification and characterization of endoleaks according to classi-
fication of standard guidelines; evaluation of graft patency; measurement of aneurysm
maximum diameter
Definition of endoleak: not reported (“Endoleak CTA classification characteristics in-
cluded: location and relation to the graft, density on delayed images, patency of the
inferior mesenteric or lumbar arteries and appearance of endograft junctions”)
Endoleak (absolute n): 154.
Prevalence of endoleak: 27.5% (154/561).
Reference standard: triple-phase CTA.
Image acquisition:
• from celiac to femoral arteries before and after IV injection of contrast medium
(Iohexol 350 mg/L, Omnipaque, GE Healthcare, Waukesha, WI, USA) at 100-120
mL with flow rate 4-5 mL/s. Bolus tracking used to determine scanning delay of
arterial phase (Care-Bolus, Siemens Healthcare).
Acquisition parameters used for arterial phase were: collimation 64 × 0.6 mm, rotation
time 0.5 s, automatic exposure modulation (Care-Dose, Siemens Healthcare)
Type of CT scanner: 64-MDCT Somatom Sensation (Siemens Healthcare, Erlangen,
Germany)
Use of contrast: yes, Iohexol 350 mg/L, Omnipaque (GE Healthcare, Waukesha, WI,
USA)
Index and comparator tests Index test: CDUS.
Image production: from celiac to femoral arteries.
Type of US: entire aorta scanned in longitudinal and transverse planes from diaphragm
down to iliac limb attachment
Use of contrast: yes, second-generation blood-pool contrast agent (stabilisedmicrobubbles
of sulphur hexafluoride; SonoVue, Bracco, Milan, Italy) administered into antecubital
vein, followed by flush of 10 mL saline solution (0.9% sodium chloride)
Operator: 2 senior radiologists.
Follow-up During study period, 95 participants initially recruited. 7 excluded from participation
because of severe allergy to iodinated contrast (n = 2) and severe renal failure (n = 5)
All paired examinationswere successful; duringCEUS examinations, obesity,meteorism,
and heavy sac calcifications were found in 21 cases but did not preclude correct evalua-
tion. No adverse events recorded during examinations. No adverse interaction observed
between the 2 contrast agents, which were administered within 2-3 hours
Notes • 95 participants initially recruited. 7 excluded from participation because of severe
allergy to iodinated contrast (n = 2) and severe renal failure (n = 5). Overall, 142 paired
examinations in 88 participants were available for comparative analysis.
• Endoleak CTA classification characteristics included: location and relation to the
graft, density on delayed images, patency of the inferior mesenteric or lumbar arteries,
and appearance of endograft junctions.
Table of Methodological Quality
Item Authors’ judgement Description
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Representative spectrum?
All tests
Yes Participants represented average patients
that after receiving EVAR are exposed to
endoleak surveillance
Acceptable reference standard?
All tests
Yes Reference standard was CTA.
Acceptable delay between tests?
All tests
Yes Within a few hours, all participants under-
went both CTA and CEUS
Partial verification avoided?
All tests
Yes All study participants accounted for and re-
sults of reference standard reported for all
Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Yes CEUS examinations and evaluations per-
formed by 2 other senior radiologists (each
with 10 years of experience in use of US
contrast material) in consensus reading,
masked to CTA findings
Index test results blinded?
All tests
Yes CTA examinations performed by 2 senior
radiologists (with 30 and 10 years of expe-
rience in vascular radiology and each with
10 years of experience in CTA), in consen-
sus reading and blinded to CEUS results
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes All paired examinations successful; during
CEUS examinations, obesity, meteorism,
and heavy sac calcifications found in 21
cases but did not preclude correct evalu-
ation. No adverse events recorded during
examinations. No adverse interaction ob-
served between the 2 contrast agents, which
were administered within 2-3 hours
Withdrawals explained?
All tests
Yes 7 excluded from participation because of
severe allergy to iodinated contrast (n = 2)
and severe renal failure (n = 5)
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Clinical features and settings People who received EVAR for AAA.
Type of stents received: not reported.
Aneurysm diameter: not reported.
Setting: vascular surgery department.
Participants 445 participants; 84.2% men; 91.2% white people; mean (± SD) age: 71.4 ± 8.5 years;
range: 38-93 years
Comorbidities: smoking (91%), coronary artery disease (51%), hypertension (64%), hy-
perlipidaemia (43%), stroke (10%), diabetes mellitus (14%), chronic obstructive pul-
monary disease (21%), and end-stage renal disease on dialysis (3%)
Geography: USA.
Recruitment period: October 1999 to June 2009.
Study design Retrospective study.
Review of prospectively maintained database designed to capture all EVAR procedures
performed between October 1999 and June 2009. Participants routinely evaluated with
CT and DUS imaging within 30 days after procedure and intermittently at 6- to 12-
month intervals after treatment
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: continuing blood flow around graft into aneurysm sac, thereby
exposing participants to risk of rupture. “Endoleaks that were identified within 30 days
of follow-up were classified as early endoleaks, whereas those detected after 30 days were
classified as late.”
Endoleak (absolute n): 154.
Prevalence of endoleak: 27.5% (100/561).
Reference standard: CTA.
Image acquisition:
• both contrast and non-contrast images obtained by performing helical scans from
diaphragm to upper thigh using a thin section CTA protocol. Non-ionic IV contrast
material administered. 3D reconstructions performed. Delay in scan determined by
bolus tracking. CTA obtained in people with normal renal function and people on
regular haemodialysis.
Type of CT scanner: GE LightSpeed 16 CT scanner (General Electric Medical Systems,
Milwaukee, WI, USA)
Use of contrast: yes, non-ionic IV contrast.
Index and comparator tests Index test: CDUS.
Image production: abdominal aorta and iliac arteries investigated in transverse, and antero-
posterior images obtained
Type of US: Sequoia 512Acuson Sonography System (SiemensMedical Solutions,Moun-
tain View, CA, USA)
Use of contrast: no.
Operator: 1 registered vascular technician.
Follow-up Missing data or loss to follow-up unclear.
Notes • “DUS imaging and CTA were evaluated with attention toward maximum
aneurysm diameter, patency of graft, and presence of an endoleak. Maximum aneurysm
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diameter was the diameter measured in the anterior-posterior axis and in transverse
plane. CTA or DUS was considered significant when a change in size by > 5 mm from
the first follow-up after surgery was noted. Similarly, an increase in size by > 5 mm from
the first visit imaging was investigated more thoroughly for possible re-intervention.”
• “Contrast material was not used in 49 CT scans, leaving 561 encounters for
comparing contrast CT imaging with DUS results.”
• “Our initial protocol included CTA and DUS at the initial visit, and most were
further followed up with CTA.”
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Unclear Sample derived from retrospective review
of database in which data of people with
AAAwho received stent did not necessarily
receive concomitant US and CTA. Partic-
ipants included were those who had both
tests available during follow-up. (“A total
of 1,062 EVARswere performed in 992 pa-
tients during this period. Medical records,
vascular database records, and follow-up
images of these patients were reviewed in
detail. National death indices were also re-
viewed for patients who were lost to fol-
low-up. A total of 3,120 postsurgical imag-
ing encounters were recorded through the
surveillance protocol. Of these 3,120 en-
counters, 1,729 were DUS encounters (1.
86 per patient), whereas 2,001 were CTA
scans (2.16 per patient), with 610 of these
encounters recording a CTA and DUS at
the same visit. Contrast material was not
used in 49 CT scans, leaving 561 encoun-
ters in 455 patients, for comparing CTA
imaging with DUS findings.”)
Acceptable reference standard?
All tests
Unclear CT scan with contrast agents. No mention
of expert who read and interpreted images
provided
Acceptable delay between tests?
All tests
Yes “Both studies should be recorded within 7
days of each other.”
Partial verification avoided?
All tests
Yes All participants accounted for and results
of reference standard reported for all
Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
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Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Unclear Not reported.
Index test results blinded?
All tests
Unclear Not reported.
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes “Of these 3,120 encounters, 610 had both
CT scan and ultrasound at the same visit.
Contrast material was not used in 49 CT
scans, leaving 561 encounters for compar-
ing contrast CT imaging withDUS results.
CT and DUS detection of endoleaks corre-
lated in 442 encounters. Discrepancies oc-
curred in 119 encounters as follows: CT
scan only endoleak in 17.8% (tot: 100;
type I: 6, type II: 91 and type III: 3) and
DUS only endoleak in 3.4% (N 19; type
II: 19) encounters. Of these 119 encoun-
ters, 99 did not require secondary interven-
tions. Eventually, 15 patients required in-
tervention after 20 discrepancy encounters:
11 patients continued with the surveillance
protocol through CT or DUS imaging,
whereas four were observed by CT imaging
only. Considering these 11 patients, DUS
eventually detected an endoleak on subse-
quent visits in five patients, DUS identi-
fied an increase in aneurysm diameter in
four patients, andDUSnever identified the
type II endoleaks in two patients.When the
endoleak raised concern or the aneurysm
enlarged, we undertook 19 secondary in-
terventions in these 15 patients: vessel em-
bolization (N 8), iliac extenders (N 5), graft
relining (N 3), graft explants (N 2), and
proximal cuff (N 1).”
Withdrawals explained?
All tests
Unclear “Of these 119 encounters, 99 did not re-
quire secondary interventions. Eventually,
15 patients required 19 re-interventions
after 20 discrepancy encounters (3.6%).
Eleven patients continued with the surveil-
lance protocol through CTA orDUS imag-
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ing, whereas four were followed up by CTA
imaging only. One of these 15 patients had
a type II endoleak that was missed by CTA
and detected on DUS on subsequent fol-
low-up. Of these 15 patients, 12 were diag-
nosed with an early endoleak, whereas the
remaining three were diagnosed with a late
endoleak. There was no rupture, graft mi-
gration, limb occlusion, or structural fail-
ure in any of these 15 patients. Table III
summarizes the secondary interventions in
these 119 encounters.”
Nerlekar 2006
Clinical features and settings People who received EVAR for AAA.
Type of stents received: not reported.
Aneurysm diameter: median: 52 (range 21-75) mm using CT; 39 (38-70) mm using US
Setting: department of surgery.
Participants 121 participants enrolled; mean age: 73 years; median: 73 years; range: 52-93 years
Comorbidities: not reported.
Geography: Australia.
Period of recruitment: 1995-2003.
Study design Retrospective review of prospectively collected data on people who received a stent for
AAA
(“Between 1995 and 2003, 121 patients underwent EVR for an AAA. Their details re-
garding age, gender, and aneurysmmorphology were entered into a prospective database.
All patients were subjected to US and CT scan investigations. In addition, digital sub-
traction angiography was performed before surgery to assess vascular anatomy and to
accurately determine aneurysm size.”
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: not provided.
Endoleak (absolute n): 20.
Prevalence of endoleak: 11.9% (29/243).
Reference standard: CT scan.
Image acquisition:
• CT coverage of participants was from celiac plexus to groin;
• thickness: collimation at 5 mm (pitch 2:1).
Type of CT scanner: high-speed Advanced 2X spiral CT scanner (GE Medical Systems,
Milwaukee, WI, USA)
Use of contrast: yes, Ultravist 370 (Schering AC, Germany).
Index and comparator tests Index test: CDUS.
Image production: not reported.
Type of US: Sonoline Elegra Ultrasound lmaging System with colour flow Doppler
(Siemens, New York, NY, USA)
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Use of contrast: no.
Operator: 1 experienced ultrasonographer.
Follow-up People with modified device configurations (n = 5), pre-existing grafts (n = 4), graft
deployment failure (n = 1) and 3 participants who died before 1 month follow-up from
study
Notes • Follow-up at 1 and 6 months after EVAR and annually thereafter.
• Repeat angiography only performed if CT or US suggested an endoleak.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants represented average patients
that after receiving EVAR are exposed to
endoleak surveillance
Acceptable reference standard?
All tests
Yes Reference standard was CTA.
Acceptable delay between tests?
All tests
Yes “There were 190 occasions in which US
andCTwere performed on the same day or
within 1 month, and these results formed
the basis of the study.”
Partial verification avoided?
All tests
Yes All study participants accounted for and re-
sults of reference standard reported for all
Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Yes “For the purpose of the study, all US
and CT scan films were reviewed by two
blinded reviewers.”
Index test results blinded?
All tests
Yes “For the purpose of the study, all US
and CT scan films were reviewed by two
blinded reviewers.”
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes No uninterpretable results.
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Withdrawals explained?
All tests
Yes “Excluded were patients with modified de-
vice configurations (n = 5), preexisting
grafts (n = 4), graft deployment failure (n
= 1) and three patients who died before 1
month follow up from the study.”
Oikonomou 2012
Clinical features and settings People who underwent EVAR for infrarenal AAA.
Type of stents received: (number of users not reported); Zenith (Cook Inc, Bloomington,
IN, USA); Excluder and C3 (WL Gore & Associates, Flagstaff, AZ, USA); Powerlink
(Endologix, Irvine, CA, USA)
Aneurysm diameter: median: 5.8 cm; range: 48-110 cm.
Setting: vascular laboratory.
Participants 100 participants; 85 men; median age: 73 years; range: 46-91 years
Comorbidities: not reported.
Geography: Germany.
Study design Cross-sectional study (consecutively selected participants, all received both tests)
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: endoleak on DUS defined as presence of persistent blood flow
and spectral signal outside graft wall. Endoleak on CTA defined as presence of contrast
agent outside graft within aneurysm sac
Endoleak (absolute n): 24.
Prevalence of endoleak: 26.7% (24/90).
Reference standard: CT scan.
Image acquisition:
• abdominal scanning performed from celiac axis to common femoral arteries.
Images reconstructed in sagittal, coronal, as well as 3D rotational views using the
InSpace 3D software (Siemens AG).
Type of CT scanner: contrast CT-scan (Siemens Somatom scanner, Munich, Germany)
Use of contrast: Solutrast 370 (ALTANA Pharma AG).
Index and comparator tests Index test: CDUS.
Image production: abdominal aorta scanned from diaphragm to distal iliac arteries in
longitudinal and transverse views using an anterior approach. Maximal aortic diameter
identified, and DUS and spectral Doppler analysis performed to detect persistent flow
outside graft wall
Type of US: CH4-1 convex transducer (Acuson Antares Ultrasound System; Siemens
Medical Solutions)
Use of contrast: no.
Operator: vascular surgeons (number not reported).
Follow-up 5 participants unsuitable for postoperative CTA due to severely impaired renal function
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Notes • Follow-up: 30 days.
• Study also used an alternative early follow-up imaging protocol consisting of:
intraoperative angiography using a multi-axis robotic C-arm (Artis Zeego; Siemens
Medical Solutions, Erlangen, Germany) with bolus injection of 20 mL of Solutrast 300
(ALTANA Pharma AG, Konstanz, Germany) at rate of 10 mL/s.
• Plain abdominal radiograph in prone position performed between the 1st and
10th postoperative day. Anteroposterior, lateral, and 45° right and left anterior oblique
projections acquired according to standardized protocol. Images analysed to identify
stent-graft integrity or limb kinking.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants represented average patients
who after receiving EVAR are exposed to
endoleak surveillance
Acceptable reference standard?
All tests
Yes Reference standard was CT scan.
Acceptable delay between tests?
All tests
Yes Median interval between DUS and CTA:
9 days; range: 0-25 days
Partial verification avoided?
All tests
Yes All study participants accounted for and re-
sults of reference standard reported for all
Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
Incorporation avoided?
All tests
Yes Index test was part of reference standard.
Reference standard results blinded?
All tests
Unclear No information reported.
Index test results blinded?
All tests
Unclear No information reported.
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes Overall, 10DUS examinationswere incon-
clusive due to participant habitus (n = 6)
or overlying bowel gas (n = 4) and were ex-
cluded from analysis
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Withdrawals explained?
All tests
Yes All participants received both tests.
5 participants unsuitable for postoperative
CTA due to severely impaired renal func-
tion
10 DUS examinations were inconclusive
due to participant habitus (n = 6) or over-
lying bowel gas (n = 4) and were excluded
from the analysis
Pages 2001
Clinical features and settings People with infrarenal AAA who received EVAR.
In 41 of these participants (21.6%), anatomical findings were compatible with stent-
graft placement
Type of stents received: not reported.
Aneurysm diameter: mean (± SD) preoperative aneurysmal diameter determined by CT
scan: 55 ± 9 mm; range: 40-90 mm. Proximal neck of aneurysm located below renal
arteries in all cases. Maximum proximal neck diameter 28 mm and minimal length 15
mm
Setting: unclear (department of surgery or department of radiology)
Participants 41 participants; 39 men; mean age: 71 years; range: 50-83 years
Comorbidities: not reported.
Geography: France.
Study design Prospectively consecutively enrolled study. Whole sample of participants who received
stent considered
Recruitment period: November 1996 to September 1999.
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: persistent blood flow or uptake of contrast between the stem graft
and walls of the aneurysmal sac
• On CT scans, endoleaks characterized by extravasation of contrast dye between
prosthesis and aneurysmal wall. On CDUS, characteristic feature was detection of a
colour and spectral signal outside the limits of the prosthesis.
• Primary endoleaks: when detected during first 30 days after endografting.
• Secondary endoleak: when detected after 30 days.
• Type I endoleaks: resulting from leakage around proximal or distal neck of stent,
through stent wall, or at junctions between modular stems.
• Type II endoleaks: resulting from recirculation in aneurysmal sac supplied by
collateral vessels from lumbar arteries or inferior mesenteric artery or both.
Endoleak (absolute n): 17.
Prevalence of endoleak: 26.6% (29/109).
Reference standard: spiral CT scan.
Image acquisition:
• 3 consecutive spiral CT scan acquisitions. |First scan without contrast dye with a
section thickness of 10 mm to locate SMA and hypogastric arteries. Next aorta
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visualized from the SMA to hypogastric arteries using 2 adjoining spiral CT scans after
injection of contrast dye;
• thickness.
Type of CT scanner: Somatom Plus S system (Siemens, Erlongen, Germany).
Use of contrast: not reported.
Index and comparator tests Index test: CDUS.
Image production: abdominal aorta visualized from celiac trunk to hypogastric arteries
first in transverse plane and then in longitudinal plane in B-mode and colour Doppler
mode. Continuous spectral analysis performed if colour Doppler findings suggested
presence of an endoleak
Type of US: 3.5-MHz curved array transducer, Apogee 800PLUS ultrasound system
(ATL, Philips, Eindhoven, the Netherlands)
Use of contrast: no.
Operator: 3 qualified angiologists.
Follow-up No loss to follow-up, missing data, or adverse events. Uninterpretable data reported
Notes Postoperative surveillance included plain abdominal roentgenography, CT scan, and
CDUS. Procedures performed prior to discharge and at 3, 6, 12, 24, and 30 months
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants represented average patients
who after receiving EVAR are exposed to
endoleak surveillance
Acceptable reference standard?
All tests
Yes Reference standard was CT scan.
Acceptable delay between tests?
All tests
Unclear Not reported.
Partial verification avoided?
All tests
Yes All study participants accounted for and re-
sults of reference standard reported for all
Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Yes CT scan and CDUS examination per-
formed by different operators at different
locations. Second operator had no knowl-
edge of results of first examination. CT
scans and videotapedCDUSprocedures re-
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viewed by independent radiologist
Index test results blinded?
All tests
Yes CT scan and CDUS examination per-
formed by different operators at different
locations. Second operator had no knowl-
edge of results of first examination. CT
scans and videotapedCDUSprocedures re-
viewed by independent radiologist
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes “In six cases, B-mode images were unin-
terpretable because of the presence of in-
testinal gas. In 55 cases, spectral study was
necessary to confirm or deny suspicion of
an endoleak based on colour Doppler find-
ings.”
Withdrawals explained?
All tests
Yes No apparent dropouts observed.
Parent 2002
Clinical features and settings People of Norfolk Surgical Group who underwent endovascular graft repair of AAA
Type of stents received: EVT-EGS/Guidant - Ancure product (Menlo Park, CA, USA)
used in all cases. Bifurcated endograft: 63 participants, tube endograft: 12 participants,
aortoiliac endograft in 8 participants
Aneurysm diameter: not reported.
Setting: unclear.
Participants 83 participants; age and gender not reported.
Comorbidities: not reported.
Geography: USA.
Study design Retrospective study.
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: absence of perigraft flow from the source vessel identified with
prior study results
Endoleak (absolute n): 23.
Prevalence of endoleak: 27.7% (23/83).
Reference standard: CT scan.
Image acquisition:
• single detector helical scanner;
• 3 separate imaging examinations performed:
◦ precontrast run for the identification of opacities;
◦ contrast run beginning 20 s after start of infusion of 120 mL of Omnipaque
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350 (Nycomed, Inc, Princeton, NJ, USA) at 4 mL/s;
◦ immediate postcontrast run for delayed imaging in search of late branch
vessel endoleaks. CT scan was diagnostic for endoleak if contrast visualized exterior to
endograft but within aneurysm sac. CT scan studies performed at Sentara Norfolk
General Hospital, read by trained radiologists, and reviewed by authors;
• thickness: 3 mm:
• ◦ precontrast run for the identification of opacities;
◦ contrast run beginning 20 s after start of infusion of 120 mL of Omnipaque
350 (Nycomed, Inc, Princeton, NJ, USA) at 4 mL/s;
◦ immediate postcontrast run for delayed imaging in search of late branch
vessel endoleaks. CT scan was diagnostic for endoleak if contrast visualized exterior to
endograft but within aneurysm sac. CT scan studies performed at Sentara Norfolk
General Hospital, read by trained radiologists, and reviewed by authors;
• thickness: 3 mm.
Type of CT scanner: not reported.
Use of contrast: yes, 120 mL Omnipaque 350 (Nycomed, Inc, Princeton, NJ, USA)
Index and comparator tests Index test: CDUS.
Image production: CDUS scan evidence of endoleak required identification of perigraft
Doppler scan signals with colour flow and confirmed with spectral analysis and mapping
of blood flow pattern. In addition, characterization of Doppler scan spectral analysis as
biphasic, monophasic, or bidirectional (to/fro) obtained from CDUS scan studies
Type of US: not reported.
Use of contrast: no.
Operator: unclear.
Follow-up 8 examinations suboptimal because of gassy abdomen or large abdominal girth
Notes
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants represented average patients
who after receiving EVAR are exposed to
endoleak surveillance
Acceptable reference standard?
All tests
Yes Reference standard was CTA.
Acceptable delay between tests?
All tests
Unclear Information reported unclear although au-
thors reported that CDUS and CT scan ex-
aminations were scheduled within 30 days
and at 3, 6, and 12 months after surgery
and then annually thereafter
Partial verification avoided?
All tests
Yes All study participants accounted for and re-
sults of reference standard reported for all
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Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
Incorporation avoided?
All tests
Yes Index test was part of reference standard.
Reference standard results blinded?
All tests
Unclear No information provided.
Index test results blinded?
All tests
Unclear No information provided.
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes 8 examinations suboptimal because of gassy
abdomen or large abdominal girth
Withdrawals explained?
All tests
Yes 42 (51%) participants never had an en-
doleak at any time in follow-up period with
CT and CDUS scan studies. Remaining 41
(49%) participants with endoleaks identi-
fied at any time in follow-up period form
basis of this analysis
Perini 2011
Clinical features and settings People who underwent EVAR for AAA.
Type of stents received: Zenith (Cook Medical, Bloomington, IA, USA), Talent
(Medtronic, Santa Rosa, CA, USA), Anaconda (Vascutek, Glasgow, UK), fenestrated
endografts (Cook Medical)
All cases performed in dedicated operating theatre with OEC 9900 Elite MD Imaging
System (GE Healthcare, Salt Lake City, UT, USA)
Number of participants for each device not reported.
Aneurysm diameter: mean (± SD): 5.5 ± 1.3. cm
Setting: vascular surgery department.
Participants 395 participants; basic characteristics not reported.
Comorbidities: not reported.
Geography: France.
Study design Retrospective study.
Recruitment period: January 2006 to December 2010.
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: not reported.
Endoleak (absolute n): 99.
Prevalence of endoleak: 25.1% (99/395).
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Reference standard: 64-slice CT scanner.
Image acquisition:
• triple-phase acquisition with unenhanced and contrast-enhanced in arterial (with
bolus tracking) and delayed phases (at 70 s) carried out from thorax to femoral
bifurcations;
• thickness: 1 mm thickness every 0.7 mm.
Type of CT scanner: 64-sliceCT scanner (PhilipsBrilliance 64CTscanner, PhilipsHealth-
care, Amsterdam, the Netherlands)
Use of contrast: yes, 2 types: Iomeron 350 (Bracco SA, Milano, Italy); Omnipaque 350
(Amersham Health, Princeton, NJ, USA)
Index and comparator tests Index test: CDUS.
Image production: typical US examination started with standard B-mode investigation
to measure aneurysm sac diameter (outer wall to outer wall, dimensions recorded as the
mean of 3 measurements). Then, blood flows from main body of endograft to femoral
arteries analysed with pulse-wave modality. In setting of fenestrated or multi-branched
endograft, visceral arteries also evaluated (feature not analysed in this study)
Type of US: convex 3.5-MHz probe, a Philips iE33 (Philips Healthcare, Amsterdam,
the Netherlands), a Vivid 7 and a Vivid 9 (GE Healthcare, Salt Lake City, UT, USA)
equipped with a convex 3.5-MHz probe
Use of contrast: yes, SonoVue (Bracco, Milan, Italy).
Operator:3 angiologists experienced in vascular ultrasonography.
Follow-up All participants completed follow-up, and no adverse events recorded during these ex-
aminations
Notes
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants represented average patients
who after receiving EVAR are exposed to
endoleak surveillance
Acceptable reference standard?
All tests
Yes Reference standard was CTA.
Acceptable delay between tests?
All tests
Yes Time interval between the 2 examinations
< 15 days.
Partial verification avoided?
All tests
Yes All study participants accounted for and re-
sults of reference standard reported for all
Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
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Incorporation avoided?
All tests
Yes Index test was part of reference standard.
Reference standard results blinded?
All tests
Yes CTAs analysed on independent dedicated
workstation (Aquarius, TeraRecon, San
Matteo, CA, USA) by both vascular sur-
geons and vascular radiologists (who were
blinded to the results of CEUS, if already
performed) to determine maximal aortic
diameter by centre-line measurements and
to depict and characterise endoleaks
Index test results blinded?
All tests
Yes All US scans performed by 3 angiologists
experienced in vascular ultrasonography
and use of US contrast material who were
blinded to CTA findings at time of exami-
nation
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes All data were interpreted.
Withdrawals explained?
All tests
Yes All participants completed follow-up, and
no adverse events recorded during these ex-
aminations
Perini 2012
Clinical features and settings People who underwent fenestrated EVAR for juxtarenal AAA.
Type of stents received: all participants received a fenestrated stent-graft.
Aneurysm diameter: mean (± SD): 5.8 ± 0.9 cm.
Setting: unclear (department of surgery or department of radiology)
Participants 62 men; mean age: 72 years: underwent fenestrated EVAR follow-up with both CTA
and CEUS
Comorbidities: not reported.
Geography: France.
Study design Retrospective analysis.
Recruitment period: January 2008 to April 2011.
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: not defined but provided a bibliographic reference (“Endoleaks
were identified and classified according to established reporting standards (Chaikof, J
Vasc Surg. 2002;35:1048-1060).”)
Endoleak (absolute n): 7.
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Prevalence of endoleak: 11.3% (7/62).
Reference standard: 64-slice CT scanner.
Image acquisition:
• triple-phase CTAs (unenhanced and contrast-enhanced in arterial (with bolus
tracking) and delayed (70 s) phases) were acquired from thorax to femoral bifurcations;
• thickness: 1-mm slice thickness at every 0.7-mm interval.
Type of CT scanner: 64-slice CT scanner (Philips Brillianee 64, Philips Healthcare, Am-
sterdam, the Netherlands)
Use of contrast: yes, 100 mL lomeron 350 (Bracco SA, Milan, Italy) or Omnipaque 350
(Amersham Health, Princeton, NJ, USA)
Index and comparator tests Index test: CDUS.
Image production: standard B-mode investigation was performed tomeasure themaximal
aneurysm sac diameter; blood flow in the visceral and renal arteries was analyzed in
colour flow and pulse wave modes. A >50% stenosis of a stented vessel was considered
significant and was identified using the peak systolic velocity and vessel/aortic systolic
ratios
Type of US: convex 3.5-MHz probe 3 machines, a Vivid 7 or a Vivid 9 (GE Healthcare,
Salt Lake City, UT, USA) or a Philips IE33 (Philips Healthcare)
Use of contrast: 2.5 mL bolus of SonoVue (Braceo, Milan, Italy) through an IV cannula,
followed by a 5 mL bolus of isotonic saline solution
Operator: unclear.
Follow-up Of 81 participants remaining, 19 paired examinations excluded because CEUS was
inadequate due to intervening bowel gas (n = 1) or ascites (n = 1) or interval between
CEUS and CTA > 7 days (n = 17)
Notes All fenestrated EVAR procedures performed in a dedicated operating theatre with OEC
9900 Elite MD Imaging System (GE Healthcare, Salt Lake City, UT, USA). The fen-
estrated endografts were custom-made by Cook Medical (Bloomington, IN, USA), and
fenestrations were stented with balloon-expandable covered grafts (Advanta V12; Atrium
Medical, Hudson, NH, USA)
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Participants represented average patients
who after receiving EVAR are exposed to
endoleak surveillance
Acceptable reference standard?
All tests
Yes Reference standard was CTA.
Acceptable delay between tests?
All tests
Unclear Unclear.
Partial verification avoided?
All tests
Yes All study participants accounted for and re-
sults of reference standard reported for all
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Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Unclear No information provided.
Index test results blinded?
All tests
Yes “All CEUS scans were performed by 3 an-
giologists who had aminimumof 6months
of supervised training and experience in
the use of ultrasound contrast material. All
these physicians were blinded to the find-
ings of the other study if already performed.
”
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes No apparent uninterpretable results.
Withdrawals explained?
All tests
Yes No apparent missing data or withdrawals.
Raman 2003
Clinical features and settings People who underwent endovascular repair of AAA (between February 1996 andNovem-
ber 2002)
Type of stents received: 247 participants received Ancure (Guidant, Menlo Park, CA; USA)
; 34 received AneuRX (Medtronic, Santa Rosa, CA, USA) endograft
Aneurysm diameter: not reported.
Setting: hospital vascular laboratory, University of Pittsburgh Medical Centre
Participants 281 participants; 246 males, 35 females; mean (± SD) age: 73 ± 7 years; range: 47-90
years
Comorbidities: not reported.
Geography: USA.
Study design Single-centre, retrospective study (all participants received both tests)
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: perigraft flow into aneurysm sac.
Endoleak (absolute n): 35.
Prevalence of endoleak: 9.9% (49/494).
Reference standard: helical CT.
Image acquisition:
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• CT scans obtained with 2.5-mm slice thickness throughout scan, which started 1
cm above celiac axis and ended at femoral bifurcation;
• thickness: 2.5 mm.
Type of CT scanner: helical CT, LightspeedQXi multi-detector-rowCT scanner (General
Electric Medical Systems, Milwaukee, WI, USA)
Use of contrast: yes, type not reported.
Index and comparator tests Index test: CDUS.
Image production: protocol consisted of obtaining longitudinal and transverse views of
proximal, mid, and distal aorta and iliac arteries. Peak systolic velocities obtained in graft
and then compared with velocities in iliac vessels to assess for presence of limb flow
anomalies including stenosis or occlusion. CFD scanning and Doppler interrogation of
sac used to rule out presence of perigraft flow
Type of US: 3- to 5-MHz transducers, Acuson 128 XP ultrasound machine (Mountain
View, CA, USA)
Use of contrast: no.
Operator: registered vascular technologist.
Follow-up No loss to follow-up, missing data, or adverse events reported (“All CT scans and CDU
[CDUS] were technically satisfactory for determination of aneurysm size and presence
of endoleak.”)
Notes • Of the 281 participants, 97 had been enrolled in a phase II Food and Drug
Administration protocol. Follow-up of these participants included same-day US, CT,
and abdominal radiograph in first postoperative month, then at 6 and 12 months, and
yearly thereafter. The other participants underwent simultaneous studies, usually only
at 1-month postoperative visit. Participants who underwent routine EVAR with
commercial endografts underwent same-day studies only 30 days postoperatively.
Residual follow-up with CT scans only at same intervals as protocol participants.
• 494 postoperative same-day CT scans and CDUS scans obtained (mean ± SD: 3.
8 ± 1.4 per participant; range: 1 to 7) over 1- to 72-month follow-up period (mean (±
SD): 34.6 ± 2 months).
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Retrospective review of all participants who
underwent endovascular repair of AAAs be-
tween February 1996 and November 2002
and had same-day CT and CDUS studies
Acceptable reference standard?
All tests
Yes Reference standard was helical CT.
Acceptable delay between tests?
All tests
Yes Yes, participants received same-day US and
CT.
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Partial verification avoided?
All tests
Yes All study participants accounted for and re-
sults of reference standard reported for all
Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Yes US scanning technologist and surgeon re-
viewing tapes were both unaware of results
of CT scan during any portion of US scan
examination or review
Index test results blinded?
All tests
Unclear Unclear.
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes “All CT scans and CDU [CDUS] were
technically satisfactory for determination
of aneurysm size and presence of endoleak.
”
Withdrawals explained?
All tests
Yes No withdrawal reported.
Sandford 2006
Clinical features and settings People who underwent EVAR were referred to Leicester Royal Infirmary for endoleak
follow-up (over 11-year period between 30 March 1994 and 8 October 2005)
Type of stents received: not reported.
Aneurysm diameter: not reported.
Setting: department of cardiovascular sciences.
Participants 310 participants who underwent EVAR. No information reported related to age and
gender
Comorbidities: not reported.
Geography: UK.
Study design Single-centre, retrospective design, participants consecutively enrolled (all participants
received both tests)
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: not described.
Endoleak (absolute n): 44 (unclear).
Prevalence of endoleak: 18.0% (44/244).
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Reference standard: contrast CT scan performed using IV contrast and Phillips Secura
single-slice spiral CT
Image acquisition: no details reported.
Type of CT scanner: Phillips Secura single-slice spiral CT.
Use of contrast: yes.
Index and comparator tests Index test: CDUS.
Image production: not reported.
Type of US: Phillips HDI 5000.
Use of contrast: no.
Operator: a trained vascular technician.
Comparator test: CT scan.
Image acquisition: not reported.
Type of CT scanner: GE Lightspeed plus 16-slice scanner (GE Healthcare, Waukesha,
WI, USA)
Use of contrast: yes, Omnipaque 350 contrast 120 mL (GE Healthcare, Milwaukee, WI,
USA)
CT scan surveillance performed using GE Lightspeed plus 16-slice scanner (GE Health-
care, Waukesha, WI, USA) using 2.5-mm acquisition slice. Omnipaque 350 contrast
120 mL (GE Healthcare, Milwaukee, WI, USA) was injected at rate of 4-5 mL/s using
SmartPrep software (GE Healthcare, Milwaukee, WI, USA). Arterial phase acquisition
obtained by a mean delay of 25 s after injection. Delayed phase obtained at 70 s after
completion of first scan. CT scan reconstruction used 0.625-mm format
Index test: colour flow DUSS performed by a trained vascular technician using Phillips
HDI 5000 ultrasound machine. No contrast used. If abnormality found on DUSS, or
views were inadequate, participants underwent CT scan, using IV contrast and a Phillips
Secura single-slice spiral CT. All participants having undergone concurrent DUSS and
CT scans were included in analysis. Concurrent scans defined as having occurred within
6 months of each other
Follow-up Follow-up period: 60 months; however, number of participants eventually lost to follow-
up unclear
Notes
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Imaging was retrospectively reviewed for
310 consecutive patients undergoing en-
dovascular aneurysm repair at a single. Pa-
tients were followed up after EVAR in a
nurse led clinic and underwent six monthly
clinical examination andduplex ultrasound
scan
Acceptable reference standard?
All tests
Yes The reference standard was CT scan
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Acceptable delay between tests?
All tests
No No: concurrent scans were defined as hav-
ing occurred within 6months of each other
Partial verification avoided?
All tests
Yes All study participants are accounted for
and results of the reference standard are re-
ported for all
Differential verification avoided?
All tests
Yes All patients who received the index test
were subjected to the same reference stan-
dard
Incorporation avoided?
All tests
Yes The index test was not part of the reference
standard
Reference standard results blinded?
All tests
Unclear Unclear
Index test results blinded?
All tests
Unclear Unclear
Relevant clinical information?
All tests
Yes Yes
Uninterpretable results reported?
All tests
Yes “Of the 1352 CDUS performed, 151
(11%) reported difficult views due to either
increased bowel gas or obesity. The propor-
tion of scanswhich reported poor viewswas
higher immediately post operatively than
subsequent scans, affecting 19 of 99 (19%)
pre-discharge scans”
Withdrawals explained?
All tests
Unclear Unclear
Sato 1998
Clinical features and settings People who were implanted with the Endovascular Technologies stent graft device
Type of stents received: not reported.
Aneurysm diameter: not reported.
Setting: division of vascular surgery.
Participants 79 participants; no demographic information provided.
Comorbidities: not reported.
Geography: USA.
Study design Retrospective review of records.
“The EnACT Core Laboratory records were reviewed from CDU [CDUS] and CT
studies that were performed in patients who were implanted with the Endovascular
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Technologies stent graft device. All of the studies were evaluated by the Core Laboratory
for endoleak and interpreted as having an endoleak present or absent or recorded as an
indeterminate study as a result of technical factors. Datawere entered into a computerized
database and analyzed for diagnostic accuracy of CDU studies as compared with CTs.”
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: not reported.
Endoleaks have been reported at a rate of 13-44%.
Endoleak (absolute n): unclear.
Prevalence of endoleak: 34.0% (34/100).
Reference standard: contrast-enhanced CT scan.
“The CTs were obtained according to study protocol. A scout CT was obtained without
contrast to identify the superior mesenteric artery. This was followed by a contrast-
enhanced CT with 3-mm-thick slices from above the superior mesenteric artery to the
level of the profunda femoris and the superficial femoral artery. No delayed images were
required with the study protocol. The CDUs were performed according to the study
protocol, which included the evaluation of the flow through the endograft, the perigraft
flow, the renal and the iliac arterial flow, the maximum diameter of aneurysm, and the
presence of branch vessel flow.”
Type of scanner: not reported.
Use of contrast: yes (type not reported).
Index and comparator tests Index test: CDUS.
Image production: B-mode image performed to assess graft, proximal and distal stents,
and AAA sac and size measurements of the AAA sac. Colour Doppler scan added, and
settings optimized to avoid excessive overgain. Doppler scan may be added to assist in
detection of perigraft flow
Type of US:low-frequency (range: 2.25-5MHz), curved array, phased array ormechanical
sector, and pulsed Doppler scan transducers
Use of contrast: not used.
Operator: > 1.
Follow-up Unclear.
Notes
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Yes.
Acceptable reference standard?
All tests
Yes Reference standard was CT scan.
Acceptable delay between tests?
All tests
Unclear No information provided.
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Partial verification avoided?
All tests
Yes All study participants accounted for and re-
sults of reference standard reported for all
Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Yes Interpretation of all CDUS and CT scans
blinded to all concurrent and prior studies
Index test results blinded?
All tests
Yes Interpretation of all CDUS and CT scans
blinded to all concurrent and prior studies
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes Of 117 studies, 103 CDUs (88%) and 114
CTs (97%) were recorded as having pres-
ence or absence of an endoleak and 14
CDUs (12%) and 3 CTs (3%) were inde-
terminate
The 14 indeterminate CDUs caused by
suboptimal imaging technique. The 3 in-
determinate CTs caused by unsatisfactory
contrast administration in 2 studies and by
extensive calcification in the third study
In 18 studies (18%), CTs and CDUs were
conflicting for endoleaks
Withdrawals explained?
All tests
Unclear Unclear whether missing data or adverse
events occurred.
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Schmieder 2009
Clinical features and settings People with AAAs who underwent elective treatment with EVAR from 11 July 1996
to 31 March 2007. Analysis excluded people with symptomatic or ruptured AAA and
isolated iliac aneurysms
Type of stents received: commercially available and investigational devices, including 160
AneuRx (Medtronic, Santa Rosa, CA, USA), 55 Ancure/EVT (Guidant, Indianapolis,
IN, USA), 13 Zenith (Cook, Bloomington, IN, USA), 5 Powerlink (Endologix, Irvine,
CA, USA), 2 Excluder (WL Gore & Associates, Flagstaff, AZ, USA), and 1 Quantum
(Cordis, New Brunswick, NJ, USA)
Aneurysm diameter: not reported.
Setting: division of vascular surgery.
Participants 236 participants;202 (86%) men; mean age at the time EVAR: 72 years; range: 51-90
years. Study population: 211 (89%) white, 20 (8%) African-American, 4 (2%) Asian,
and 1 Hispanic
Comorbidities: not reported.
Geography: USA.
Study design Retrospective longitudinal study (from cohort of 496 consecutive participants, 236 par-
ticipants had paired CDUS and CT scan)
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: not reported (“Endoleaks were categorized as type I, type II, type
III or indeterminate.”)
Endoleak (absolute n):75.
Prevalence of endoleak: 15.9% (75/472).
Reference standard: contrast CT scan.
Image acquisition:
• 2.5-mm acquisition slice. Arterial phase acquisition obtained by mean delay of 25
s after injection. Delayed phase obtained at 70 s after completion of first scan. CT scan
reconstruction used 0.625-mm format. Interpretation of CT scan results performed by
radiology.
Type of scanner: GE Light-speed plus 16-slice scanner (GE Healthcare, Waukesha, WI,
USA)
Use of contrast: yes, Omnipaque 350 contrast (120 mL; GE Healthcare, Milwaukee, WI,
USA)
Index and comparator tests Index test: CDUS.
Image production: endograft, proximal and distal fixation points, and AAA sac imaged in
B-mode. Size of AAA sac measured
Type of US: range: 2.5-5 MHz curved array, phased array, or mechanical sector, and
pulsed Doppler scan transducer
Use of contrast: no.
Operator: 1 (“The US examinations were performed by vascular doctors dedicated to US
imaging.”)
Follow-up Unclear.
Notes
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Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
No From cohort of 496 consecutive partici-
pants, 236 participants had paired CDUS
and CT scan
Acceptable reference standard?
All tests
Yes Reference standard was CT scan.
Acceptable delay between tests?
All tests
No Mean interval between CDUS and CT
scans 18 days; range: 0-90 days, and 33%of
paired studies performed 4 days from each
other. CT scan obtained before CDUS scan
69% of time (n = 325), CDUS study ob-
tained before CT scan 15% of time (n =
71), and both studies obtained on the same
day 16% of time (n = 76)
Partial verification avoided?
All tests
Yes All study participants accounted for and re-
sults of reference standard reported for all
Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Yes US examinations performed by vascular
doctors dedicated to US imaging, blinded
to results of CTA
Index test results blinded?
All tests
Yes Interpretation of CT scan results per-
formed by radiology staff, whereas vascular
surgery staff interpreted CDUS results
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Unclear Uninterpretable data of participants ex-
cluded. No specific numbers reported
Withdrawals explained?
All tests
Unclear No information provided.
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Ten Bosch 2010
Clinical features and settings People who underwent endovascular repair for infrarenal AAA.
Type of stent received: Talent (Medtronic, Minneapolis, MN. USA).
Aneurysm diameter: not reported.
Setting: department of vascular surgery.
Participants 83 participants consecutively enrolled for CEUS and CTA imaging during surveillance
after EVAR
Comorbidities: not reported.
Geography: the Netherlands.
Study design Prospectively enrolled consecutive participants; all had target condition; all received both
tests
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: presence of persistent intrasac flow outside graft. Endoleaks clas-
sified as type IA/B, II, III, or IV
Endoleak (absolute n): unclear.
Prevalence of endoleak: 21.3% (27/127).
Reference standard: triple-phase (unenhanced and contrast-enhanced in arterial and
delayed phases) CTA
Image acquisition:
• images acquired in arterial phase, triggered by contrast medium passing aorta, and
in delayed phase 70 s after IV contrast medium injection.
CTA performed from diaphragm to common femoral arteries after continuous IV ad-
ministration of iodinated contrast agent (Xenetix 300; Laboratoire Andre Guerbet,
Aulnaysous Bois, France)
Parameters: high-speed mode capability, rotation time 0.5 s, table speed 24 mm per
rotation, collimation of 1.5 mm, and slice thickness 3 mm
Type of CT scanner: multidetector 16-slice spiraI CT scanner (Somatom Sensation;
Siemens, Forchheim, Germany)
Use of contrast: yes, iodinated contrast agent (Xenetix 300; Laboratoire Andre Guerbet,
Aulnaysous Bois, France)
Index and comparator tests Index test: CDUS.
Image production: continuous real-time tissue harmonic imaging for endoleak detection
performed for 15 minutes during sonographic contrast agent infusion at mechanical
index of 0.4-0.5 and at low acoustic power
Type of US: 3.5-MHz curved array transducer (Aloka 550-5000; Biomedic, Almere, the
Netherlands)
Use of contrast: yes, 5 mL SonoVue (Bracco, Milan, Italy) containing 8 µL sulphur
hexafluoride microbubbles per millilitre with 55 mL saline solution
Operator: 3 (“three well trained vascular technicians dedicated to US imaging”)
Follow-up “Seven of the 113 patients were excluded from participation in the study because of
severe iodinated contrast allergy (n = 3) or severe renal insufficiency (n = 4), which pre-
cluded CT angiography. The remaining 106 patients who were eligible for the study
were prospectively enrolled far dual-modality imaging after consent. Overall, 62 of 189
potential paired examinations were excluded from comparative analysis for one of the
following reasons: time interval between CT angiography and US examinations exceed-
ing 30 days as a consequence of logistic problems (n = 53), failure to performUS because
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of obesity (n = 2) or bowel gas (n = 1), and failure to receive CT angiography as a result
of study protocol violation (n = 6).”
Notes • “Seven of 113 patients enrolled were excluded from participation in the study
because of severe iodinated contrast allergy (n 3) or severe renal insufficiency (n 4),
which precluded CT angiography.”
• “Overall, 62 of 189 potential paired examinations were excluded from
comparative analysis for one of the following reasons: time interval between CT
angiography and US examinations exceeding 30 days as a consequence of logistic
problems (n = 53), failure to perform US because of obesity (n = 2) or bowel gas (n = 1)
, and failure to receive CT angiography as a result of study protocol violation (n = 6).”
• Aim of study was to investigate accuracy of CEUS as an alternative to CTA in the
follow-up of participants after EVAR with regard to detection of endoleaks and
changes in AAA dimensions. Study prospectively enrolled 106 participants.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes 106 participants who were eligible were
prospectively enrolled for dual-modality
imaging after consent. Overall, 127 of 189
potential paired examinations in 83 partic-
ipants available for comparative analysis
Acceptable reference standard?
All tests
Yes CTA triple-phase (unenhanced and con-
trast-enhanced in arterial and delayed
phases) performed
Acceptable delay between tests?
All tests
Yes Participants with time interval between
CTA and US examinations > 30 days were
excluded
Partial verification avoided?
All tests
Yes All study participants accounted for and re-
sults of reference standard reported for all
Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Yes “Each of the three vascular technicians in-
dependently measured AAA sac diameters
and reported the presence or absence of en-
doleak at the endof each contrast-enhanced
US examination; technicians were blinded
to the results of CT angiography. AAA di-
mensions on contrast-enhanced US were
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recorded as themeans of the threemeasure-
ments.”
Index test results blinded?
All tests
Yes “Each of the three vascular technicians in-
dependently measured AAA sac diameters
and reported the presence or absence of en-
doleak at the endof each contrast-enhanced
US examination; technicians were blinded
to the results of CT angiography. AAA di-
mensions on contrast-enhanced US were
recorded as themeans of the threemeasure-
ments.”
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes Failure to perform US because of obesity
(n = 2) or bowel gas (n = 1), and failure to
receiveCTAdue to study protocol violation
(n = 6)
Withdrawals explained?
All tests
Unclear 7/113 participants enrolled were excluded
because of severe iodinated contrast allergy
(n = 3) or severe renal insufficiency (n = 4)
, which precluded CTA
Overall, 62/189 potential paired examina-
tionswere excluded fromcomparative anal-
ysis for 1 of the following reasons: time in-
terval between CTA and US examinations
> 30 days as consequence of logistic prob-
lems (n = 53), failure to perform US be-
cause of obesity (n = 2) or bowel gas (n =
1), and failure to receive CTA due to study
protocol violation (n = 6)
Thompson 1998
Clinical features and settings 20 people who received endovascular grafts for infrarenal aortic aneurysms
Type of stent received: 6 aortic tube endografts (Endovascular Technologies EGS, Menlo
Park, CA, USA), 3 bifurcated systems (Stentor; Mintec, Freeport, Bahamas), and 11
tapered aorto-uni-iliac graft
Aneurysm diameter: median transverse diameter: 5.2 cm; range: 4.8-7.3 cm measured by
CT
Setting: department of surgery.
Participants Median age: 72 years; range: 68-84 years; median aneurysm diameter: 5.2 cm; range:
4.8-7.3 cm measured by CT; 5.0 cm; range: 4.3-7.0 cm measured by duplex imaging;
median follow-up: 14 months; range: 6-31 months
Comorbidities: not reported.
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Geography: UK.
Study design All participants who had a technically successful EVAR were entered into a standard
prospective surveillance programme at 3, 6, 12, 18, and 24 months following repair
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: to presence or absence of flow within aneurysm sac.
Endoleak (absolute n):75.
Prevalence of endoleak: 15.9% (49/494).
Reference standard: contrast CT scan.
Image acquisition:
• initial tomogram determined cranial extent of proximal metallic stent. 30 s
following IV injection of contrast, serial 10-mm slices performed from renal arteries to
level of femoral head. Endograft imaged to determine presence of thrombus within
graft lumen.
Type of CT scanner: Siemens HiQ scanner (Munich, Germany).
Use of contrast: yes (type unclear).
Index and comparator tests Index test: CDUS.
Image production: “Duplex imaging was performed with the patient supine using a 3.5
MHz curved linear array transducer, HDI Ultramark 9 (ATL, Letchworth, UK). Colour
Doppler ultrasonography was utilized to image flow within the graft, and any flow
disturbance was noted. Endoleaks were specifically sought with the colour Doppler set
to detect low flow.”
Type of US: 3.5-MHz curved linear array transducer, HDI Ultramark 9 (ATL, Letch-
worth, UK)
Use of contrast: no.
Operator: 2 (“Diagnostic imaging was performed by investigators.”)
Follow-up Unclear.
Notes
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Up to December 1996, EVAR was at-
tempted in 48 participants, with primary
success in 43. 20 of these participants fol-
lowed for ≥ 6 months and formed group
for study. Median age: 72 years; range: 68-
84 years; median aneurysm diameter: 5.2
cm; range: 4.8-7.3 cm as measured by CT
and 5.0 cm; range: 4.3-7.0 cm as measured
by duplex imaging; median follow-up: 14;
range: 6-31 months
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Acceptable reference standard?
All tests
Yes Reference standard was CT scan.
Acceptable delay between tests?
All tests
Yes Yes: CT and US examinations performed
on same day.
Partial verification avoided?
All tests
Yes All study participants accounted for and re-
sults of reference standard reported for all
Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Yes “Diagnostic imaging was performed by
investigators (G.F. and T.H.) who were
blinded of the result from the other imag-
ing technique and previous scans.”
Index test results blinded?
All tests
Unclear “Diagnostic imaging was performed by
investigators (G.F. and T.H.) who were
blinded of the result from the other imag-
ing technique and previous scans.”
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Unclear Unclear.
Withdrawals explained?
All tests
Yes No withdrawals.
Wolf 2000
Clinical features and settings People who received endovascular repair of AAA with bifurcated endograft
Type of stent received: AneuRx (Medtronic).
Aneurysm diameter: not reported.
Setting: vascular surgery department, Stanford University Hospital.
Participants 100 consecutive participants (age and gender not reported).
Comorbidities: not reported.
Geography: USA.
Study design Prospective cross-sectional study (consecutively selected participants, all received both
tests)
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Wolf 2000 (Continued)
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: no definition reported.
Endoleak (absolute n): unclear.
Prevalence of endoleak: 38.0% (62/163).
Reference standard: CTA.
Image acquisition:
• “single detector-row CT scans were acquired at a pitch 2.0 with a 3.0 mm
nominal section thickness from the celiac origin to the infrarenal aorta, followed by a
5.0 mm nominal section thickness to the femoral bifurcation. Multi detector-row CT
scans were acquired at pitch 6.0 with a 2.5 mm nominal section thickness throughout
the entire scan. All images were reconstructed at intervals equal to 50% of nominal
section thickness and viewed interactively on a workstation. Biphasic enhanced CT was
performed on using the same protocol and imager (HiSpeed Advantage, IGE Medical
Systems, Slough, UK).”
Type of CT scanner: CT scanner (both General Electric Medical Systems, Milwaukee,
WI, USA)
Use of contrast: yes (type not reported).
Index and comparator tests Index test: CDUS.
Image production: “The protocol included transverse and sagittal imaging and peak sys-
tolic diameter measurements at the largest region of the proximal, mid, and distal seg-
ments of the abdominal aorta. Visible segments of the iliac arteries were also measured.
Close attention was given to the stent device in gray scale and in colour Doppler scanning
to rule out endoleak and graft compression.”
Type of US: Sequoia 512 ultrasound scanning system (Acuson, Mountain View, CA,
USA) and sector V4 transducer
Use of contrast: no.
Operator: 1 (“the vascular technologist was not aware of the CT scan”)
Follow-up No apparent loss to follow-up, missing data, or adverse events
Notes • “Standardized duplex scanning protocol was used for assessing the abdominal
aorta. The protocol included transverse and sagittal imaging and peak systolic diameter
measurements at the largest region of the proximal, mid, and distal segments of the
abdominal aorta. Visible segments of the iliac arteries were also measured. Close
attention was given to the stent device in gray scale and in colour Doppler scanning to
rule out endoleak and graft compression. All duplex ultrasound scans were reviewed by
a vascular surgeon.”
• “Follow-up protocol included CT angiography before discharge, duplex scan at 1
month, and CT angiography at 6 months, 1 year, and yearly thereafter. To compare
CT and duplex scans, we obtained both studies, whenever possible, within a period of
7 days from each other.”
• “A total of 268 postoperative CT scans (2.7 ± 1.7 scans per patient) and 214
postoperative duplex scans (2.1 ± 1.9 scans per patient) were obtained over 1 to 30
months of follow-up (mean interval, 9 ± 7 months).”
Table of Methodological Quality
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Wolf 2000 (Continued)
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Enrolled participants who “underwent en-
dovascular repair for AAAwith the AneuRx
(Medtronic) bifurcated endograft at Stan-
ford University Hospital from October
1996 toMay 1999. Follow-up protocol in-
cluded CT angiography before discharge,
duplex scan at 1 month, and CT angiogra-
phy at 6 months, 1 year, and yearly there-
after.”
Acceptable reference standard?
All tests
Yes Reference standard was CT scan.
Acceptable delay between tests?
All tests
Unclear Delay between 2 tests in 24 participants
unclear.
“To compare CT and duplex scans, we
obtained both studies, whenever possible,
within a period of 7 days from each other.
CT and duplex scans were obtained con-
currently (within 7 days of each other) in
166 instances in 76 patients (1-6 scan pairs
per patient). These concurrent scan pairs
form the basis for the comparison between
the tests.”
Partial verification avoided?
All tests
Yes All study participants accounted for and re-
sults of reference standard reported for all
Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Yes “During the examination and the reading
of the duplex scan, the vascular technolo-
gist was not aware of the CT scan results.”
Index test results blinded?
All tests
Yes “In addition to a formal reading by a radi-
ologist who was unaware of the duplex scan
result, CT angiograms were reviewed by a
panel of radiologists and vascular surgeons
to confirm the presence or absence of an
endoleak.”
Relevant clinical information?
All tests
Yes Yes.
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Wolf 2000 (Continued)
Uninterpretable results reported?
All tests
Yes “All CT scans were technically satisfac-
tory. Delayed scans, which were obtained
routinely after September 1998, were per-
formed in 57% of CT scans. Sixteen (7%)
duplex scans in 10 patients were technically
inadequate for determination of aneurysm
size and presence of endoleak.”
Withdrawals explained?
All tests
Unclear Unclear.
Zannetti 2000
Clinical features and settings People who underwent EVAR.
Type of stents received: “The AneuRxstent graft was employed in 144 procedures, the Gore
Excluder in 9 procedures, and the Talent graft in one.”
Aneurysm diameter: mean (± SD) AAA diameter: 50.2 ± 8.3 mm.
Setting: unit of vascular surgery.
Participants 108 participants; mean (± SD) age: 70.1 ± 6.7 years; ASA IV: n = 19 (19%); Eurostar
classification A: n = 18 (17%); B: n = 62 (61%); C: n = 7 (7%); D: n = 7 (7%); E: n= 8
(8%)
Comorbidities: not reported.
Geography: Italy.
Study design Consecutively enrolled participants. “After surgery, patients were entered in a follow-up
protocol consisting of colour-duplex and CT scan examinations scheduled at 1, 6, 12
months after surgery, and every 6 months thereafter.Mean follow up of the study cohort
was 8.5 months.”
Target condition and reference standard(s) Target condition: endoleak.
Definition of endoleak: flow “outside the endograft and within the aneurysmal sac.”
Endoleak (absolute n): 12.
Prevalence of endoleak: 37.5% (12/32).
Reference standard: contrast-enhanced CT.
Image acquisition:
• contrast-enhanced CT scan performed with 5-mm slices in 162 (82%) studies
and with 3-mm thick slices in balance, from above SMA to level of origin of common
femoral artery. Spiral (78) or axial CT (120) scans obtained at different time intervals
according to study protocol. Spiral CT acquired with collimation 5 mm, table speed 5
mm, pitch 1.
Type of CT scanner: not reported.
Use of contrast: mean 140 mL of iso-osmotic, non-ionic iodinated contrast media injected
25 s before imaging acquisition
Index and comparator tests Index test: CDUS.
Image production: “The scanhead was applied in both the transverse and longitudinal
views to obtain colour andDoppler optimisation.The entire AAA sac, proximal anddistal
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Zannetti 2000 (Continued)
necks, the aorta, iliac and femoral arteries were systematically imaged and measurements
were performed on both sagittal and transverse views. The presence of perigraft endoleaks
was suspected when a reproducible colour signal outside the endograft and within the
aneurysmal sac was visualised. All suspected endoleaks were further evaluated with the
Doppler signal to avoid colour artefacts.”
Type of US: C4-2-MHz curved array transducer (ATL 3000 HDI system, Advanced
Technology Laboratory)
Use of contrast: no.
Operator: 2 (“All duplex scan examinations were performed by two vascular surgeons
with the same machine (ATL HDI).”)
Follow-up “Compliance with the study protocol was not achieved in 51 patients for different reasons
including perioperative death (two patients), conversion to open repair (four patients),
duplex scan performed in a different centre in patients from out of town and refusal
Three patients (2%) were excluded from the study protocol because of inadequate duplex
visualisation of the abdominal aortic aneurysm (AAA) sac due to obesity or intestinal
gas.”
Notes 198 concurrent all duplex-scan examinations performed.
Table of Methodological Quality
Item Authors’ judgement Description
Representative spectrum?
All tests
Yes Consecutive participants who received
EVAR received both index test and refer-
ence standard
Acceptable reference standard?
All tests
Yes Reference standard was CT scan.
Acceptable delay between tests?
All tests
Unclear Not reported.
Partial verification avoided?
All tests
Yes All study participants accounted for and re-
sults of reference standard reported for all
Differential verification avoided?
All tests
Yes All participants who received index test
subjected to same reference standard
Incorporation avoided?
All tests
Yes Index test not part of reference standard.
Reference standard results blinded?
All tests
Yes “The interpretation of all colour-duplex
and CT scans was blinded to all concurrent
and prior studies.”
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Zannetti 2000 (Continued)
Index test results blinded?
All tests
Yes “The interpretation of all colour-duplex
and CT scans was blinded to all concurrent
and prior studies.”
Relevant clinical information?
All tests
Yes Yes.
Uninterpretable results reported?
All tests
Yes “With respect to the presence of endoleak,
CT and colour-duplex scans were conflict-
ing in 4 cases (2%)
In detail, duplex scan failed to show one
endoleak (1 false negative) and revealed 3
endoleaks not confirmed by CT examina-
tion (3 false positives). Digital subtraction
angiography performed on these 4 patients
revealed the absence of endoleak in all cases
With respect to type of endoleak, of the 11
endoleaks detected both byCT and colour-
duplex scan, there was discordance in 2
cases. Based on the 2 colour duplex-scan ex-
aminations, reperfusion of the aneurysmal
sac appeared in continuity with the inferior
mesenteric artery and the 2 endoleaks were
classified as non-graft-related. Inversely, in
these 2 patients CT scan revealed accumu-
lation of the majority of contrast media in
the area of the proximal implant zone, sug-
gesting the presence of a graft-related en-
doleak in accordance with digital subtrac-
tion angiography obtained subsequently.”
Withdrawals explained?
All tests
Yes “Compliance with the study protocol was
not achieved in 51 patients for different
reasons including perioperative death (two
patients), conversion to open repair (four
patients), duplex scan performed in a dif-
ferent centre in patients from out of town
and refusal
Three patients (2%) were excluded from
the study protocol because of inadequate
duplex visualisation of the abdominal aor-
tic aneurysm (AAA) sac due to obesity or
intestinal gas.”
2D: two-dimensional; 3D: three-dimensional; 4D: four-dimensional; AAA: abdominal aortic aneurysm; ASA: American Society of
Anesthesiology; BMI: body mass index; CCDS: colour-coded duplex sonography; CDI: colour Doppler imaging; CDUS: colour
duplex ultrasound; CE-CDUS: contrast-enhanced colour duplex ultrasound; CEUS: contrast-enhanced ultrasound; CFD: colour
flow duplex; CI: confidence interval; CPS: contrast pulse sequences; CT: computed tomography; CTA: computed tomography
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angiography; DSA: digital subtraction angiography; DUS: duplex ultrasound; DUSS: duplex ultrasound sonography; erAAA: emer-
gency abdominal aortic aneurysm; EVAR: endovascular aneurysm repair; GPS: global positioning system; IV: intravenous; LDCE:
low-dose contrast-enhanced; MRA: magnetic resonance angiography; MS-CT: multi-slice computer tomography; n: number of
participants; s: second; SD: standard deviation; SMA: superior mesenteric artery; US: ultrasound.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Almaroof 2013 Performed EVAR surveillance using US and CT scan but did not evaluate endoleaks
Beeman 2009 People without insurance coverage could not receive US test and were excluded
Bredahl 2013 Target conditions: volume estimation of residual sac after EVAR
Chisci 2012 Study was a follow-up protocol based on colour DUS + plain abdominal radiography and CTA on demand
Clevert 2008a 36 included participants were with known or suspected treated and untreated aortic lesions detected by CTA
Clevert 2013 Target condition was not endoleak (time-to-peak i.e. time between point where contrast agent was first seen in
stent graft until it was first seen in aneurysmal sac, of all digitally stored CEUS video sequences showing an
endoleak, to confirm type of endoleak in uncertain cases
Collins 2007 CT scan performed only when US was positive (for 160 screening only 35 CT scans performed)
Elkouri 2004 Data insufficient to perform a contingency table.
Greenfield 2002 Not all participants included received both tests: US performed only when CT scan results were positive
Han 2010 Study limited to diameter measurements after endovascular aortic aneurysm repair
Harrison 2011 Study considered participants from a registry where participants who received EVAR required CT scan only when
DUS was not diagnostic. In addition, data reported were insufficient
Hertault 2015 Study did not sufficiently provide data for 2 × 2 table production
Manning 2009 Ultrasonography and CT not performed concurrently.
Millen 2013 Study evaluated a subset of participants with CEUS with unresolved issues
Napoli 2004 US not performed concurrently to CT scan.
Nyheim 2013 Study did not report sufficient data for inclusion.
Ormesher 2014 Reference standard angiography (not CTA).
Pfister 2009 Participants included based on suspect of endoleak.
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(Continued)
Sommer 2012 Not consecutive participants. Included people with suspect of endoleak at previous imaging study, or with post-
operative endoleaks
Sorrentino 2015 Retrospective study that was not performed for purpose of performing an accuracy study
Troutman 2014 Follow-up study of Beeman 2009; study included subsequent participants who never received CT scan
Yang 2015 Included participants were a selected population with endoleaks
CEUS: colour enhanced ultrasound; CT: computed tomography; CTA: computed tomography angiography; DUS: duplex ultrasound;
EVAR: endovascular aneurysm repair; US: ultrasound.
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D A T A
Presented below are all the data for all of the tests entered into the review.
Tests. Data tables by test
Test
No. of
studies
No. of
participants
1 All colour duplex ultrasound
(CDUS)
42 5691
2 CDUS (unit of analysis: number
of individuals)
16 1135
3 Contrast-enhanced colour
duplex ultrasound (CE-CDUS)
(unit of analysis: number of
individuals)
11 931
4 CE-CDUS endoleak types I and
III
7 792
5 Subgroup CDUS (unit of
analysis: number of individuals)
7 400
6 Subgroup CE-CDUS (unit of
analysis: number of individuals)
7 403
7 CDUS (unit of analysis: number
of scans)
18 3689
8 CE-CDUS (unit of analysis:
number of scans)
8 756
9 CDUS (excluding outliers; unit
of analysis: number of scans)
16 3041
10 CE-CDUS (excluding outliers;
unit of analysis: number of
scans)
7 660
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Test 1. All colour duplex ultrasound (CDUS).
Review: Ultrasonography for endoleak detection after endoluminal abdominal aortic aneurysm repair
Test: 1 All colour duplex ultrasound (CDUS)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Abbas 2014 17 1 0 12 1.00 [ 0.80, 1.00 ] 0.92 [ 0.64, 1.00 ]
AbuRahma 2005 23 4 11 329 0.68 [ 0.49, 0.83 ] 0.99 [ 0.97, 1.00 ]
Arsicot 2014 12 5 2 29 0.86 [ 0.57, 0.98 ] 0.85 [ 0.69, 0.95 ]
Ashoke 2005b 4 12 2 48 0.67 [ 0.22, 0.96 ] 0.80 [ 0.68, 0.89 ]
Ashoke 2005c 6 3 1 13 0.86 [ 0.42, 1.00 ] 0.81 [ 0.54, 0.96 ]
Badri 2010 20 13 17 264 0.54 [ 0.37, 0.71 ] 0.95 [ 0.92, 0.97 ]
Bendick 2003 8 2 0 10 1.00 [ 0.63, 1.00 ] 0.83 [ 0.52, 0.98 ]
Cantisani 2011 23 0 1 84 0.96 [ 0.79, 1.00 ] 1.00 [ 0.96, 1.00 ]
Clevert 2008b 15 2 0 26 1.00 [ 0.78, 1.00 ] 0.93 [ 0.76, 0.99 ]
Clevert 2011 4 0 0 31 1.00 [ 0.40, 1.00 ] 1.00 [ 0.89, 1.00 ]
Costa 2013 15 1 4 40 0.79 [ 0.54, 0.94 ] 0.98 [ 0.87, 1.00 ]
d’Audiffret 2001 31 4 1 53 0.97 [ 0.84, 1.00 ] 0.93 [ 0.83, 0.98 ]
Demirpolat 2011 17 1 0 30 1.00 [ 0.80, 1.00 ] 0.97 [ 0.83, 1.00 ]
Fran a 2013 12 2 10 26 0.55 [ 0.32, 0.76 ] 0.93 [ 0.76, 0.99 ]
Gargiulo 2014 2 0 1 19 0.67 [ 0.09, 0.99 ] 1.00 [ 0.82, 1.00 ]
Giannoni 2003 8 21 0 52 1.00 [ 0.63, 1.00 ] 0.71 [ 0.59, 0.81 ]
Giannoni 2007 7 1 0 21 1.00 [ 0.59, 1.00 ] 0.95 [ 0.77, 1.00 ]
Golzarian 2002 17 3 5 28 0.77 [ 0.55, 0.92 ] 0.90 [ 0.74, 0.98 ]
Gray 2012 25 62 0 372 1.00 [ 0.86, 1.00 ] 0.86 [ 0.82, 0.89 ]
Gurtler 2013 0 0 0 0 0.0 [ 0.0, 0.0 ] 0.0 [ 0.0, 0.0 ]
Heilberger 1997 26 4 2 81 0.93 [ 0.76, 0.99 ] 0.95 [ 0.88, 0.99 ]
Henao 2006 6 3 0 11 1.00 [ 0.54, 1.00 ] 0.79 [ 0.49, 0.95 ]
Iezzi 2009 39 8 1 36 0.98 [ 0.87, 1.00 ] 0.82 [ 0.67, 0.92 ]
McLafferty 2002 7 1 0 68 1.00 [ 0.59, 1.00 ] 0.99 [ 0.92, 1.00 ]
McWilliams 1999 3 6 0 11 1.00 [ 0.29, 1.00 ] 0.65 [ 0.38, 0.86 ]
McWilliams 2002 4 19 16 57 0.20 [ 0.06, 0.44 ] 0.75 [ 0.64, 0.84 ]
Motta 2012 34 0 3 105 0.92 [ 0.78, 0.98 ] 1.00 [ 0.97, 1.00 ]
Nagre 2011 54 19 100 388 0.35 [ 0.28, 0.43 ] 0.95 [ 0.93, 0.97 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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(. . . Continued)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Nerlekar 2006 27 6 2 208 0.93 [ 0.77, 0.99 ] 0.97 [ 0.94, 0.99 ]
Oikonomou 2012 18 3 6 63 0.75 [ 0.53, 0.90 ] 0.95 [ 0.87, 0.99 ]
Pages 2001 14 5 15 75 0.48 [ 0.29, 0.67 ] 0.94 [ 0.86, 0.98 ]
Parent 2002 23 18 0 42 1.00 [ 0.85, 1.00 ] 0.70 [ 0.57, 0.81 ]
Perini 2011 83 20 16 276 0.84 [ 0.75, 0.90 ] 0.93 [ 0.90, 0.96 ]
Perini 2012 5 1 2 54 0.71 [ 0.29, 0.96 ] 0.98 [ 0.90, 1.00 ]
Raman 2003 21 18 28 427 0.43 [ 0.29, 0.58 ] 0.96 [ 0.94, 0.98 ]
Sandford 2006 15 18 12 199 0.56 [ 0.35, 0.75 ] 0.92 [ 0.87, 0.95 ]
Sato 1998 33 17 1 49 0.97 [ 0.85, 1.00 ] 0.74 [ 0.62, 0.84 ]
Schmieder 2009 48 62 27 335 0.64 [ 0.52, 0.75 ] 0.84 [ 0.80, 0.88 ]
Ten Bosch 2010 22 45 5 55 0.81 [ 0.62, 0.94 ] 0.55 [ 0.45, 0.65 ]
Thompson 1998 4 0 0 16 1.00 [ 0.40, 1.00 ] 1.00 [ 0.79, 1.00 ]
Wolf 2000 51 3 11 98 0.82 [ 0.70, 0.91 ] 0.97 [ 0.92, 0.99 ]
Zannetti 2000 11 3 1 17 0.92 [ 0.62, 1.00 ] 0.85 [ 0.62, 0.97 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 2. CDUS (unit of analysis: number of individuals).
Review: Ultrasonography for endoleak detection after endoluminal abdominal aortic aneurysm repair
Test: 2 CDUS (unit of analysis: number of individuals)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Arsicot 2014 12 5 2 29 0.86 [ 0.57, 0.98 ] 0.85 [ 0.69, 0.95 ]
Bendick 2003 8 2 0 10 1.00 [ 0.63, 1.00 ] 0.83 [ 0.52, 0.98 ]
Cantisani 2011 14 6 10 78 0.58 [ 0.37, 0.78 ] 0.93 [ 0.85, 0.97 ]
Clevert 2008b 5 2 10 26 0.33 [ 0.12, 0.62 ] 0.93 [ 0.76, 0.99 ]
Clevert 2011 2 3 1 28 0.67 [ 0.09, 0.99 ] 0.90 [ 0.74, 0.98 ]
d’Audiffret 2001 31 4 1 53 0.97 [ 0.84, 1.00 ] 0.93 [ 0.83, 0.98 ]
Golzarian 2002 17 3 5 28 0.77 [ 0.55, 0.92 ] 0.90 [ 0.74, 0.98 ]
Heilberger 1997 26 0 1 66 0.96 [ 0.81, 1.00 ] 1.00 [ 0.95, 1.00 ]
Henao 2006 3 1 3 11 0.50 [ 0.12, 0.88 ] 0.92 [ 0.62, 1.00 ]
Iezzi 2009 25 16 15 28 0.63 [ 0.46, 0.77 ] 0.64 [ 0.48, 0.78 ]
McLafferty 2002 7 1 0 68 1.00 [ 0.59, 1.00 ] 0.99 [ 0.92, 1.00 ]
Oikonomou 2012 18 3 6 63 0.75 [ 0.53, 0.90 ] 0.95 [ 0.87, 0.99 ]
Parent 2002 23 18 0 42 1.00 [ 0.85, 1.00 ] 0.70 [ 0.57, 0.81 ]
Sandford 2006 15 18 29 182 0.34 [ 0.20, 0.50 ] 0.91 [ 0.86, 0.95 ]
Thompson 1998 4 0 0 16 1.00 [ 0.40, 1.00 ] 1.00 [ 0.79, 1.00 ]
Zannetti 2000 11 3 1 17 0.92 [ 0.62, 1.00 ] 0.85 [ 0.62, 0.97 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 3. Contrast-enhanced colour duplex ultrasound (CE-CDUS) (unit of analysis: number of individuals).
Review: Ultrasonography for endoleak detection after endoluminal abdominal aortic aneurysm repair
Test: 3 Contrast-enhanced colour duplex ultrasound (CE-CDUS) (unit of analysis: number of individuals)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Bendick 2003 8 2 0 10 1.00 [ 0.63, 1.00 ] 0.83 [ 0.52, 0.98 ]
Cantisani 2011 23 0 1 84 0.96 [ 0.79, 1.00 ] 1.00 [ 0.96, 1.00 ]
Clevert 2008b 15 2 0 26 1.00 [ 0.78, 1.00 ] 0.93 [ 0.76, 0.99 ]
Clevert 2011 4 0 0 31 1.00 [ 0.40, 1.00 ] 1.00 [ 0.89, 1.00 ]
Gargiulo 2014 2 0 1 19 0.67 [ 0.09, 0.99 ] 1.00 [ 0.82, 1.00 ]
Giannoni 2007 7 1 0 21 1.00 [ 0.59, 1.00 ] 0.95 [ 0.77, 1.00 ]
Heilberger 1997 26 4 2 81 0.93 [ 0.76, 0.99 ] 0.95 [ 0.88, 0.99 ]
Henao 2006 6 3 0 11 1.00 [ 0.54, 1.00 ] 0.79 [ 0.49, 0.95 ]
Iezzi 2009 39 8 1 36 0.98 [ 0.87, 1.00 ] 0.82 [ 0.67, 0.92 ]
Perini 2011 83 20 16 276 0.84 [ 0.75, 0.90 ] 0.93 [ 0.90, 0.96 ]
Perini 2012 5 1 2 54 0.71 [ 0.29, 0.96 ] 0.98 [ 0.90, 1.00 ]
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Test 4. CE-CDUS endoleak types I and III.
Review: Ultrasonography for endoleak detection after endoluminal abdominal aortic aneurysm repair
Test: 4 CE-CDUS endoleak types I and III
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Cantisani 2011 1 1 1 105 0.50 [ 0.01, 0.99 ] 0.99 [ 0.95, 1.00 ]
Clevert 2008b 5 1 0 37 1.00 [ 0.48, 1.00 ] 0.97 [ 0.86, 1.00 ]
Giannoni 2007 1 0 0 28 1.00 [ 0.03, 1.00 ] 1.00 [ 0.88, 1.00 ]
Heilberger 1997 26 4 2 81 0.93 [ 0.76, 0.99 ] 0.95 [ 0.88, 0.99 ]
Henao 2006 1 0 0 19 1.00 [ 0.03, 1.00 ] 1.00 [ 0.82, 1.00 ]
Iezzi 2009 3 0 0 81 1.00 [ 0.29, 1.00 ] 1.00 [ 0.96, 1.00 ]
Perini 2011 21 0 0 374 1.00 [ 0.84, 1.00 ] 1.00 [ 0.99, 1.00 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 5. Subgroup CDUS (unit of analysis: number of individuals).
Review: Ultrasonography for endoleak detection after endoluminal abdominal aortic aneurysm repair
Test: 5 Subgroup CDUS (unit of analysis: number of individuals)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Bendick 2003 6 0 2 12 0.75 [ 0.35, 0.97 ] 1.00 [ 0.74, 1.00 ]
Cantisani 2011 14 6 10 78 0.58 [ 0.37, 0.78 ] 0.93 [ 0.85, 0.97 ]
Clevert 2008b 5 2 10 26 0.33 [ 0.12, 0.62 ] 0.93 [ 0.76, 0.99 ]
Clevert 2011 2 3 1 28 0.67 [ 0.09, 0.99 ] 0.90 [ 0.74, 0.98 ]
Heilberger 1997 26 0 1 66 0.96 [ 0.81, 1.00 ] 1.00 [ 0.95, 1.00 ]
Henao 2006 3 1 3 11 0.50 [ 0.12, 0.88 ] 0.92 [ 0.62, 1.00 ]
Iezzi 2009 25 16 15 28 0.63 [ 0.46, 0.77 ] 0.64 [ 0.48, 0.78 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 6. Subgroup CE-CDUS (unit of analysis: number of individuals).
Review: Ultrasonography for endoleak detection after endoluminal abdominal aortic aneurysm repair
Test: 6 Subgroup CE-CDUS (unit of analysis: number of individuals)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Bendick 2003 8 2 0 10 1.00 [ 0.63, 1.00 ] 0.83 [ 0.52, 0.98 ]
Cantisani 2011 23 0 1 84 0.96 [ 0.79, 1.00 ] 1.00 [ 0.96, 1.00 ]
Clevert 2008b 15 2 0 26 1.00 [ 0.78, 1.00 ] 0.93 [ 0.76, 0.99 ]
Clevert 2011 4 0 0 31 1.00 [ 0.40, 1.00 ] 1.00 [ 0.89, 1.00 ]
Heilberger 1997 26 4 1 62 0.96 [ 0.81, 1.00 ] 0.94 [ 0.85, 0.98 ]
Henao 2006 6 3 0 11 1.00 [ 0.54, 1.00 ] 0.79 [ 0.49, 0.95 ]
Iezzi 2009 39 8 1 36 0.98 [ 0.87, 1.00 ] 0.82 [ 0.67, 0.92 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 7. CDUS (unit of analysis: number of scans).
Review: Ultrasonography for endoleak detection after endoluminal abdominal aortic aneurysm repair
Test: 7 CDUS (unit of analysis: number of scans)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
AbuRahma 2005 23 4 11 329 0.68 [ 0.49, 0.83 ] 0.99 [ 0.97, 1.00 ]
Ashoke 2005b 4 12 2 48 0.67 [ 0.22, 0.96 ] 0.80 [ 0.68, 0.89 ]
Ashoke 2005c 6 3 1 13 0.86 [ 0.42, 1.00 ] 0.81 [ 0.54, 0.96 ]
Badri 2010 20 13 17 264 0.54 [ 0.37, 0.71 ] 0.95 [ 0.92, 0.97 ]
Costa 2013 15 1 4 40 0.79 [ 0.54, 0.94 ] 0.98 [ 0.87, 1.00 ]
Demirpolat 2011 17 1 0 30 1.00 [ 0.80, 1.00 ] 0.97 [ 0.83, 1.00 ]
Fran a 2013 12 2 10 26 0.55 [ 0.32, 0.76 ] 0.93 [ 0.76, 0.99 ]
Giannoni 2003 5 0 3 45 0.63 [ 0.24, 0.91 ] 1.00 [ 0.92, 1.00 ]
Gray 2012 25 62 0 372 1.00 [ 0.86, 1.00 ] 0.86 [ 0.82, 0.89 ]
McWilliams 1999 1 6 2 11 0.33 [ 0.01, 0.91 ] 0.65 [ 0.38, 0.86 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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(. . . Continued)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
McWilliams 2002 2 4 18 63 0.10 [ 0.01, 0.32 ] 0.94 [ 0.85, 0.98 ]
Nagre 2011 54 19 100 388 0.35 [ 0.28, 0.43 ] 0.95 [ 0.93, 0.97 ]
Nerlekar 2006 27 6 2 208 0.93 [ 0.77, 0.99 ] 0.97 [ 0.94, 0.99 ]
Pages 2001 14 5 15 75 0.48 [ 0.29, 0.67 ] 0.94 [ 0.86, 0.98 ]
Raman 2003 21 18 28 427 0.43 [ 0.29, 0.58 ] 0.96 [ 0.94, 0.98 ]
Sato 1998 33 17 1 49 0.97 [ 0.85, 1.00 ] 0.74 [ 0.62, 0.84 ]
Schmieder 2009 48 62 27 335 0.64 [ 0.52, 0.75 ] 0.84 [ 0.80, 0.88 ]
Wolf 2000 51 3 11 98 0.82 [ 0.70, 0.91 ] 0.97 [ 0.92, 0.99 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
Test 8. CE-CDUS (unit of analysis: number of scans).
Review: Ultrasonography for endoleak detection after endoluminal abdominal aortic aneurysm repair
Test: 8 CE-CDUS (unit of analysis: number of scans)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Abbas 2014 17 1 0 12 1.00 [ 0.80, 1.00 ] 0.92 [ 0.64, 1.00 ]
Costa 2013 15 1 4 40 0.79 [ 0.54, 0.94 ] 0.98 [ 0.87, 1.00 ]
Giannoni 2003 8 21 0 52 1.00 [ 0.63, 1.00 ] 0.71 [ 0.59, 0.81 ]
Gurtler 2013 84 8 3 105 0.97 [ 0.90, 0.99 ] 0.93 [ 0.87, 0.97 ]
McWilliams 1999 3 6 0 11 1.00 [ 0.29, 1.00 ] 0.65 [ 0.38, 0.86 ]
McWilliams 2002 4 19 16 57 0.20 [ 0.06, 0.44 ] 0.75 [ 0.64, 0.84 ]
Motta 2012 34 0 3 105 0.92 [ 0.78, 0.98 ] 1.00 [ 0.97, 1.00 ]
Ten Bosch 2010 22 45 5 55 0.81 [ 0.62, 0.94 ] 0.55 [ 0.45, 0.65 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
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Test 9. CDUS (excluding outliers; unit of analysis: number of scans).
Review: Ultrasonography for endoleak detection after endoluminal abdominal aortic aneurysm repair
Test: 9 CDUS (excluding outliers; unit of analysis: number of scans)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
AbuRahma 2005 23 4 11 329 0.68 [ 0.49, 0.83 ] 0.99 [ 0.97, 1.00 ]
Ashoke 2005b 4 12 2 48 0.67 [ 0.22, 0.96 ] 0.80 [ 0.68, 0.89 ]
Ashoke 2005c 6 3 1 13 0.86 [ 0.42, 1.00 ] 0.81 [ 0.54, 0.96 ]
Badri 2010 20 13 17 264 0.54 [ 0.37, 0.71 ] 0.95 [ 0.92, 0.97 ]
Costa 2013 15 1 4 40 0.79 [ 0.54, 0.94 ] 0.98 [ 0.87, 1.00 ]
Demirpolat 2011 17 1 0 30 1.00 [ 0.80, 1.00 ] 0.97 [ 0.83, 1.00 ]
Fran a 2013 12 2 10 26 0.55 [ 0.32, 0.76 ] 0.93 [ 0.76, 0.99 ]
Giannoni 2003 5 0 3 45 0.63 [ 0.24, 0.91 ] 1.00 [ 0.92, 1.00 ]
Gray 2012 25 62 0 372 1.00 [ 0.86, 1.00 ] 0.86 [ 0.82, 0.89 ]
McWilliams 1999 1 6 2 11 0.33 [ 0.01, 0.91 ] 0.65 [ 0.38, 0.86 ]
Nerlekar 2006 27 6 2 208 0.93 [ 0.77, 0.99 ] 0.97 [ 0.94, 0.99 ]
Pages 2001 14 5 15 75 0.48 [ 0.29, 0.67 ] 0.94 [ 0.86, 0.98 ]
Raman 2003 21 18 28 427 0.43 [ 0.29, 0.58 ] 0.96 [ 0.94, 0.98 ]
Sato 1998 33 17 1 49 0.97 [ 0.85, 1.00 ] 0.74 [ 0.62, 0.84 ]
Schmieder 2009 48 62 27 335 0.64 [ 0.52, 0.75 ] 0.84 [ 0.80, 0.88 ]
Wolf 2000 51 3 11 98 0.82 [ 0.70, 0.91 ] 0.97 [ 0.92, 0.99 ]
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Test 10. CE-CDUS (excluding outliers; unit of analysis: number of scans).
Review: Ultrasonography for endoleak detection after endoluminal abdominal aortic aneurysm repair
Test: 10 CE-CDUS (excluding outliers; unit of analysis: number of scans)
Study TP FP FN TN Sensitivity Specificity Sensitivity Specificity
Abbas 2014 17 1 0 12 1.00 [ 0.80, 1.00 ] 0.92 [ 0.64, 1.00 ]
Costa 2013 15 1 4 40 0.79 [ 0.54, 0.94 ] 0.98 [ 0.87, 1.00 ]
Giannoni 2003 8 21 0 52 1.00 [ 0.63, 1.00 ] 0.71 [ 0.59, 0.81 ]
Gurtler 2013 84 8 3 105 0.97 [ 0.90, 0.99 ] 0.93 [ 0.87, 0.97 ]
McWilliams 1999 3 6 0 11 1.00 [ 0.29, 1.00 ] 0.65 [ 0.38, 0.86 ]
Motta 2012 34 0 3 105 0.92 [ 0.78, 0.98 ] 1.00 [ 0.97, 1.00 ]
Ten Bosch 2010 22 45 5 55 0.81 [ 0.62, 0.94 ] 0.55 [ 0.45, 0.65 ]
0 0.2 0.4 0.6 0.8 1 0 0.2 0.4 0.6 0.8 1
A D D I T I O N A L T A B L E S
Table 1. Classification scheme of endoleaks
Endoleak type Description
Type I Attachment site leak-proximal or distal.
Type I endoleak are the most common that occur after endovascular repair
Typical in participants with complex arterial anatomy.
Type II Collateral vessel-leak.
Frequent type of endoleak characterized by retrograde blood flow through aortic branch vessels into the aneurism
sac
Type III Graft failure.
Type III endoleaks are caused by a structural failure of the stent-graft including fractures, holes of the device during
production or junctional separations. Recurring stresses due to arterial pulsation or the aneurysmal pressure can be
potential causes. Type III are infrequent
Type IV Graft wall porosity.
Type IV are caused by stent porosity.
Type V Endotension.
This type of endoleak related to the expansion of the aneurysm. The cause is unknown
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Table 2. QUADAS methodological items and operational definitions
Item definition Item question Assessment
1. Representative spectrum (spectrum bias) Was the spectrum of participants represen-
tative of the patients who will receive the
test in practice?
Yes: if the study includes a consecutive se-
ries of participants referred for follow-up to
detect potential endoleaks
No: if the referred participants were not
under follow-up for endoleak detection
Unclear: insufficient information to make
a judgement.
2. Acceptable reference standard Was the reference standard likely to classify
the target condition correctly?
Yes: CT scan test with contrast agents per-
formed and images evaluated by a radiolo-
gist
No: reference standard didnotmeet criteria
outlined above.
Unclear: insufficient information to make
a judgement.
3. Acceptable delay between tests Was time period between reference stan-
dard and index test short enough to be rea-
sonably sure that target condition did not
change between the 2 tests?
Yes: time period between index test and ref-
erence standard ≤ 4 weeks
No: time period > 4 weeks.
Unclear: insufficient information to make
a judgement.
4. Partial verification avoided Did the whole sample or a random selec-
tion of the sample, receive verification us-
ing a reference standard of diagnosis?
Yes: all study participants accounted for
and results of reference standard reported
for all
No: not all participants who received index
test received verification by reference stan-
dard
Unclear: insufficient information to make
a judgement.
5. Differential verification avoided Did participants receive the same reference
standard regardless of the index test result?
Yes: all participants who received index test
were subjected to same reference standard
No: not all participants who received index
test were subjected to same reference stan-
dard.;
Unclear: insufficient information to make
a judgement.
6. Incorporation avoided Was the reference standard independent of
the index test (i.e. the index test did not
form part of the reference standard)?
Yes: index test was not part of reference
standard.
No: index test was clearly part of reference
standard.
Unclear: insufficient informationwas given
to make a judgement
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Table 2. QUADAS methodological items and operational definitions (Continued)
7. Reference standard results blinded Were the index test results interpretedwith-
out knowledge of the results of the refer-
ence standard?
Yes: explicitly stated that index test was in-
terpreted without knowledge of reference
standard
No: if assessor of index test was aware of
results of reference standard
Unclear: insufficient information to make
a judgement.
8. Index test results blinded Was the execution of the reference standard
described in sufficient detail to permit its
replication?
Yes: explicitly stated that reference standard
was interpreted without knowledge of in-
dex test
No: if assessor of reference standard was
aware of results of index test
Unclear: insufficient information to make
a judgement.
9. Relevant clinical information Were the same clinical data available when
the index test results were interpreted as
would be available when the test is used in
practice?
Yes: clinical data (age, gender, symptoms,
type of stent) would ordinarily be available
in clinical practice when index test was be-
ing interpreted AND these same clinical
data were available in this study when in-
dex test was being interpreted
No: above clinical data were not available
when index test and reference standard
were interpreted
Unclear: insufficient information to make
a judgement.
10. Uninterpretable results reported Were uninterpretable/intermediate test re-
sults reported?
Yes: reported results for all study par-
ticipants, including those with uninter-
pretable, indeterminate, or intermediate re-
sults of index test and reference standard
No: uninterpretable, indeterminate, or in-
termediate results of index test or reference
standard were not reported OR results of
index test and reference standard were not
reported for all study participants
Unclear: insufficient information to make
a judgement.
11. Withdrawals explained Were withdrawals from the study ex-
plained?
Yes: clear what happened to all participants
who entered study, e.g. if a flow diagram
of study participants reported explaining
any withdrawals or exclusions, or numbers
recruited match those in analysis
No: appeared that some participants who
entered study did not complete study, i.e.
did not receive both index test and refer-
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Table 2. QUADAS methodological items and operational definitions (Continued)
ence standard, and these participants were
not accounted for
Unclear: insufficient information to make
a judgement.
CT: computed tomography.
Table 3. Distribution of the type of stent across the 21 included studies that reported the brand name
Type
of
stent
Ana-
conda
AneuRx
Tal-
ent
Medtronic
Ex-
cluder
An-
cure Van-
guard
En-
dovas-
cu-
lar
Tech-
nol-
ogy
Zenith
Ad-
vanta Pow-
er-
link
JomedMintecSten-
ford
En-
durantPow-
er-
link
Sten-
tor
Quan-
tum
Low
Pro-
file
Abu-
Rahma
2005
- 55 - 37 86 - - - - - - - - - - - - -
Ashoke
2005c
- 3 2 5 - - - - - - - - - - - - - -
Ar-
sicot
2014
30 2 - 8 - - - 28 - 2 - - - 1 - - - 4
Ashoke
2005b
- 3 - - - - - 13 - - - - - - - - - -
Badri
2010
- - 5 - - - - 54 - - - - - - - - - -
Can-
ti-
sani
2011
- - 55 50 - - - - - 12 6 - - - - - - -
d’Audiffret
2001
- 2 1 - - 56 11 - - - - 7 12 - - - - -
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Table 3. Distribution of the type of stent across the 21 included studies that reported the brand name (Continued)
Gargiulo
2014
- - - - - - - - - - - - - - - - - -
Gi-
an-
noni
2007
- - 3 24 - 3 - - - - - - - - - - - -
Iezzi
2009
- 1 46 28 - 1 - 8 - - - - - - - - - -
McLaf-
ferty
2002
- 79 - - - - - - - - - - - - - - - -
McWilliams
1999
- 3 - - - 14 - - - - - - - - - 1 - -
Motta
2012
- - 43 20 - - - 6 - - - - - 14 - - - -
Par-
ent
2002
- - - - 83 - - - - - - - - - - - - -
Ra-
man
2003
- 34 - - 247 - - - - - - - - - - - - -
Sato
1998
- - - - - - 79 - - - - - - - - - - -
Schmieder
2009
- 160 - 2 55 - - 13 - - - - - - 5 - 1 -
Ten
Bosch
2010
- - 83 - - - - - - - - - - - - - - -
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Table 3. Distribution of the type of stent across the 21 included studies that reported the brand name (Continued)
Thomp-
son
1998
- - - - - - 6 - - - - - - - - 3 - -
Wolf
2000
- 100 - - - - - - - - - - - - - - - -
Zan-
netti
2000
- 144 1 9 - - - - - - - - - - - - - -
Table 4. Diagnostic accuracy estimates for colour duplex ultrasound and contrast-enhanced colour duplex ultrasound
Imaging method Summary sensitiv-
ity
% (95% CI)
Summary
specificity
% (95% CI)
DOR
(95% CI)
LR+ (95% CI) LR- (95% CI)
Studies with accuracy estimates based on number of individual participants
CDUS (16 studies) 82 (66 to 91) 93 (87 to 96) 56 (19 to 164) 11.0 (6.0 to 20.0) 0.19 (0.100 to 0.39)
CE-CDUS (11
studies)
94 (85 to 98) 95 (90 to 98) 299 (95 to 935) 19.5 (9.1 to 41.7) 0.07 (0.03 to 0.16)
Subgroup analysis 1: diagnostic performance of studies that estimated accuracy before and after administration of contrast
(7 studies; analyses based on number of individual participants)
CDUS 67 (47 to 83) 94 (80 to 99) 35 (5 to 246) 12.0 (2.8 to 51.8) 0.34 (0.18 to 0.63)
CE-CDUS 97 (92 to 99) 95 (85 to 98) 531 (131 to 2147) 17.7 (6.0 to 51.6) 0.03 (0.01 to 0.09)
Subgroup analysis 2: diagnostic performance of CE-CDUS for type I and type III endoleaks
CE-CDUS (7 stud-
ies)
97 (81 to 99) 99 (96 to 100) 7073 (254 to 196,
804)
220.7 (25.9 to
1875.5)
0.031 (0.004 to 0.
22)
Studies with accuracy estimates based on scan performed
CDUS (18 studies) 72 (55 to 85) 95 (90 to 96) 37 (16 to 87) 11.1 (6.8 to 18.1) 0.29 (0.17 to 0.51)
CE-CDUS (8 stud-
ies)
91 (68 to 98) 89 (71 to 96) 77 (9 to 605) 8.2 (2.7 to 24.6) 0.11 (0.03 to 0.43)
Studies with accuracy estimates based on scan performed (excluding outliers McWilliams 2002 and Nagre 2011)
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Table 4. Diagnostic accuracy estimates for colour duplex ultrasound and contrast-enhanced colour duplex ultrasound (Con-
tinued)
CDUS (16 studies) 77 (64 to 87) 93 (89 to 96) 48 (21 to 110) 11.7 (6.8 to 20.0) 0.24 (0.14 to 0.41)
CE-CDUS (6 stud-
ies)
93 (84 to 97) 91 (70 to 98) 125 (23 to 689) 9.9 (2.7 to 36) 0.08 (0.03 to 0.19)
CDUS: colour duplex ultrasound; CE-CDUS: contrast-enhanced colour duplex ultrasound; CI: confidence interval; DOR: diagnostic
odds ratio; LR+: positive likelihood ratio; LR-: negative likelihood ratio; NE: not estimable.
Table 5. Covariate analyses for colour duplex ultrasound and contrast-enhance colour duplex ultrasound studies (based on
individual participants data)
CDUS studies (n = 16) CE-CDUS studies (n = 11)
Covariates Summary sensitiv-
ity
% (95% CI)
Summary
specificity
% (95% CI)
Covariates Summary sensitiv-
ity
% (95% CI)
Summary
specificity
% (95% CI)
Age Age
< 72 years (6 stud-
ies)
80 (50 to 95) 94 (89 to 97) < 72 years (4 stud-
ies)
96 (87 to 99) 96 (84 to 98)
≥ 72 years (10 stud-
ies)
86 (63 to 95) 90 (81 to 95) ≥ 72 years (7 stud-
ies)
88 (73 to 95) 94 (87 to 97)
P value 0.65 0.25 P value 0.07 0.76
Gender Gender
Men<95 (7 studies) 78 (64 to 88) 90 (82 to 94) Men < 95 (3 studies) NE NE
Men ≥ 95 (9 stud-
ies)
91 (59 to 99) 94 (85 to 98) Men ≥ 95 (8 stud-
ies)
92 (76 to 98) 93 (89 to 96)
P value 0.59 0.43 P value NE NE
Study design (direction) Study design (direction)
Prospective (7 stud-
ies)
68 (50 to 83) 92 (82 to 96) Prospective (7 stud-
ies)
95 (83 to 99) 94 (86 to 98)
Retrospective/
unclear (9 studies)
92 (73 to 98) 91 (84 to 96) Retrospective/
unclear (4 studies)
92 (74 to 98) 96 (90 to 99)
P value 0.09 0.99 P value 0.76 0.74
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Table 5. Covariate analyses for colour duplex ultrasound and contrast-enhance colour duplex ultrasound studies (based on
individual participants data) (Continued)
Publication year Publication year
Before 2006 (8 stud-
ies)
96 (87 to 99) 94 (84 to 98) Before 2006 (2 stud-
ies)
NE NE
After 2005 (8 stud-
ies)
58 (43 to 71) 90 (83 to 94) After 2005 (9 stud-
ies)
94 (82 to 98) 96 (89 to 99)
P value < 0.001 0.42 P value NE NE
Number of US operators Number of US operators
1 operator (4 stud-
ies)
71 (30 to 94) 91 (87 to 94) 1 operator (2 stud-
ies)
NE NE
> 1 operators (8
studies)
76 (60 to 87) 92 (83 to 97) > 1 operators (6
studies)
95 (82 to 99) 96 (84 to 99)
P value 1 1 P value NE NE
Country Country
Americas (4 studies) 99 (03 to 99) 91 (71 to 98) Americas (2 studies) NE NE
Europe (12 studies) 78 (61 to 89) 92 (87 to 96) Europe (9 studies) 92 (83 to 97) 97 (91 to 99)
P value 0.85 0.88 P value NE NE
Sample Sample
< 100 (5 studies) 88 (67 to 96) 90 (82 to 95) < 100 (8 studies) 96 (83 to 99) 94 (86 to 98)
> 100 (11 studies) 76 (46 to 92) 95 (90 to 98) > 100 (3 studies) NE NE
P value 0.42 0.19 P value NE NE
Quality Quality
High quality (4
studies)
53 (40 to 66) 88 (72 to 96) High quality (5
studies)
96 (88 to 99) 97 (78 to 99)
Low/unclear quality
(12 studies)
91 (77 to 97) 93 (87 to 96) Low/unclear quality
(6 studies)
90 (77 to 96) 93 (87 to 97)
P value < 0.001 0.36 P value 0.19 0.94
CDUS: colour duplex ultrasound; CE-CDUS: Contrast enhanced ultrasound; n: number of participants; NE: not estimable.
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A P P E N D I C E S
Appendix 1. MEDLINE search strategy
Database: Ovid MEDLINE(R) <1946 to June Week 4 2016>
Search Strategy:
--------------------------------------------------------------------------------
1 exp Aortic Aneurysm/ (46359)
2 Aorta, Abdominal/su [Surgery] (6353)
3 (abdom* adj3 aneurysm?).tw,kf. (15464)
4 (aort* adj3 aneurysm?).tw,kf. (28288)
5 (abdom* adj3 aort*).tw,kf. (27434)
6 (aort* adj3 morphol*).tw,kf. (688)
7 (EVAR or TEVAR or EVRAR).tw,kf. (2885)
8 AAA*.tw,kf. (11472)
9 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 (69611)
10 Blood Vessel Prosthesis/ (25694)
11 Blood Vessel Prosthesis Implantation/ (18366)
12 Endovascular Procedures/ (9182)
13 endovascular.tw,kf. (29367)
14 endoluminal*.tw,kf. (3584)
15 endoprosthe*.tw,kf. (5932)
16 exp stents/ (61420)
17 stent*.tw,kf. (68589)
18 graft*.tw,kf. (253134)
19 endograft*.tw,kf. (2351)
20 prosthe*.tw,kf. (99022)
21 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 (439973)
22 (aort* or abdominal).tw,kf. (419347)
23 21 and 22 (52737)
24 9 or 23 (100506)
25 postoperative complications/ or anastomotic leak/ or prosthesis failure/ (333258)
26 (endoleak* or endotension).tw,kf. (3100)
27 perigraft leak*.tw,kf. (59)
28 perigraft flow.tw,kf. (21)
29 follow-up.tw,kf. (659655)
30 surveillance.tw,kf. (114489)
31 postoperative.tw,kf. (334207)
32 outcome.tw,kf. (658736)
33 evaluat*.tw,kf. (2336505)
34 effecti*.tw,kf. (1269598)
35 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 (4461903)
36 us.fs. (222575)
37 ultrasonics/ (22680)
38 ultrasonography/ (64866)
39 ultrasonography, Doppler/ (12929)
40 ultrasonography, Doppler, color/ (12269)
41 ultrasonography, Doppler, duplex/ (5659)
42 ultrasonography, Doppler, pulsed/ (1323)
43 ultrasound.tw,kf. (161980)
44 ultrasonic imaging.tw,kf. (810)
45 ultrasonogra*.tw,kf. (81040)
46 echograph*.tw,kf. (8722)
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47 (USS or DUS or CDUS or CEUS).tw,kf. (2865)
48 (doppler or duplex).tw,kf. (107732)
49 sonograph*.tw,kf. (44251)
50 sonogram*.tw,kf. (3324)
51 (contrast adj4 US).tw,kf. (1441)
52 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 (454360)
53 24 and 35 and 52 (5902)
Appendix 2. Embase search strategy
Database: Embase <1980 to 2016 Week 26>
Search Strategy:
--------------------------------------------------------------------------------
1 exp aorta aneurysm/ (47427)
2 abdominal aorta/su [Surgery] (2043)
3 exp aorta surgery/ (29048)
4 (abdom* adj3 aneurysm?).tw,kw. (20433)
5 (aort* adj3 aneurysm?).tw,kw. (36443)
6 (aort* adj3 endograft*).tw,kw. (915)
7 (aneurysm? adj3 repair).tw,kw. (9318)
8 (aort* adj3 morphol*).tw,kw. (1084)
9 (abdom* adj3 aort*).tw,kw. (35653)
10 (EVAR or TEVAR or EVRAR).tw,kw. (5136)
11 AAA*.tw,kw. (16173)
12 or/1-11 (96271)
13 exp blood vessel prosthesis/ (14328)
14 exp blood vessel transplantation/ (93394)
15 endovascular surgery/ (18987)
16 endovascular.tw,kw. (49927)
17 endoluminal*.tw,kw. (5226)
18 endoprosthe*.tw,kw. (7086)
19 endograft*.tw,kw. (3479)
20 stents/ (70924)
21 (stent* or graft*).tw,kw. (449027)
22 prosthe*.tw,kw. (119669)
23 or/13-22 (636877)
24 (aort* or abdominal).tw,kw. (580126)
25 23 and 24 (76044)
26 12 or 25 (141573)
27 Postoperative Complications/ (54233)
28 prosthesis failure/ or endoleak/ (20256)
29 (endoleak* or endotension).tw,kw. (4757)
30 perigraft leak*.tw,kw. (71)
31 perigraft flow.tw,kw. (24)
32 follow-up.tw,kw. (1048410)
33 surveillance.tw,kw. (167616)
34 postoperative.tw,kw. (453187)
35 outcome.tw,kw. (1019612)
36 evaluat*.tw,kw. (3446507)
37 effecti*.tw,kw. (1807515)
38 or/27-37 (6263385)
39 ultrasound/ (129176)
40 echography/ or doppler echography/ (283071)
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41 ultrasound.tw,kw. (271703)
42 ultrasonic imaging.tw,kw. (1112)
43 ultrasonogra*.tw,kw. (124686)
44 echograph*.tw,kw. (11056)
45 (USS or DUS or CDUS or CEUS).tw,kw. (6070)
46 (doppler or duplex).tw,kw. (157018)
47 sonograph*.tw,kw. (62821)
48 sonogram*.tw,kw. (4204)
49 (contrast adj4 US).tw,kw. (2217)
50 or/39-49 (645379)
51 26 and 38 and 50 (7359)
Appendix 3. LILACS search strategy
Database : LILACS
Search on : endoleak [Subject descriptor] or endoleak [Words] or perigraft [Words]
Total of references : 44
http://bases.bireme.br/cgi-bin/wxislind.exe/iah/online/
Appendix 4. ISI Conference Proceedings Citation Index search
# 31 451 #30 AND #23 AND #16
Indexes=CPCI-S Timespan=1950-2016
# 30 540,587 #29 OR #28 OR #27 OR #26 OR #25 OR #24
# 29 2,623 TS=(contrast NEAR/4 US)
# 28 57,226 TS=(sonograph* or sonogram*)
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(Continued)
# 27 203,502 TS=(doppler or duplex)
# 26 4,337 TS=(USS or DUS or CDUS or CEUS)
# 25 5,344 TS=echograph*
# 24 343,215 TS=(ultrasound or ultrasonic)
# 23 3,564,463 #22 OR #21 OR #20 OR #19 OR #18 OR #17
# 22 1,583,294 TS=evaluation
# 21 1,682,133 TS=(surveillance or postoperative or outcome)
# 20 761,871 TS=follow-up
# 19 53 TS=perigraft flow
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(Continued)
# 18 111 TS=perigraft leak*
# 17 3,473 TS=(endoleak* or endotension)
# 16 79,264 #15 OR #7
# 15 46,235 #14 AND #13
# 14 406,141 TS=(aort* or abdominal)
# 13 519,126 #12 OR #11 OR #10 OR #9 OR #8
# 12 96,378 TS=prosthe*
# 11 408,581 TS=(stent* or graft*)
# 10 8,742 TS=(endoprosthe* or endograft*)
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(Continued)
# 9 4,381 TS=endoluminal
# 8 38,274 TS=endovascular
# 7 45,797 #6 OR #5 OR #4 OR #3 OR #2 OR #1
# 6 16,206 TS=AAA*
# 5 3,631 TS=(EVAR or TEVAR or EVRAR)
# 4 28,911 TS=(abdom* NEAR/3 aort*)
# 3 1,004 TS=(aort* NEAR/3 endograft*)
# 2 13,331 TS=(aort* NEAR/3 aneurysm?)
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(Continued)
# 1 7,773 TS=(abdom* NEAR/3 aneurysm?)
Appendix 5. Zetoc search
29 for: any: endoleak
Appendix 6. Trials registries
Clinicaltrials.gov
10 studies found for: endoleak and ultrasound
WHO
4 records for 4 trials found for: endoleak and ultrasound
ISRCTN
0 results for endoleak
Appendix 7. Study distribution based on the type of ultrasound and the unit of analysis used
Study ID Type of ultrasound Unit of analysis
number of individuals
Unit of analysis
number of scans
Abbas 2014 CE-CDUS -
AbuRahma 2005 CDUS -
Arsicot 2014 CDUS
Ashoke 2005b CDUS -
Ashoke 2005c CDUS -
Badri 2010 CDUS -
Bendick 2003 CDUS/CE-CDUS -
Cantisani 2011 CDUS/CE-CDUS -
Clevert 2008b CDUS/CE-CDUS -
Clevert 2011 CDUS/CE-CDUS -
Costa 2013 CDUS/CE-CDUS -
d’Audiffret 2001 CDUS
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(Continued)
Demirpolat 2011 CDUS -
França 2013 CDUS -
Gargiulo 2014 CE-CDUS
Giannoni 2003 CDUS/CE-CDUS -
Giannoni 2007 CE-CDUS -
Golzarian 2002 CDUS -
Gray 2012 CDUS -
Gurtler 2013 CE-CDUS -
Heilberger 1997 CDUS/CE-CDUS -
Henao 2006 CDUS/CE-CDUS -
Iezzi 2009 CDUS/CE-CDUS -
McLafferty 2002 CDUS -
McWilliams 1999 CDUS/CE-CDUS -
McWilliams 2002 CDUS/CE-CDUS -
Motta 2012 CE-CDUS -
Nagre 2011 CDUS -
Nerlekar 2006 CDUS -
Oikonomou 2012 CDUS -
Pages 2001 CDUS -
Parent 2002 CDUS -
Perini 2011 CE-CDUS -
Perini 2012 CE-CDUS -
Raman 2003 CDUS -
Sandford 2006 CDUS -
Sato 1998 CDUS -
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(Continued)
Schmieder 2009 CDUS -
Ten Bosch 2010 CE-CDUS -
Thompson 1998 CDUS -
Wolf 2000 CDUS -
Zannetti 2000 CDUS -
CDUS: colour duplex ultrasound; CE-CDUS: contrast-enhanced colour duplex ultrasound
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The current unit of analysis was not specified in the protocol (Abraha 2013).
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